<?properties open_access?>
<?DTDIdentifier.IdentifierValue -//Springer-Verlag//DTD A++ V2.4//EN?>
<?DTDIdentifier.IdentifierType public?>
<?SourceDTD.DTDName A++V2.4.dtd?>
<?SourceDTD.Version 2.4?>
<?ConverterInfo.XSLTName springer2nlmx2.xsl?>
<?ConverterInfo.Version 1?>
<processing-meta base-tagset="archiving" mathml-version="3.0" table-model="xhtml" tagset-family="jats">
  <restricted-by>pmc</restricted-by>
</processing-meta>
<front>
  <journal-meta>
    <journal-id journal-id-type="nlm-ta">BMC Bioinformatics</journal-id>
    <journal-id journal-id-type="iso-abbrev">BMC Bioinformatics</journal-id>
    <journal-title-group>
      <journal-title>BMC Bioinformatics</journal-title>
    </journal-title-group>
    <issn pub-type="epub">1471-2105</issn>
    <publisher>
      <publisher-name>BioMed Central</publisher-name>
      <publisher-loc>London</publisher-loc>
    </publisher>
  </journal-meta>
  <article-meta>
    <article-id pub-id-type="pmcid">8728953</article-id>
    <article-id pub-id-type="publisher-id">4522</article-id>
    <article-id pub-id-type="doi">10.1186/s12859-021-04522-9</article-id>
    <article-categories>
      <subj-group subj-group-type="heading">
        <subject>Research</subject>
      </subj-group>
    </article-categories>
    <title-group>
      <article-title>M2PP: a novel computational model for predicting drug-targeted pathogenic proteins</article-title>
    </title-group>
    <contrib-group>
      <contrib contrib-type="author">
        <name>
          <surname>Wang</surname>
          <given-names>Shiming</given-names>
        </name>
        <xref ref-type="aff" rid="Aff1"/>
      </contrib>
      <contrib contrib-type="author" corresp="yes">
        <name>
          <surname>Li</surname>
          <given-names>Jie</given-names>
        </name>
        <address>
          <email>jieli@hit.edu.cn</email>
        </address>
        <xref ref-type="aff" rid="Aff1"/>
      </contrib>
      <contrib contrib-type="author" corresp="yes">
        <name>
          <surname>Wang</surname>
          <given-names>Yadong</given-names>
        </name>
        <address>
          <email>ydwang@hit.edu.cn</email>
        </address>
        <xref ref-type="aff" rid="Aff1"/>
      </contrib>
      <aff id="Aff1"><institution-wrap><institution-id institution-id-type="GRID">grid.19373.3f</institution-id><institution-id institution-id-type="ISNI">0000 0001 0193 3564</institution-id><institution>School of Computer Science and Technology, </institution><institution>Harbin Institute of Technology, </institution></institution-wrap>Harbin, Heilongjiang 150001 China </aff>
    </contrib-group>
    <pub-date pub-type="epub">
      <day>4</day>
      <month>1</month>
      <year>2022</year>
    </pub-date>
    <pub-date pub-type="pmc-release">
      <day>4</day>
      <month>1</month>
      <year>2022</year>
    </pub-date>
    <pub-date pub-type="collection">
      <year>2022</year>
    </pub-date>
    <volume>23</volume>
    <elocation-id>7</elocation-id>
    <history>
      <date date-type="received">
        <day>15</day>
        <month>6</month>
        <year>2021</year>
      </date>
      <date date-type="accepted">
        <day>7</day>
        <month>12</month>
        <year>2021</year>
      </date>
    </history>
    <permissions>
      <copyright-statement>© The Author(s) 2021</copyright-statement>
      <license>
        <ali:license_ref specific-use="textmining" content-type="ccbylicense">https://creativecommons.org/licenses/by/4.0/</ali:license_ref>
        <license-p><bold>Open Access</bold>This article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if changes were made. The images or other third party material in this article are included in the article's Creative Commons licence, unless indicated otherwise in a credit line to the material. If material is not included in the article's Creative Commons licence and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this licence, visit <ext-link ext-link-type="uri" xlink:href="https://creativecommons.org/licenses/by/4.0/">http://creativecommons.org/licenses/by/4.0/</ext-link>. The Creative Commons Public Domain Dedication waiver (<ext-link ext-link-type="uri" xlink:href="https://creativecommons.org/publicdomain/zero/1.0/">http://creativecommons.org/publicdomain/zero/1.0/</ext-link>) applies to the data made available in this article, unless otherwise stated in a credit line to the data.</license-p>
      </license>
    </permissions>
    <abstract id="Abs1">
      <sec>
        <title>Background</title>
        <p id="Par1">Detecting pathogenic proteins is the origin way to understand the mechanism and resist the invasion of diseases, making pathogenic protein prediction develop into an urgent problem to be solved. Prediction for genome-wide proteins may be not necessarily conducive to rapidly cure diseases as developing new drugs specifically for the predicted pathogenic protein always need major expenditures on time and cost. In order to facilitate disease treatment, computational method to predict pathogenic proteins which are targeted by existing drugs should be exploited.</p>
      </sec>
      <sec>
        <title>Results</title>
        <p id="Par2">In this study, we proposed a novel computational model to predict drug-targeted pathogenic proteins, named as M2PP. Three types of features were presented on our constructed heterogeneous network (including target proteins, diseases and drugs), which were based on the neighborhood similarity information, drug-inferred information and path information. Then, a random forest regression model was trained to score unconfirmed target-disease pairs. Five-fold cross-validation experiment was implemented to evaluate model’s prediction performance, where M2PP achieved advantageous results compared with other state-of-the-art methods. In addition, M2PP accurately predicted high ranked pathogenic proteins for common diseases with public biomedical literature as supporting evidence, indicating its excellent ability.</p>
      </sec>
      <sec>
        <title>Conclusions</title>
        <p id="Par3">M2PP is an effective and accurate model to predict drug-targeted pathogenic proteins, which could provide convenience for the future biological researches.</p>
      </sec>
    </abstract>
    <kwd-group xml:lang="en">
      <title>Keywords</title>
      <kwd>Disease</kwd>
      <kwd>Pathogenic proteins</kwd>
      <kwd>Target</kwd>
      <kwd>Prediction</kwd>
    </kwd-group>
    <funding-group>
      <award-group>
        <funding-source>
          <institution>the National Key Research and Development Program of China</institution>
        </funding-source>
        <award-id>2016YFC0901905</award-id>
        <award-id>2016YFC0901905</award-id>
        <award-id>2016YFC0901905</award-id>
        <principal-award-recipient>
          <name>
            <surname>Wang</surname>
            <given-names>Shiming</given-names>
          </name>
          <name>
            <surname>Li</surname>
            <given-names>Jie</given-names>
          </name>
          <name>
            <surname>Wang</surname>
            <given-names>Yadong</given-names>
          </name>
        </principal-award-recipient>
      </award-group>
    </funding-group>
    <custom-meta-group>
      <custom-meta>
        <meta-name>issue-copyright-statement</meta-name>
        <meta-value>© The Author(s) 2022</meta-value>
      </custom-meta>
    </custom-meta-group>
  </article-meta>
</front>
<body>
  <sec id="Sec1">
    <title>Background</title>
    <p id="Par13">Overcoming diseases is the eternal goal of human beings, and the current treatment strategies mainly depend on drugs, aiming to act on the target genes or proteins to alleviate the symptoms or even prevent the attack of the disease [<xref ref-type="bibr" rid="CR1">1</xref>]. In the drug-target-disease mechanism, identifying the disease-caused protein is a crucial and fundamental problem, also becomes challenge at the same time [<xref ref-type="bibr" rid="CR2">2</xref>]. Currently, computational methods to predict pathogenic targets have been widely applied because of their high efficiency and low consumption prior to in vitro or in vivo biological experimental methods [<xref ref-type="bibr" rid="CR3">3</xref>]. During the past decades, various prediction methods have been presented with different performances.</p>
    <p id="Par14">Earlier researches mainly focused on the protein–protein interaction (PPI) network, whose topological structure was directly used to predict disease-gene associations [<xref ref-type="bibr" rid="CR4">4</xref>, <xref ref-type="bibr" rid="CR5">5</xref>]. However, the large number of false positives in the PPI network from public databases made these methods difficult to acquire higher prediction accuracy. Hence, the disease-related clinical data was added into later studies, which were based on GWAS [<xref ref-type="bibr" rid="CR6">6</xref>–<xref ref-type="bibr" rid="CR8">8</xref>] and gene expression [<xref ref-type="bibr" rid="CR9">9</xref>–<xref ref-type="bibr" rid="CR13">13</xref>], respectively. Although these methods obtained more accurate prediction than methods which applied PPI network alone, limitations still existed. For example, even the comprehensive platform TCGA [<xref ref-type="bibr" rid="CR14">14</xref>] could only provide limited available data about uncommon cancers, let alone other non-cancer diseases, which greatly restricted the performance of these methods. Difficult to break limitations on the data source, researchers have begun to conduct in-depth research on algorithms, where the most widely used were about machine learning. Model GCN-MF combined the graph convolutional network with matrix factorization for disease-gene association identification [<xref ref-type="bibr" rid="CR15">15</xref>]. Natarajan et al. derived features of diseases and genes for the inductive matrix completion [<xref ref-type="bibr" rid="CR16">16</xref>]. Method CATAPULT was proposed by training a biased support vector machine model with features derived from a heterogeneous network [<xref ref-type="bibr" rid="CR17">17</xref>]. Zeng et al. considered this problem as the recommender system, presenting a probability-based collaborative filtering model to predict pathogenic human genes [<xref ref-type="bibr" rid="CR18">18</xref>]. Luo et al. developed a method to predict disease–gene associations with multimodal deep learning [<xref ref-type="bibr" rid="CR19">19</xref>]. Although these efforts on algorithm development made prediction results improved, most methods still extracted valid information only from gene data and disease data. Actually, utilizing other information besides gene and disease to solve the prediction problem is essential and urgent in such intricate biological networks.</p>
    <p id="Par15">The ultimate objective of predicting pathogenic genes or proteins is to find a breakthrough for disease treatment. If predicting on the whole gene (protein) set, even though a novel gene-disease (protein-disease) association is successfully predicted, it will still be a long process to treat the disease specifically for this gene (protein). The reason comes from many aspects, for example, the research and development for new drugs usually take a long time. Actually, reducing the scope of the whole protein set to drug-targeted protein set will be more conducive for the disease treatment in clinical research, because for a novel predicted protein-disease association, the drugs which target this protein can be regarded as a candidate collection for the disease treatment instead of developing new drugs. Hence, we proposed a method to predict drug-targeted pathogenic proteins, named as M2PP. First, the target, disease and drug set were collected to construct association networks and similarity networks. Then, features were constructed for each target-disease pair based on the neighborhood similarity information, drug-inferred information and path information, respectively. Finally, a random forest regression model was trained to score unconfirmed target-disease pairs.</p>
  </sec>
  <sec id="Sec2">
    <title>Method</title>
    <sec id="Sec3">
      <title>Data collection</title>
      <p id="Par16">We collected the drug-targeted single human target proteins from DrugBank [<xref ref-type="bibr" rid="CR20">20</xref>], where the drugs were approved by the Food and Drug Administration (FDA) [<xref ref-type="bibr" rid="CR21">21</xref>]. For these targets, we extracted diseases which had curated associations with them from the Comparative Toxicogenomics Database (CTD) [<xref ref-type="bibr" rid="CR22">22</xref>]. Then, three sets (a target set, a disease set and a drug set) were constructed. Next, we reduced these sets to make sure that any element in one set had association with both the other two sets (all associations were from DrugBank and CTD). Finally, we obtained 1002 targets, 1035 diseases and 1095 drugs (Fig. <xref rid="Fig1" ref-type="fig">1</xref>a)). The target set, disease set and drug set were represented as <inline-formula id="IEq1"><alternatives><tex-math id="M1">\documentclass[12pt]{minimal}
				\usepackage{amsmath}
				\usepackage{wasysym} 
				\usepackage{amsfonts} 
				\usepackage{amssymb} 
				\usepackage{amsbsy}
				\usepackage{mathrsfs}
				\usepackage{upgreek}
				\setlength{\oddsidemargin}{-69pt}
				\begin{document}$$T = \left\{ {t_{1} ,t_{2} , \ldots ,t_{nT} } \right\}.$$\end{document}</tex-math><mml:math id="M2"><mml:mrow><mml:mi>T</mml:mi><mml:mo>=</mml:mo><mml:mfenced close="}" open="{"><mml:mrow><mml:msub><mml:mi>t</mml:mi><mml:mn>1</mml:mn></mml:msub><mml:mo>,</mml:mo><mml:msub><mml:mi>t</mml:mi><mml:mn>2</mml:mn></mml:msub><mml:mo>,</mml:mo><mml:mo>…</mml:mo><mml:mo>,</mml:mo><mml:msub><mml:mi>t</mml:mi><mml:mrow><mml:mi mathvariant="italic">nT</mml:mi></mml:mrow></mml:msub></mml:mrow></mml:mfenced><mml:mo>.</mml:mo></mml:mrow></mml:math><inline-graphic xlink:href="12859_2021_4522_Article_IEq1.gif"/></alternatives></inline-formula><inline-formula id="IEq2"><alternatives><tex-math id="M3">\documentclass[12pt]{minimal}
				\usepackage{amsmath}
				\usepackage{wasysym} 
				\usepackage{amsfonts} 
				\usepackage{amssymb} 
				\usepackage{amsbsy}
				\usepackage{mathrsfs}
				\usepackage{upgreek}
				\setlength{\oddsidemargin}{-69pt}
				\begin{document}$${\text{ D}} = \left\{ {{\text{d}}_{1} ,{\text{d}}_{2} , \ldots ,{\text{d}}_{{{\text{nD}}}} } \right\}$$\end{document}</tex-math><mml:math id="M4"><mml:mrow><mml:mrow><mml:mspace width="0.333333em"/><mml:mtext>D</mml:mtext></mml:mrow><mml:mo>=</mml:mo><mml:mfenced close="}" open="{"><mml:mrow><mml:msub><mml:mtext>d</mml:mtext><mml:mn>1</mml:mn></mml:msub><mml:mo>,</mml:mo><mml:msub><mml:mtext>d</mml:mtext><mml:mn>2</mml:mn></mml:msub><mml:mo>,</mml:mo><mml:mo>…</mml:mo><mml:mo>,</mml:mo><mml:msub><mml:mtext>d</mml:mtext><mml:mtext>nD</mml:mtext></mml:msub></mml:mrow></mml:mfenced></mml:mrow></mml:math><inline-graphic xlink:href="12859_2021_4522_Article_IEq2.gif"/></alternatives></inline-formula> and <inline-formula id="IEq3"><alternatives><tex-math id="M5">\documentclass[12pt]{minimal}
				\usepackage{amsmath}
				\usepackage{wasysym} 
				\usepackage{amsfonts} 
				\usepackage{amssymb} 
				\usepackage{amsbsy}
				\usepackage{mathrsfs}
				\usepackage{upgreek}
				\setlength{\oddsidemargin}{-69pt}
				\begin{document}$${\text{ M}} = \left\{ {{\text{m}}_{1} ,{\text{m}}_{2} , \ldots ,{\text{m}}_{{{\text{nM}}}} } \right\}$$\end{document}</tex-math><mml:math id="M6"><mml:mrow><mml:mrow><mml:mspace width="0.333333em"/><mml:mtext>M</mml:mtext></mml:mrow><mml:mo>=</mml:mo><mml:mfenced close="}" open="{"><mml:mrow><mml:msub><mml:mtext>m</mml:mtext><mml:mn>1</mml:mn></mml:msub><mml:mo>,</mml:mo><mml:msub><mml:mtext>m</mml:mtext><mml:mn>2</mml:mn></mml:msub><mml:mo>,</mml:mo><mml:mo>…</mml:mo><mml:mo>,</mml:mo><mml:msub><mml:mtext>m</mml:mtext><mml:mtext>nM</mml:mtext></mml:msub></mml:mrow></mml:mfenced></mml:mrow></mml:math><inline-graphic xlink:href="12859_2021_4522_Article_IEq3.gif"/></alternatives></inline-formula>, respectively.<fig id="Fig1"><label>Fig. 1</label><caption><p>The framework of M2PP. <bold>a</bold> Construct the target set, disease set and drug set; <bold>b</bold> Construct heterogeneous networks: the target-disease association network, target-drug interaction network, disease-drug association network, disease-disease similarity network, target-target similarity network and drug-drug topological structure similarity network; <bold>c</bold> Construct features for target-disease pairs; <bold>d</bold> Train the random forest model and predict association scores for unconfirmed target-disease pairs</p></caption><graphic xlink:href="12859_2021_4522_Fig1_HTML" id="MO1"/></fig></p>
    </sec>
    <sec id="Sec4">
      <title>Network construction</title>
      <p id="Par17">First, we constructed three association networks among the target, disease and drug set: (1) the target-disease association network, including 7342 curated associations from CTD, whose adjacency matrix was represented as <inline-formula id="IEq4"><alternatives><tex-math id="M7">\documentclass[12pt]{minimal}
				\usepackage{amsmath}
				\usepackage{wasysym} 
				\usepackage{amsfonts} 
				\usepackage{amssymb} 
				\usepackage{amsbsy}
				\usepackage{mathrsfs}
				\usepackage{upgreek}
				\setlength{\oddsidemargin}{-69pt}
				\begin{document}$${\text{TDA}}^{{{\text{nT}} \times {\text{nD}}}}$$\end{document}</tex-math><mml:math id="M8"><mml:msup><mml:mrow><mml:mtext>TDA</mml:mtext></mml:mrow><mml:mrow><mml:mtext>nT</mml:mtext><mml:mo>×</mml:mo><mml:mtext>nD</mml:mtext></mml:mrow></mml:msup></mml:math><inline-graphic xlink:href="12859_2021_4522_Article_IEq4.gif"/></alternatives></inline-formula>; (2) the target-drug interaction network, including 38,871 curated interactions from DrugBank and CTD, representing its adjacency matrix as <inline-formula id="IEq5"><alternatives><tex-math id="M9">\documentclass[12pt]{minimal}
				\usepackage{amsmath}
				\usepackage{wasysym} 
				\usepackage{amsfonts} 
				\usepackage{amssymb} 
				\usepackage{amsbsy}
				\usepackage{mathrsfs}
				\usepackage{upgreek}
				\setlength{\oddsidemargin}{-69pt}
				\begin{document}$${\text{TDI}}^{{{\text{nT}} \times {\text{nM}}}}$$\end{document}</tex-math><mml:math id="M10"><mml:msup><mml:mrow><mml:mtext>TDI</mml:mtext></mml:mrow><mml:mrow><mml:mtext>nT</mml:mtext><mml:mo>×</mml:mo><mml:mtext>nM</mml:mtext></mml:mrow></mml:msup></mml:math><inline-graphic xlink:href="12859_2021_4522_Article_IEq5.gif"/></alternatives></inline-formula>; (3) the disease-drug association network, including 35,319 curated associations from CTD, with adjacency matrix of <inline-formula id="IEq6"><alternatives><tex-math id="M11">\documentclass[12pt]{minimal}
				\usepackage{amsmath}
				\usepackage{wasysym} 
				\usepackage{amsfonts} 
				\usepackage{amssymb} 
				\usepackage{amsbsy}
				\usepackage{mathrsfs}
				\usepackage{upgreek}
				\setlength{\oddsidemargin}{-69pt}
				\begin{document}$${\text{DDA}}^{{{\text{nD}} \times {\text{nM}}}}$$\end{document}</tex-math><mml:math id="M12"><mml:msup><mml:mrow><mml:mtext>DDA</mml:mtext></mml:mrow><mml:mrow><mml:mtext>nD</mml:mtext><mml:mo>×</mml:mo><mml:mtext>nM</mml:mtext></mml:mrow></mml:msup></mml:math><inline-graphic xlink:href="12859_2021_4522_Article_IEq6.gif"/></alternatives></inline-formula>. For target <inline-formula id="IEq7"><alternatives><tex-math id="M13">\documentclass[12pt]{minimal}
				\usepackage{amsmath}
				\usepackage{wasysym} 
				\usepackage{amsfonts} 
				\usepackage{amssymb} 
				\usepackage{amsbsy}
				\usepackage{mathrsfs}
				\usepackage{upgreek}
				\setlength{\oddsidemargin}{-69pt}
				\begin{document}$${\text{ t}}_{{\text{i}}}$$\end{document}</tex-math><mml:math id="M14"><mml:msub><mml:mrow><mml:mspace width="0.333333em"/><mml:mtext>t</mml:mtext></mml:mrow><mml:mtext>i</mml:mtext></mml:msub></mml:math><inline-graphic xlink:href="12859_2021_4522_Article_IEq7.gif"/></alternatives></inline-formula>
<inline-formula id="IEq8"><alternatives><tex-math id="M15">\documentclass[12pt]{minimal}
				\usepackage{amsmath}
				\usepackage{wasysym} 
				\usepackage{amsfonts} 
				\usepackage{amssymb} 
				\usepackage{amsbsy}
				\usepackage{mathrsfs}
				\usepackage{upgreek}
				\setlength{\oddsidemargin}{-69pt}
				\begin{document}$$\left( {1 \le {\text{i}} \le {\text{nT}}} \right)$$\end{document}</tex-math><mml:math id="M16"><mml:mfenced close=")" open="("><mml:mrow><mml:mn>1</mml:mn><mml:mo>≤</mml:mo><mml:mtext>i</mml:mtext><mml:mo>≤</mml:mo><mml:mtext>nT</mml:mtext></mml:mrow></mml:mfenced></mml:math><inline-graphic xlink:href="12859_2021_4522_Article_IEq8.gif"/></alternatives></inline-formula> and disease <inline-formula id="IEq9"><alternatives><tex-math id="M17">\documentclass[12pt]{minimal}
				\usepackage{amsmath}
				\usepackage{wasysym} 
				\usepackage{amsfonts} 
				\usepackage{amssymb} 
				\usepackage{amsbsy}
				\usepackage{mathrsfs}
				\usepackage{upgreek}
				\setlength{\oddsidemargin}{-69pt}
				\begin{document}$${\text{d}}_{{\text{j}}}$$\end{document}</tex-math><mml:math id="M18"><mml:msub><mml:mtext>d</mml:mtext><mml:mtext>j</mml:mtext></mml:msub></mml:math><inline-graphic xlink:href="12859_2021_4522_Article_IEq9.gif"/></alternatives></inline-formula>
<inline-formula id="IEq10"><alternatives><tex-math id="M19">\documentclass[12pt]{minimal}
				\usepackage{amsmath}
				\usepackage{wasysym} 
				\usepackage{amsfonts} 
				\usepackage{amssymb} 
				\usepackage{amsbsy}
				\usepackage{mathrsfs}
				\usepackage{upgreek}
				\setlength{\oddsidemargin}{-69pt}
				\begin{document}$$\left( {1 \le {\text{j}} \le {\text{nD}}} \right)$$\end{document}</tex-math><mml:math id="M20"><mml:mfenced close=")" open="("><mml:mrow><mml:mn>1</mml:mn><mml:mo>≤</mml:mo><mml:mtext>j</mml:mtext><mml:mo>≤</mml:mo><mml:mtext>nD</mml:mtext></mml:mrow></mml:mfenced></mml:math><inline-graphic xlink:href="12859_2021_4522_Article_IEq10.gif"/></alternatives></inline-formula>, if the known association between them was existed,<inline-formula id="IEq11"><alternatives><tex-math id="M21">\documentclass[12pt]{minimal}
				\usepackage{amsmath}
				\usepackage{wasysym} 
				\usepackage{amsfonts} 
				\usepackage{amssymb} 
				\usepackage{amsbsy}
				\usepackage{mathrsfs}
				\usepackage{upgreek}
				\setlength{\oddsidemargin}{-69pt}
				\begin{document}$${\text{ TDA}}_{{{\text{i}},{\text{j}}}} = 1$$\end{document}</tex-math><mml:math id="M22"><mml:mrow><mml:msub><mml:mrow><mml:mspace width="0.333333em"/><mml:mtext>TDA</mml:mtext></mml:mrow><mml:mrow><mml:mtext>i</mml:mtext><mml:mo>,</mml:mo><mml:mtext>j</mml:mtext></mml:mrow></mml:msub><mml:mo>=</mml:mo><mml:mn>1</mml:mn></mml:mrow></mml:math><inline-graphic xlink:href="12859_2021_4522_Article_IEq11.gif"/></alternatives></inline-formula>; otherwise,<inline-formula id="IEq12"><alternatives><tex-math id="M23">\documentclass[12pt]{minimal}
				\usepackage{amsmath}
				\usepackage{wasysym} 
				\usepackage{amsfonts} 
				\usepackage{amssymb} 
				\usepackage{amsbsy}
				\usepackage{mathrsfs}
				\usepackage{upgreek}
				\setlength{\oddsidemargin}{-69pt}
				\begin{document}$${\text{ TDA}}_{{{\text{i}},{\text{j}}}} = 0$$\end{document}</tex-math><mml:math id="M24"><mml:mrow><mml:msub><mml:mrow><mml:mspace width="0.333333em"/><mml:mtext>TDA</mml:mtext></mml:mrow><mml:mrow><mml:mtext>i</mml:mtext><mml:mo>,</mml:mo><mml:mtext>j</mml:mtext></mml:mrow></mml:msub><mml:mo>=</mml:mo><mml:mn>0</mml:mn></mml:mrow></mml:math><inline-graphic xlink:href="12859_2021_4522_Article_IEq12.gif"/></alternatives></inline-formula>. Analogously did <inline-formula id="IEq13"><alternatives><tex-math id="M25">\documentclass[12pt]{minimal}
				\usepackage{amsmath}
				\usepackage{wasysym} 
				\usepackage{amsfonts} 
				\usepackage{amssymb} 
				\usepackage{amsbsy}
				\usepackage{mathrsfs}
				\usepackage{upgreek}
				\setlength{\oddsidemargin}{-69pt}
				\begin{document}$${\text{ TDI }}$$\end{document}</tex-math><mml:math id="M26"><mml:mrow><mml:mspace width="0.333333em"/><mml:mtext>TDI</mml:mtext><mml:mspace width="0.333333em"/></mml:mrow></mml:math><inline-graphic xlink:href="12859_2021_4522_Article_IEq13.gif"/></alternatives></inline-formula> and <inline-formula id="IEq14"><alternatives><tex-math id="M27">\documentclass[12pt]{minimal}
				\usepackage{amsmath}
				\usepackage{wasysym} 
				\usepackage{amsfonts} 
				\usepackage{amssymb} 
				\usepackage{amsbsy}
				\usepackage{mathrsfs}
				\usepackage{upgreek}
				\setlength{\oddsidemargin}{-69pt}
				\begin{document}$${\text{ DDA}}$$\end{document}</tex-math><mml:math id="M28"><mml:mrow><mml:mspace width="0.333333em"/><mml:mtext>DDA</mml:mtext></mml:mrow></mml:math><inline-graphic xlink:href="12859_2021_4522_Article_IEq14.gif"/></alternatives></inline-formula>.</p>
      <p id="Par18">Then, we constructed the similarity networks:</p>
      <p id="Par19">(1) The disease-disease similarity network. We calculated the disease semantic similarities based on the Medical Subject Headings (MESH) descriptors [<xref ref-type="bibr" rid="CR23">23</xref>] by the IDSSIM algorithm [<xref ref-type="bibr" rid="CR24">24</xref>] and based on Disease Ontology (DO) [<xref ref-type="bibr" rid="CR25">25</xref>] by Wang et al.’s method [<xref ref-type="bibr" rid="CR26">26</xref>], respectively. For a disease-disease pair, the mean value of the two similarities was computed to construct the semantic similarity matrix <inline-formula id="IEq15"><alternatives><tex-math id="M29">\documentclass[12pt]{minimal}
				\usepackage{amsmath}
				\usepackage{wasysym} 
				\usepackage{amsfonts} 
				\usepackage{amssymb} 
				\usepackage{amsbsy}
				\usepackage{mathrsfs}
				\usepackage{upgreek}
				\setlength{\oddsidemargin}{-69pt}
				\begin{document}$${\text{DDS}}\_{\text{S}}^{{{\text{nD}} \times {\text{nD}}}}$$\end{document}</tex-math><mml:math id="M30"><mml:mrow><mml:mtext>DDS</mml:mtext><mml:mi>_</mml:mi><mml:msup><mml:mrow><mml:mtext>S</mml:mtext></mml:mrow><mml:mrow><mml:mtext>nD</mml:mtext><mml:mo>×</mml:mo><mml:mtext>nD</mml:mtext></mml:mrow></mml:msup></mml:mrow></mml:math><inline-graphic xlink:href="12859_2021_4522_Article_IEq15.gif"/></alternatives></inline-formula>. Then, we calculated diseases’ topological structure similarity [<xref ref-type="bibr" rid="CR27">27</xref>], whose matrix was represented as <inline-formula id="IEq16"><alternatives><tex-math id="M31">\documentclass[12pt]{minimal}
				\usepackage{amsmath}
				\usepackage{wasysym} 
				\usepackage{amsfonts} 
				\usepackage{amssymb} 
				\usepackage{amsbsy}
				\usepackage{mathrsfs}
				\usepackage{upgreek}
				\setlength{\oddsidemargin}{-69pt}
				\begin{document}$${\text{DDS}}\_{\text{T}}^{{{\text{nD}} \times {\text{nD}}}}$$\end{document}</tex-math><mml:math id="M32"><mml:mrow><mml:mtext>DDS</mml:mtext><mml:mi>_</mml:mi><mml:msup><mml:mrow><mml:mtext>T</mml:mtext></mml:mrow><mml:mrow><mml:mtext>nD</mml:mtext><mml:mo>×</mml:mo><mml:mtext>nD</mml:mtext></mml:mrow></mml:msup></mml:mrow></mml:math><inline-graphic xlink:href="12859_2021_4522_Article_IEq16.gif"/></alternatives></inline-formula>:<disp-formula id="Equ1"><label>1</label><alternatives><tex-math id="M33">\documentclass[12pt]{minimal}
				\usepackage{amsmath}
				\usepackage{wasysym} 
				\usepackage{amsfonts} 
				\usepackage{amssymb} 
				\usepackage{amsbsy}
				\usepackage{mathrsfs}
				\usepackage{upgreek}
				\setlength{\oddsidemargin}{-69pt}
				\begin{document}$${\text{DDS}}\_{\text{T}}_{i,j} = {\text{exp}}\left( { - \alpha ||TDA_{,i} - TDA_{,j}||^{2} } \right)$$\end{document}</tex-math><mml:math id="M34" display="block"><mml:mrow><mml:mtext>DDS</mml:mtext><mml:mi>_</mml:mi><mml:msub><mml:mtext>T</mml:mtext><mml:mrow><mml:mi>i</mml:mi><mml:mo>,</mml:mo><mml:mi>j</mml:mi></mml:mrow></mml:msub><mml:mo>=</mml:mo><mml:mtext>exp</mml:mtext><mml:mfenced close=")" open="("><mml:mrow><mml:mo>-</mml:mo><mml:mrow><mml:mi>α</mml:mi><mml:mo stretchy="false">|</mml:mo><mml:mo stretchy="false">|</mml:mo><mml:mi>T</mml:mi><mml:mi>D</mml:mi></mml:mrow><mml:msub><mml:mi>A</mml:mi><mml:mrow><mml:mo>,</mml:mo><mml:mi>i</mml:mi></mml:mrow></mml:msub><mml:mo>-</mml:mo><mml:mi>T</mml:mi><mml:mi>D</mml:mi><mml:msub><mml:mi>A</mml:mi><mml:mrow><mml:mo>,</mml:mo><mml:mi>j</mml:mi></mml:mrow></mml:msub><mml:msup><mml:mrow><mml:mo stretchy="false">|</mml:mo><mml:mo stretchy="false">|</mml:mo></mml:mrow><mml:mn>2</mml:mn></mml:msup></mml:mrow></mml:mfenced></mml:mrow></mml:math><graphic xlink:href="12859_2021_4522_Article_Equ1.gif" position="anchor"/></alternatives></disp-formula><disp-formula id="Equa"><alternatives><tex-math id="M35">\documentclass[12pt]{minimal}
				\usepackage{amsmath}
				\usepackage{wasysym} 
				\usepackage{amsfonts} 
				\usepackage{amssymb} 
				\usepackage{amsbsy}
				\usepackage{mathrsfs}
				\usepackage{upgreek}
				\setlength{\oddsidemargin}{-69pt}
				\begin{document}$$\alpha = \alpha ^{\prime } /\frac{1}{{nD}}\sum\limits_{{k = 1}}^{{nD}} {||TDA_{,k} ||} ^{2}$$\end{document}</tex-math><mml:math id="M36" display="block"><mml:mrow><mml:mi>α</mml:mi><mml:mo>=</mml:mo><mml:msup><mml:mi>α</mml:mi><mml:mo>′</mml:mo></mml:msup><mml:mo stretchy="false">/</mml:mo><mml:mfrac><mml:mn>1</mml:mn><mml:mrow><mml:mi mathvariant="italic">nD</mml:mi></mml:mrow></mml:mfrac><mml:munderover><mml:mo movablelimits="false">∑</mml:mo><mml:mrow><mml:mrow><mml:mi>k</mml:mi><mml:mo>=</mml:mo><mml:mn>1</mml:mn></mml:mrow></mml:mrow><mml:mrow><mml:mi mathvariant="italic">nD</mml:mi></mml:mrow></mml:munderover><mml:msup><mml:mrow><mml:mrow><mml:mo stretchy="false">|</mml:mo><mml:mo stretchy="false">|</mml:mo><mml:mi>T</mml:mi><mml:mi>D</mml:mi></mml:mrow><mml:msub><mml:mi>A</mml:mi><mml:mrow><mml:mo>,</mml:mo><mml:mi>k</mml:mi></mml:mrow></mml:msub><mml:mrow><mml:mo stretchy="false">|</mml:mo><mml:mo stretchy="false">|</mml:mo></mml:mrow></mml:mrow><mml:mn>2</mml:mn></mml:msup></mml:mrow></mml:math><graphic xlink:href="12859_2021_4522_Article_Equa.gif" position="anchor"/></alternatives></disp-formula>where <inline-formula id="IEq17"><alternatives><tex-math id="M37">\documentclass[12pt]{minimal}
				\usepackage{amsmath}
				\usepackage{wasysym} 
				\usepackage{amsfonts} 
				\usepackage{amssymb} 
				\usepackage{amsbsy}
				\usepackage{mathrsfs}
				\usepackage{upgreek}
				\setlength{\oddsidemargin}{-69pt}
				\begin{document}$$1 \le {\text{i}},{\text{j}} \le {\text{nD}}$$\end{document}</tex-math><mml:math id="M38"><mml:mrow><mml:mn>1</mml:mn><mml:mo>≤</mml:mo><mml:mtext>i</mml:mtext><mml:mo>,</mml:mo><mml:mtext>j</mml:mtext><mml:mo>≤</mml:mo><mml:mtext>nD</mml:mtext></mml:mrow></mml:math><inline-graphic xlink:href="12859_2021_4522_Article_IEq17.gif"/></alternatives></inline-formula>; <inline-formula id="IEq18"><alternatives><tex-math id="M39">\documentclass[12pt]{minimal}
				\usepackage{amsmath}
				\usepackage{wasysym} 
				\usepackage{amsfonts} 
				\usepackage{amssymb} 
				\usepackage{amsbsy}
				\usepackage{mathrsfs}
				\usepackage{upgreek}
				\setlength{\oddsidemargin}{-69pt}
				\begin{document}$$TDA_{,i}$$\end{document}</tex-math><mml:math id="M40"><mml:mrow><mml:mi>T</mml:mi><mml:mi>D</mml:mi><mml:msub><mml:mi>A</mml:mi><mml:mrow><mml:mo>,</mml:mo><mml:mi>i</mml:mi></mml:mrow></mml:msub></mml:mrow></mml:math><inline-graphic xlink:href="12859_2021_4522_Article_IEq18.gif"/></alternatives></inline-formula> was the <italic>i</italic>th column of <inline-formula id="IEq19"><alternatives><tex-math id="M41">\documentclass[12pt]{minimal}
				\usepackage{amsmath}
				\usepackage{wasysym} 
				\usepackage{amsfonts} 
				\usepackage{amssymb} 
				\usepackage{amsbsy}
				\usepackage{mathrsfs}
				\usepackage{upgreek}
				\setlength{\oddsidemargin}{-69pt}
				\begin{document}$$TDA$$\end{document}</tex-math><mml:math id="M42"><mml:mrow><mml:mi mathvariant="italic">TDA</mml:mi></mml:mrow></mml:math><inline-graphic xlink:href="12859_2021_4522_Article_IEq19.gif"/></alternatives></inline-formula>; <inline-formula id="IEq20"><alternatives><tex-math id="M43">\documentclass[12pt]{minimal}
				\usepackage{amsmath}
				\usepackage{wasysym} 
				\usepackage{amsfonts} 
				\usepackage{amssymb} 
				\usepackage{amsbsy}
				\usepackage{mathrsfs}
				\usepackage{upgreek}
				\setlength{\oddsidemargin}{-69pt}
				\begin{document}$$\alpha^{\prime}$$\end{document}</tex-math><mml:math id="M44"><mml:msup><mml:mi>α</mml:mi><mml:mo>′</mml:mo></mml:msup></mml:math><inline-graphic xlink:href="12859_2021_4522_Article_IEq20.gif"/></alternatives></inline-formula> was set to 1 according to previous study [<xref ref-type="bibr" rid="CR28">28</xref>]. For the two similarity matrices <inline-formula id="IEq21"><alternatives><tex-math id="M45">\documentclass[12pt]{minimal}
				\usepackage{amsmath}
				\usepackage{wasysym} 
				\usepackage{amsfonts} 
				\usepackage{amssymb} 
				\usepackage{amsbsy}
				\usepackage{mathrsfs}
				\usepackage{upgreek}
				\setlength{\oddsidemargin}{-69pt}
				\begin{document}$${\text{DDS}}\_{\text{S}}$$\end{document}</tex-math><mml:math id="M46"><mml:mrow><mml:mtext>DDS</mml:mtext><mml:mi>_</mml:mi><mml:mtext>S</mml:mtext></mml:mrow></mml:math><inline-graphic xlink:href="12859_2021_4522_Article_IEq21.gif"/></alternatives></inline-formula> and <inline-formula id="IEq22"><alternatives><tex-math id="M47">\documentclass[12pt]{minimal}
				\usepackage{amsmath}
				\usepackage{wasysym} 
				\usepackage{amsfonts} 
				\usepackage{amssymb} 
				\usepackage{amsbsy}
				\usepackage{mathrsfs}
				\usepackage{upgreek}
				\setlength{\oddsidemargin}{-69pt}
				\begin{document}$${\text{DDS}}\_{\text{T}}$$\end{document}</tex-math><mml:math id="M48"><mml:mrow><mml:mtext>DDS</mml:mtext><mml:mi>_</mml:mi><mml:mtext>T</mml:mtext></mml:mrow></mml:math><inline-graphic xlink:href="12859_2021_4522_Article_IEq22.gif"/></alternatives></inline-formula>, we proposed an integration way based on the entropy to get the final disease similarity matrix <inline-formula id="IEq23"><alternatives><tex-math id="M49">\documentclass[12pt]{minimal}
				\usepackage{amsmath}
				\usepackage{wasysym} 
				\usepackage{amsfonts} 
				\usepackage{amssymb} 
				\usepackage{amsbsy}
				\usepackage{mathrsfs}
				\usepackage{upgreek}
				\setlength{\oddsidemargin}{-69pt}
				\begin{document}$${\text{DDS}}^{{{\text{nD}} \times {\text{nD}}}}$$\end{document}</tex-math><mml:math id="M50"><mml:msup><mml:mrow><mml:mtext>DDS</mml:mtext></mml:mrow><mml:mrow><mml:mtext>nD</mml:mtext><mml:mo>×</mml:mo><mml:mtext>nD</mml:mtext></mml:mrow></mml:msup></mml:math><inline-graphic xlink:href="12859_2021_4522_Article_IEq23.gif"/></alternatives></inline-formula>. The entropy of row <inline-formula id="IEq24"><alternatives><tex-math id="M51">\documentclass[12pt]{minimal}
				\usepackage{amsmath}
				\usepackage{wasysym} 
				\usepackage{amsfonts} 
				\usepackage{amssymb} 
				\usepackage{amsbsy}
				\usepackage{mathrsfs}
				\usepackage{upgreek}
				\setlength{\oddsidemargin}{-69pt}
				\begin{document}$$i$$\end{document}</tex-math><mml:math id="M52"><mml:mi>i</mml:mi></mml:math><inline-graphic xlink:href="12859_2021_4522_Article_IEq24.gif"/></alternatives></inline-formula> in matrix <inline-formula id="IEq25"><alternatives><tex-math id="M53">\documentclass[12pt]{minimal}
				\usepackage{amsmath}
				\usepackage{wasysym} 
				\usepackage{amsfonts} 
				\usepackage{amssymb} 
				\usepackage{amsbsy}
				\usepackage{mathrsfs}
				\usepackage{upgreek}
				\setlength{\oddsidemargin}{-69pt}
				\begin{document}$${\text{W}}^{x \times y}$$\end{document}</tex-math><mml:math id="M54"><mml:msup><mml:mrow><mml:mtext>W</mml:mtext></mml:mrow><mml:mrow><mml:mi>x</mml:mi><mml:mo>×</mml:mo><mml:mi>y</mml:mi></mml:mrow></mml:msup></mml:math><inline-graphic xlink:href="12859_2021_4522_Article_IEq25.gif"/></alternatives></inline-formula> was represented as <inline-formula id="IEq26"><alternatives><tex-math id="M55">\documentclass[12pt]{minimal}
				\usepackage{amsmath}
				\usepackage{wasysym} 
				\usepackage{amsfonts} 
				\usepackage{amssymb} 
				\usepackage{amsbsy}
				\usepackage{mathrsfs}
				\usepackage{upgreek}
				\setlength{\oddsidemargin}{-69pt}
				\begin{document}$${\text{E}}_{i}^{{\text{W }}}$$\end{document}</tex-math><mml:math id="M56"><mml:msubsup><mml:mtext>E</mml:mtext><mml:mrow><mml:mi>i</mml:mi></mml:mrow><mml:mrow><mml:mtext>W</mml:mtext><mml:mspace width="0.333333em"/></mml:mrow></mml:msubsup></mml:math><inline-graphic xlink:href="12859_2021_4522_Article_IEq26.gif"/></alternatives></inline-formula>:<disp-formula id="Equ2"><label>2</label><alternatives><tex-math id="M57">\documentclass[12pt]{minimal}
				\usepackage{amsmath}
				\usepackage{wasysym} 
				\usepackage{amsfonts} 
				\usepackage{amssymb} 
				\usepackage{amsbsy}
				\usepackage{mathrsfs}
				\usepackage{upgreek}
				\setlength{\oddsidemargin}{-69pt}
				\begin{document}$${\text{E}}_{i}^{{\text{W }}} = - \mathop \sum \limits_{j = 1}^{y} p_{i,j} {\text{log}}\left( {p_{i,j} } \right)$$\end{document}</tex-math><mml:math id="M58" display="block"><mml:mrow><mml:msubsup><mml:mtext>E</mml:mtext><mml:mrow><mml:mi>i</mml:mi></mml:mrow><mml:mrow><mml:mtext>W</mml:mtext><mml:mspace width="0.333333em"/></mml:mrow></mml:msubsup><mml:mo>=</mml:mo><mml:mo>-</mml:mo><mml:munderover><mml:mo movablelimits="false">∑</mml:mo><mml:mrow><mml:mi>j</mml:mi><mml:mo>=</mml:mo><mml:mn>1</mml:mn></mml:mrow><mml:mi>y</mml:mi></mml:munderover><mml:msub><mml:mi>p</mml:mi><mml:mrow><mml:mi>i</mml:mi><mml:mo>,</mml:mo><mml:mi>j</mml:mi></mml:mrow></mml:msub><mml:mtext>log</mml:mtext><mml:mfenced close=")" open="("><mml:msub><mml:mi>p</mml:mi><mml:mrow><mml:mi>i</mml:mi><mml:mo>,</mml:mo><mml:mi>j</mml:mi></mml:mrow></mml:msub></mml:mfenced></mml:mrow></mml:math><graphic xlink:href="12859_2021_4522_Article_Equ2.gif" position="anchor"/></alternatives></disp-formula><disp-formula id="Equb"><alternatives><tex-math id="M59">\documentclass[12pt]{minimal}
				\usepackage{amsmath}
				\usepackage{wasysym} 
				\usepackage{amsfonts} 
				\usepackage{amssymb} 
				\usepackage{amsbsy}
				\usepackage{mathrsfs}
				\usepackage{upgreek}
				\setlength{\oddsidemargin}{-69pt}
				\begin{document}$$p_{{i,j}} = {{{\text{W}}_{{i,j}} } \mathord{\left/ {\vphantom {{{\text{W}}_{{i,j}} } {\sum\limits_{{k = 1}}^{y} {{\text{W}}_{{i,k}} } }}} \right. \kern-\nulldelimiterspace} {\sum\limits_{{k = 1}}^{y} {{\text{W}}_{{i,k}} } }}$$\end{document}</tex-math><mml:math id="M60" display="block"><mml:mrow><mml:msub><mml:mi>p</mml:mi><mml:mrow><mml:mi>i</mml:mi><mml:mo>,</mml:mo><mml:mi>j</mml:mi></mml:mrow></mml:msub><mml:mo>=</mml:mo><mml:mrow><mml:msub><mml:mtext>W</mml:mtext><mml:mrow><mml:mi>i</mml:mi><mml:mo>,</mml:mo><mml:mi>j</mml:mi></mml:mrow></mml:msub><mml:mrow><mml:mo stretchy="true">/</mml:mo></mml:mrow><mml:mrow><mml:munderover><mml:mo movablelimits="false">∑</mml:mo><mml:mrow><mml:mrow><mml:mi>k</mml:mi><mml:mo>=</mml:mo><mml:mn>1</mml:mn></mml:mrow></mml:mrow><mml:mi>y</mml:mi></mml:munderover><mml:msub><mml:mtext>W</mml:mtext><mml:mrow><mml:mi>i</mml:mi><mml:mo>,</mml:mo><mml:mi>k</mml:mi></mml:mrow></mml:msub></mml:mrow></mml:mrow></mml:mrow></mml:math><graphic xlink:href="12859_2021_4522_Article_Equb.gif" position="anchor"/></alternatives></disp-formula></p>
      <p id="Par20">According to the formula above, the entropy of disease <inline-formula id="IEq27"><alternatives><tex-math id="M61">\documentclass[12pt]{minimal}
				\usepackage{amsmath}
				\usepackage{wasysym} 
				\usepackage{amsfonts} 
				\usepackage{amssymb} 
				\usepackage{amsbsy}
				\usepackage{mathrsfs}
				\usepackage{upgreek}
				\setlength{\oddsidemargin}{-69pt}
				\begin{document}$${\text{d}}_{{\text{i}}}$$\end{document}</tex-math><mml:math id="M62"><mml:msub><mml:mtext>d</mml:mtext><mml:mtext>i</mml:mtext></mml:msub></mml:math><inline-graphic xlink:href="12859_2021_4522_Article_IEq27.gif"/></alternatives></inline-formula> in matrix <inline-formula id="IEq28"><alternatives><tex-math id="M63">\documentclass[12pt]{minimal}
				\usepackage{amsmath}
				\usepackage{wasysym} 
				\usepackage{amsfonts} 
				\usepackage{amssymb} 
				\usepackage{amsbsy}
				\usepackage{mathrsfs}
				\usepackage{upgreek}
				\setlength{\oddsidemargin}{-69pt}
				\begin{document}$${\text{DDS}}\_{\text{S}}$$\end{document}</tex-math><mml:math id="M64"><mml:mrow><mml:mtext>DDS</mml:mtext><mml:mi>_</mml:mi><mml:mtext>S</mml:mtext></mml:mrow></mml:math><inline-graphic xlink:href="12859_2021_4522_Article_IEq28.gif"/></alternatives></inline-formula> and <inline-formula id="IEq29"><alternatives><tex-math id="M65">\documentclass[12pt]{minimal}
				\usepackage{amsmath}
				\usepackage{wasysym} 
				\usepackage{amsfonts} 
				\usepackage{amssymb} 
				\usepackage{amsbsy}
				\usepackage{mathrsfs}
				\usepackage{upgreek}
				\setlength{\oddsidemargin}{-69pt}
				\begin{document}$${\text{DDS}}\_{\text{T}}$$\end{document}</tex-math><mml:math id="M66"><mml:mrow><mml:mtext>DDS</mml:mtext><mml:mi>_</mml:mi><mml:mtext>T</mml:mtext></mml:mrow></mml:math><inline-graphic xlink:href="12859_2021_4522_Article_IEq29.gif"/></alternatives></inline-formula> was calculated and represented as <inline-formula id="IEq30"><alternatives><tex-math id="M67">\documentclass[12pt]{minimal}
				\usepackage{amsmath}
				\usepackage{wasysym} 
				\usepackage{amsfonts} 
				\usepackage{amssymb} 
				\usepackage{amsbsy}
				\usepackage{mathrsfs}
				\usepackage{upgreek}
				\setlength{\oddsidemargin}{-69pt}
				\begin{document}$${\text{E}}_{i}^{{{\text{DDS}}\_{\text{S }}}}$$\end{document}</tex-math><mml:math id="M68"><mml:msubsup><mml:mtext>E</mml:mtext><mml:mrow><mml:mi>i</mml:mi></mml:mrow><mml:mrow><mml:mtext>DDS</mml:mtext><mml:mi>_</mml:mi><mml:mrow><mml:mtext>S</mml:mtext><mml:mspace width="0.333333em"/></mml:mrow></mml:mrow></mml:msubsup></mml:math><inline-graphic xlink:href="12859_2021_4522_Article_IEq30.gif"/></alternatives></inline-formula> and <inline-formula id="IEq31"><alternatives><tex-math id="M69">\documentclass[12pt]{minimal}
				\usepackage{amsmath}
				\usepackage{wasysym} 
				\usepackage{amsfonts} 
				\usepackage{amssymb} 
				\usepackage{amsbsy}
				\usepackage{mathrsfs}
				\usepackage{upgreek}
				\setlength{\oddsidemargin}{-69pt}
				\begin{document}$${\text{E}}_{i}^{{{\text{DDS}}\_{\text{T }}}}$$\end{document}</tex-math><mml:math id="M70"><mml:msubsup><mml:mtext>E</mml:mtext><mml:mrow><mml:mi>i</mml:mi></mml:mrow><mml:mrow><mml:mtext>DDS</mml:mtext><mml:mi>_</mml:mi><mml:mrow><mml:mtext>T</mml:mtext><mml:mspace width="0.333333em"/></mml:mrow></mml:mrow></mml:msubsup></mml:math><inline-graphic xlink:href="12859_2021_4522_Article_IEq31.gif"/></alternatives></inline-formula>, respectively. All diseases could be divided into two subsets, <inline-formula id="IEq32"><alternatives><tex-math id="M71">\documentclass[12pt]{minimal}
				\usepackage{amsmath}
				\usepackage{wasysym} 
				\usepackage{amsfonts} 
				\usepackage{amssymb} 
				\usepackage{amsbsy}
				\usepackage{mathrsfs}
				\usepackage{upgreek}
				\setlength{\oddsidemargin}{-69pt}
				\begin{document}$${\text{D}}\_{\text{A}}$$\end{document}</tex-math><mml:math id="M72"><mml:mrow><mml:mtext>D</mml:mtext><mml:mi>_</mml:mi><mml:mtext>A</mml:mtext></mml:mrow></mml:math><inline-graphic xlink:href="12859_2021_4522_Article_IEq32.gif"/></alternatives></inline-formula> and <inline-formula id="IEq33"><alternatives><tex-math id="M73">\documentclass[12pt]{minimal}
				\usepackage{amsmath}
				\usepackage{wasysym} 
				\usepackage{amsfonts} 
				\usepackage{amssymb} 
				\usepackage{amsbsy}
				\usepackage{mathrsfs}
				\usepackage{upgreek}
				\setlength{\oddsidemargin}{-69pt}
				\begin{document}$${\text{D}}\_{\text{B}}$$\end{document}</tex-math><mml:math id="M74"><mml:mrow><mml:mtext>D</mml:mtext><mml:mi>_</mml:mi><mml:mtext>B</mml:mtext></mml:mrow></mml:math><inline-graphic xlink:href="12859_2021_4522_Article_IEq33.gif"/></alternatives></inline-formula>:<disp-formula id="Equ3"><label>3</label><alternatives><tex-math id="M75">\documentclass[12pt]{minimal}
				\usepackage{amsmath}
				\usepackage{wasysym} 
				\usepackage{amsfonts} 
				\usepackage{amssymb} 
				\usepackage{amsbsy}
				\usepackage{mathrsfs}
				\usepackage{upgreek}
				\setlength{\oddsidemargin}{-69pt}
				\begin{document}$${\text{D}}\_{\text{A}} = \left\{ {{\text{d}}_{{\text{i}}} {\text{|E}}_{i}^{{{\text{DDS}}\_{\text{S }}}} \le {\text{E}}_{i}^{{{\text{DDS}}\_{\text{T }}}} ,1 \le {\text{i}} \le {\text{nD}}} \right\}$$\end{document}</tex-math><mml:math id="M76" display="block"><mml:mrow><mml:mtext>D</mml:mtext><mml:mi>_</mml:mi><mml:mtext>A</mml:mtext><mml:mo>=</mml:mo><mml:mfenced close="}" open="{"><mml:mrow><mml:msub><mml:mtext>d</mml:mtext><mml:mtext>i</mml:mtext></mml:msub><mml:msubsup><mml:mtext>|E</mml:mtext><mml:mrow><mml:mi>i</mml:mi></mml:mrow><mml:mrow><mml:mtext>DDS</mml:mtext><mml:mi>_</mml:mi><mml:mrow><mml:mtext>S</mml:mtext><mml:mspace width="0.333333em"/></mml:mrow></mml:mrow></mml:msubsup><mml:mo>≤</mml:mo><mml:msubsup><mml:mtext>E</mml:mtext><mml:mrow><mml:mi>i</mml:mi></mml:mrow><mml:mrow><mml:mtext>DDS</mml:mtext><mml:mi>_</mml:mi><mml:mrow><mml:mtext>T</mml:mtext><mml:mspace width="0.333333em"/></mml:mrow></mml:mrow></mml:msubsup><mml:mo>,</mml:mo><mml:mn>1</mml:mn><mml:mo>≤</mml:mo><mml:mtext>i</mml:mtext><mml:mo>≤</mml:mo><mml:mtext>nD</mml:mtext></mml:mrow></mml:mfenced></mml:mrow></mml:math><graphic xlink:href="12859_2021_4522_Article_Equ3.gif" position="anchor"/></alternatives></disp-formula><disp-formula id="Equ4"><label>4</label><alternatives><tex-math id="M77">\documentclass[12pt]{minimal}
				\usepackage{amsmath}
				\usepackage{wasysym} 
				\usepackage{amsfonts} 
				\usepackage{amssymb} 
				\usepackage{amsbsy}
				\usepackage{mathrsfs}
				\usepackage{upgreek}
				\setlength{\oddsidemargin}{-69pt}
				\begin{document}$${\text{D}}\_{\text{B}} = \left\{ {{\text{d}}_{{\text{j}}} {\text{|E}}_{j}^{{{\text{DDS}}\_{\text{T }}}} &lt; {\text{E}}_{j}^{{{\text{DDS}}\_{\text{S }}}} ,1 \le {\text{j}} \le {\text{nD}}} \right\}$$\end{document}</tex-math><mml:math id="M78" display="block"><mml:mrow><mml:mtext>D</mml:mtext><mml:mi>_</mml:mi><mml:mtext>B</mml:mtext><mml:mo>=</mml:mo><mml:mfenced close="}" open="{"><mml:mrow><mml:msub><mml:mtext>d</mml:mtext><mml:mtext>j</mml:mtext></mml:msub><mml:msubsup><mml:mtext>|E</mml:mtext><mml:mrow><mml:mi>j</mml:mi></mml:mrow><mml:mrow><mml:mtext>DDS</mml:mtext><mml:mi>_</mml:mi><mml:mrow><mml:mtext>T</mml:mtext><mml:mspace width="0.333333em"/></mml:mrow></mml:mrow></mml:msubsup><mml:mo>&lt;</mml:mo><mml:msubsup><mml:mtext>E</mml:mtext><mml:mrow><mml:mi>j</mml:mi></mml:mrow><mml:mrow><mml:mtext>DDS</mml:mtext><mml:mi>_</mml:mi><mml:mrow><mml:mtext>S</mml:mtext><mml:mspace width="0.333333em"/></mml:mrow></mml:mrow></mml:msubsup><mml:mo>,</mml:mo><mml:mn>1</mml:mn><mml:mo>≤</mml:mo><mml:mtext>j</mml:mtext><mml:mo>≤</mml:mo><mml:mtext>nD</mml:mtext></mml:mrow></mml:mfenced></mml:mrow></mml:math><graphic xlink:href="12859_2021_4522_Article_Equ4.gif" position="anchor"/></alternatives></disp-formula></p>
      <p id="Par21">The similarity matrix <inline-formula id="IEq34"><alternatives><tex-math id="M79">\documentclass[12pt]{minimal}
				\usepackage{amsmath}
				\usepackage{wasysym} 
				\usepackage{amsfonts} 
				\usepackage{amssymb} 
				\usepackage{amsbsy}
				\usepackage{mathrsfs}
				\usepackage{upgreek}
				\setlength{\oddsidemargin}{-69pt}
				\begin{document}$${\text{DDS}}$$\end{document}</tex-math><mml:math id="M80"><mml:mtext>DDS</mml:mtext></mml:math><inline-graphic xlink:href="12859_2021_4522_Article_IEq34.gif"/></alternatives></inline-formula> could be divided into four parts by <inline-formula id="IEq35"><alternatives><tex-math id="M81">\documentclass[12pt]{minimal}
				\usepackage{amsmath}
				\usepackage{wasysym} 
				\usepackage{amsfonts} 
				\usepackage{amssymb} 
				\usepackage{amsbsy}
				\usepackage{mathrsfs}
				\usepackage{upgreek}
				\setlength{\oddsidemargin}{-69pt}
				\begin{document}$${\text{D}}\_{\text{A}}$$\end{document}</tex-math><mml:math id="M82"><mml:mrow><mml:mtext>D</mml:mtext><mml:mi>_</mml:mi><mml:mtext>A</mml:mtext></mml:mrow></mml:math><inline-graphic xlink:href="12859_2021_4522_Article_IEq35.gif"/></alternatives></inline-formula> and <inline-formula id="IEq36"><alternatives><tex-math id="M83">\documentclass[12pt]{minimal}
				\usepackage{amsmath}
				\usepackage{wasysym} 
				\usepackage{amsfonts} 
				\usepackage{amssymb} 
				\usepackage{amsbsy}
				\usepackage{mathrsfs}
				\usepackage{upgreek}
				\setlength{\oddsidemargin}{-69pt}
				\begin{document}$${\text{D}}\_{\text{B}}$$\end{document}</tex-math><mml:math id="M84"><mml:mrow><mml:mtext>D</mml:mtext><mml:mi>_</mml:mi><mml:mtext>B</mml:mtext></mml:mrow></mml:math><inline-graphic xlink:href="12859_2021_4522_Article_IEq36.gif"/></alternatives></inline-formula>:<disp-formula id="Equ5"><label>5</label><alternatives><tex-math id="M85">\documentclass[12pt]{minimal}
				\usepackage{amsmath}
				\usepackage{wasysym} 
				\usepackage{amsfonts} 
				\usepackage{amssymb} 
				\usepackage{amsbsy}
				\usepackage{mathrsfs}
				\usepackage{upgreek}
				\setlength{\oddsidemargin}{-69pt}
				\begin{document}$${\text{DDS}} = \left[ {\begin{array}{*{20}c} {{\text{similarity matrix between D}}\_{\text{A and }} {\text{D}}\_{\text{A}}} &amp; {{\text{similarity matrix between D}}\_{\text{A and }} {\text{D}}\_{\text{B}}} \\ {{\text{similarity matrix between D}}\_{\text{B and }} {\text{D}}\_{\text{A}}} &amp; {{\text{similarity matrix between D}}\_{\text{B and }} {\text{D}}\_{\text{B}}} \\ \end{array} } \right]$$\end{document}</tex-math><mml:math id="M86" display="block"><mml:mrow><mml:mtext>DDS</mml:mtext><mml:mo>=</mml:mo><mml:mfenced close="]" open="["><mml:mrow><mml:mtable><mml:mtr><mml:mtd><mml:mrow><mml:mrow><mml:mtext>similarity matrix between D</mml:mtext></mml:mrow><mml:mi>_</mml:mi><mml:mrow><mml:mtext>A and</mml:mtext><mml:mspace width="0.333333em"/></mml:mrow><mml:mtext>D</mml:mtext><mml:mi>_</mml:mi><mml:mtext>A</mml:mtext></mml:mrow></mml:mtd><mml:mtd><mml:mrow><mml:mrow><mml:mtext>similarity matrix between D</mml:mtext></mml:mrow><mml:mi>_</mml:mi><mml:mrow><mml:mtext>A and</mml:mtext><mml:mspace width="0.333333em"/></mml:mrow><mml:mtext>D</mml:mtext><mml:mi>_</mml:mi><mml:mtext>B</mml:mtext></mml:mrow></mml:mtd></mml:mtr><mml:mtr><mml:mtd><mml:mrow><mml:mrow/><mml:mrow><mml:mrow><mml:mtext>similarity matrix between D</mml:mtext></mml:mrow><mml:mi>_</mml:mi><mml:mrow><mml:mtext>B and</mml:mtext><mml:mspace width="0.333333em"/></mml:mrow><mml:mtext>D</mml:mtext><mml:mi>_</mml:mi><mml:mtext>A</mml:mtext></mml:mrow></mml:mrow></mml:mtd><mml:mtd><mml:mrow><mml:mrow><mml:mtext>similarity matrix between D</mml:mtext></mml:mrow><mml:mi>_</mml:mi><mml:mrow><mml:mtext>B and</mml:mtext><mml:mspace width="0.333333em"/></mml:mrow><mml:mtext>D</mml:mtext><mml:mi>_</mml:mi><mml:mtext>B</mml:mtext></mml:mrow></mml:mtd></mml:mtr></mml:mtable></mml:mrow></mml:mfenced></mml:mrow></mml:math><graphic xlink:href="12859_2021_4522_Article_Equ5.gif" position="anchor"/></alternatives></disp-formula></p>
      <p id="Par22">A low entropy value meant little random information from the similarities. Hence, the upper left and lower right part of <inline-formula id="IEq37"><alternatives><tex-math id="M87">\documentclass[12pt]{minimal}
				\usepackage{amsmath}
				\usepackage{wasysym} 
				\usepackage{amsfonts} 
				\usepackage{amssymb} 
				\usepackage{amsbsy}
				\usepackage{mathrsfs}
				\usepackage{upgreek}
				\setlength{\oddsidemargin}{-69pt}
				\begin{document}$${\text{DDS}}$$\end{document}</tex-math><mml:math id="M88"><mml:mtext>DDS</mml:mtext></mml:math><inline-graphic xlink:href="12859_2021_4522_Article_IEq37.gif"/></alternatives></inline-formula> were defined as below:<disp-formula id="Equ6"><label>6</label><alternatives><tex-math id="M89">\documentclass[12pt]{minimal}
				\usepackage{amsmath}
				\usepackage{wasysym} 
				\usepackage{amsfonts} 
				\usepackage{amssymb} 
				\usepackage{amsbsy}
				\usepackage{mathrsfs}
				\usepackage{upgreek}
				\setlength{\oddsidemargin}{-69pt}
				\begin{document}$${\text{similarity matrix between D}}\_{\text{A and }} {\text{D}}\_{\text{A}} = {\text{DDS}}\_{\text{S}}_{{{\text{D}}\_{\text{A}},{\text{D}}\_{\text{A}}}}$$\end{document}</tex-math><mml:math id="M90" display="block"><mml:mrow><mml:mrow><mml:mtext>similarity matrix between D</mml:mtext></mml:mrow><mml:mi>_</mml:mi><mml:mrow><mml:mtext>A and</mml:mtext><mml:mspace width="0.333333em"/></mml:mrow><mml:mtext>D</mml:mtext><mml:mi>_</mml:mi><mml:mtext>A</mml:mtext><mml:mo>=</mml:mo><mml:mtext>DDS</mml:mtext><mml:mi>_</mml:mi><mml:msub><mml:mtext>S</mml:mtext><mml:mrow><mml:mtext>D</mml:mtext><mml:mi>_</mml:mi><mml:mtext>A</mml:mtext><mml:mo>,</mml:mo><mml:mtext>D</mml:mtext><mml:mi>_</mml:mi><mml:mtext>A</mml:mtext></mml:mrow></mml:msub></mml:mrow></mml:math><graphic xlink:href="12859_2021_4522_Article_Equ6.gif" position="anchor"/></alternatives></disp-formula><disp-formula id="Equ7"><label>7</label><alternatives><tex-math id="M91">\documentclass[12pt]{minimal}
				\usepackage{amsmath}
				\usepackage{wasysym} 
				\usepackage{amsfonts} 
				\usepackage{amssymb} 
				\usepackage{amsbsy}
				\usepackage{mathrsfs}
				\usepackage{upgreek}
				\setlength{\oddsidemargin}{-69pt}
				\begin{document}$${\text{similarity matrix between D}}\_{\text{B and }} {\text{D}}\_{\text{B}} = {\text{DDS}}\_{\text{T}}_{{{\text{D}}\_{\text{B}},{\text{D}}\_{\text{B}}}}$$\end{document}</tex-math><mml:math id="M92" display="block"><mml:mrow><mml:mrow><mml:mtext>similarity matrix between D</mml:mtext></mml:mrow><mml:mi>_</mml:mi><mml:mrow><mml:mtext>B and</mml:mtext><mml:mspace width="0.333333em"/></mml:mrow><mml:mtext>D</mml:mtext><mml:mi>_</mml:mi><mml:mtext>B</mml:mtext><mml:mo>=</mml:mo><mml:mtext>DDS</mml:mtext><mml:mi>_</mml:mi><mml:msub><mml:mtext>T</mml:mtext><mml:mrow><mml:mtext>D</mml:mtext><mml:mi>_</mml:mi><mml:mtext>B</mml:mtext><mml:mo>,</mml:mo><mml:mtext>D</mml:mtext><mml:mi>_</mml:mi><mml:mtext>B</mml:mtext></mml:mrow></mml:msub></mml:mrow></mml:math><graphic xlink:href="12859_2021_4522_Article_Equ7.gif" position="anchor"/></alternatives></disp-formula></p>
      <p id="Par23">The similarities between <inline-formula id="IEq38"><alternatives><tex-math id="M93">\documentclass[12pt]{minimal}
				\usepackage{amsmath}
				\usepackage{wasysym} 
				\usepackage{amsfonts} 
				\usepackage{amssymb} 
				\usepackage{amsbsy}
				\usepackage{mathrsfs}
				\usepackage{upgreek}
				\setlength{\oddsidemargin}{-69pt}
				\begin{document}$${\text{D}}\_{\text{A}}$$\end{document}</tex-math><mml:math id="M94"><mml:mrow><mml:mtext>D</mml:mtext><mml:mi>_</mml:mi><mml:mtext>A</mml:mtext></mml:mrow></mml:math><inline-graphic xlink:href="12859_2021_4522_Article_IEq38.gif"/></alternatives></inline-formula> and <inline-formula id="IEq39"><alternatives><tex-math id="M95">\documentclass[12pt]{minimal}
				\usepackage{amsmath}
				\usepackage{wasysym} 
				\usepackage{amsfonts} 
				\usepackage{amssymb} 
				\usepackage{amsbsy}
				\usepackage{mathrsfs}
				\usepackage{upgreek}
				\setlength{\oddsidemargin}{-69pt}
				\begin{document}$${\text{D}}\_{\text{B}}$$\end{document}</tex-math><mml:math id="M96"><mml:mrow><mml:mtext>D</mml:mtext><mml:mi>_</mml:mi><mml:mtext>B</mml:mtext></mml:mrow></mml:math><inline-graphic xlink:href="12859_2021_4522_Article_IEq39.gif"/></alternatives></inline-formula> were still integrated based on the entropy. <inline-formula id="IEq40"><alternatives><tex-math id="M97">\documentclass[12pt]{minimal}
				\usepackage{amsmath}
				\usepackage{wasysym} 
				\usepackage{amsfonts} 
				\usepackage{amssymb} 
				\usepackage{amsbsy}
				\usepackage{mathrsfs}
				\usepackage{upgreek}
				\setlength{\oddsidemargin}{-69pt}
				\begin{document}$${\text{D}}\_{\text{A}}$$\end{document}</tex-math><mml:math id="M98"><mml:mrow><mml:mtext>D</mml:mtext><mml:mi>_</mml:mi><mml:mtext>A</mml:mtext></mml:mrow></mml:math><inline-graphic xlink:href="12859_2021_4522_Article_IEq40.gif"/></alternatives></inline-formula> was divided into two subsets, <inline-formula id="IEq41"><alternatives><tex-math id="M99">\documentclass[12pt]{minimal}
				\usepackage{amsmath}
				\usepackage{wasysym} 
				\usepackage{amsfonts} 
				\usepackage{amssymb} 
				\usepackage{amsbsy}
				\usepackage{mathrsfs}
				\usepackage{upgreek}
				\setlength{\oddsidemargin}{-69pt}
				\begin{document}$${\text{D}}\_{\text{A}}\_{\text{a}}$$\end{document}</tex-math><mml:math id="M100"><mml:mrow><mml:mtext>D</mml:mtext><mml:mi>_</mml:mi><mml:mtext>A</mml:mtext><mml:mi>_</mml:mi><mml:mtext>a</mml:mtext></mml:mrow></mml:math><inline-graphic xlink:href="12859_2021_4522_Article_IEq41.gif"/></alternatives></inline-formula> and <inline-formula id="IEq42"><alternatives><tex-math id="M101">\documentclass[12pt]{minimal}
				\usepackage{amsmath}
				\usepackage{wasysym} 
				\usepackage{amsfonts} 
				\usepackage{amssymb} 
				\usepackage{amsbsy}
				\usepackage{mathrsfs}
				\usepackage{upgreek}
				\setlength{\oddsidemargin}{-69pt}
				\begin{document}$${\text{D}}\_{\text{A}}\_{\text{b}}$$\end{document}</tex-math><mml:math id="M102"><mml:mrow><mml:mtext>D</mml:mtext><mml:mi>_</mml:mi><mml:mtext>A</mml:mtext><mml:mi>_</mml:mi><mml:mtext>b</mml:mtext></mml:mrow></mml:math><inline-graphic xlink:href="12859_2021_4522_Article_IEq42.gif"/></alternatives></inline-formula>:<disp-formula id="Equ8"><label>8</label><alternatives><tex-math id="M103">\documentclass[12pt]{minimal}
				\usepackage{amsmath}
				\usepackage{wasysym} 
				\usepackage{amsfonts} 
				\usepackage{amssymb} 
				\usepackage{amsbsy}
				\usepackage{mathrsfs}
				\usepackage{upgreek}
				\setlength{\oddsidemargin}{-69pt}
				\begin{document}$${\text{D}}\_{\text{A}}\_{\text{a}} = \left\{ {{\text{d}}_{{\text{i}}} {\text{|E}}_{i}^{{{\text{DDS}}\_{\text{S}}_{{{\text{D}}\_{\text{A}},{\text{D}}\_{\text{B}}}} { }}} \le {\text{E}}_{i}^{{{\text{DDS}}\_{\text{T}}_{{{\text{D}}\_{\text{A}},{\text{D}}\_{\text{B}}}} { }}} ,1 \le {\text{i}} \le \left| {{\text{D}}\_{\text{A}}} \right|} \right\}$$\end{document}</tex-math><mml:math id="M104" display="block"><mml:mrow><mml:mtext>D</mml:mtext><mml:mi>_</mml:mi><mml:mtext>A</mml:mtext><mml:mi>_</mml:mi><mml:mtext>a</mml:mtext><mml:mo>=</mml:mo><mml:mfenced close="}" open="{"><mml:mrow><mml:msub><mml:mtext>d</mml:mtext><mml:mtext>i</mml:mtext></mml:msub><mml:msubsup><mml:mtext>|E</mml:mtext><mml:mrow><mml:mi>i</mml:mi></mml:mrow><mml:mrow><mml:mtext>DDS</mml:mtext><mml:mi>_</mml:mi><mml:msub><mml:mtext>S</mml:mtext><mml:mrow><mml:mtext>D</mml:mtext><mml:mi>_</mml:mi><mml:mtext>A</mml:mtext><mml:mo>,</mml:mo><mml:mtext>D</mml:mtext><mml:mi>_</mml:mi><mml:mtext>B</mml:mtext></mml:mrow></mml:msub><mml:mrow/></mml:mrow></mml:msubsup><mml:mo>≤</mml:mo><mml:msubsup><mml:mtext>E</mml:mtext><mml:mrow><mml:mi>i</mml:mi></mml:mrow><mml:mrow><mml:mtext>DDS</mml:mtext><mml:mi>_</mml:mi><mml:msub><mml:mtext>T</mml:mtext><mml:mrow><mml:mtext>D</mml:mtext><mml:mi>_</mml:mi><mml:mtext>A</mml:mtext><mml:mo>,</mml:mo><mml:mtext>D</mml:mtext><mml:mi>_</mml:mi><mml:mtext>B</mml:mtext></mml:mrow></mml:msub><mml:mrow/></mml:mrow></mml:msubsup><mml:mo>,</mml:mo><mml:mn>1</mml:mn><mml:mo>≤</mml:mo><mml:mtext>i</mml:mtext><mml:mo>≤</mml:mo><mml:mfenced close="|" open="|"><mml:mrow><mml:mtext>D</mml:mtext><mml:mi>_</mml:mi><mml:mtext>A</mml:mtext></mml:mrow></mml:mfenced></mml:mrow></mml:mfenced></mml:mrow></mml:math><graphic xlink:href="12859_2021_4522_Article_Equ8.gif" position="anchor"/></alternatives></disp-formula><disp-formula id="Equ9"><label>9</label><alternatives><tex-math id="M105">\documentclass[12pt]{minimal}
				\usepackage{amsmath}
				\usepackage{wasysym} 
				\usepackage{amsfonts} 
				\usepackage{amssymb} 
				\usepackage{amsbsy}
				\usepackage{mathrsfs}
				\usepackage{upgreek}
				\setlength{\oddsidemargin}{-69pt}
				\begin{document}$${\text{D}}\_{\text{A}}\_{\text{b}} = \left\{ {{\text{d}}_{{\text{j}}} {\text{|E}}_{j}^{{{\text{DDS}}\_{\text{T}}_{{{\text{D}}\_{\text{A}},{\text{D}}\_{\text{B}}}} { }}} &lt; {\text{E}}_{j}^{{{\text{DDS}}\_{\text{S}}_{{{\text{D}}\_{\text{A}},{\text{D}}\_{\text{B}}}} { }}} ,1 \le {\text{j}} \le \left| {{\text{D}}\_{\text{A}}} \right|} \right\}$$\end{document}</tex-math><mml:math id="M106" display="block"><mml:mrow><mml:mtext>D</mml:mtext><mml:mi>_</mml:mi><mml:mtext>A</mml:mtext><mml:mi>_</mml:mi><mml:mtext>b</mml:mtext><mml:mo>=</mml:mo><mml:mfenced close="}" open="{"><mml:mrow><mml:msub><mml:mtext>d</mml:mtext><mml:mtext>j</mml:mtext></mml:msub><mml:msubsup><mml:mtext>|E</mml:mtext><mml:mrow><mml:mi>j</mml:mi></mml:mrow><mml:mrow><mml:mtext>DDS</mml:mtext><mml:mi>_</mml:mi><mml:msub><mml:mtext>T</mml:mtext><mml:mrow><mml:mtext>D</mml:mtext><mml:mi>_</mml:mi><mml:mtext>A</mml:mtext><mml:mo>,</mml:mo><mml:mtext>D</mml:mtext><mml:mi>_</mml:mi><mml:mtext>B</mml:mtext></mml:mrow></mml:msub><mml:mrow/></mml:mrow></mml:msubsup><mml:mo>&lt;</mml:mo><mml:msubsup><mml:mtext>E</mml:mtext><mml:mrow><mml:mi>j</mml:mi></mml:mrow><mml:mrow><mml:mtext>DDS</mml:mtext><mml:mi>_</mml:mi><mml:msub><mml:mtext>S</mml:mtext><mml:mrow><mml:mtext>D</mml:mtext><mml:mi>_</mml:mi><mml:mtext>A</mml:mtext><mml:mo>,</mml:mo><mml:mtext>D</mml:mtext><mml:mi>_</mml:mi><mml:mtext>B</mml:mtext></mml:mrow></mml:msub><mml:mrow/></mml:mrow></mml:msubsup><mml:mo>,</mml:mo><mml:mn>1</mml:mn><mml:mo>≤</mml:mo><mml:mtext>j</mml:mtext><mml:mo>≤</mml:mo><mml:mfenced close="|" open="|"><mml:mrow><mml:mtext>D</mml:mtext><mml:mi>_</mml:mi><mml:mtext>A</mml:mtext></mml:mrow></mml:mfenced></mml:mrow></mml:mfenced></mml:mrow></mml:math><graphic xlink:href="12859_2021_4522_Article_Equ9.gif" position="anchor"/></alternatives></disp-formula></p>
      <p id="Par24">The <inline-formula id="IEq43"><alternatives><tex-math id="M107">\documentclass[12pt]{minimal}
				\usepackage{amsmath}
				\usepackage{wasysym} 
				\usepackage{amsfonts} 
				\usepackage{amssymb} 
				\usepackage{amsbsy}
				\usepackage{mathrsfs}
				\usepackage{upgreek}
				\setlength{\oddsidemargin}{-69pt}
				\begin{document}$${\text{similarity matrix between D}}\_{\text{A and }} {\text{D}}\_{\text{B}}$$\end{document}</tex-math><mml:math id="M108"><mml:mrow><mml:mrow><mml:mtext>similarity matrix between D</mml:mtext></mml:mrow><mml:mi>_</mml:mi><mml:mrow><mml:mtext>A and</mml:mtext><mml:mspace width="0.333333em"/></mml:mrow><mml:mtext>D</mml:mtext><mml:mi>_</mml:mi><mml:mtext>B</mml:mtext></mml:mrow></mml:math><inline-graphic xlink:href="12859_2021_4522_Article_IEq43.gif"/></alternatives></inline-formula> could be represented as below:<disp-formula id="Equ10"><label>10</label><alternatives><tex-math id="M109">\documentclass[12pt]{minimal}
				\usepackage{amsmath}
				\usepackage{wasysym} 
				\usepackage{amsfonts} 
				\usepackage{amssymb} 
				\usepackage{amsbsy}
				\usepackage{mathrsfs}
				\usepackage{upgreek}
				\setlength{\oddsidemargin}{-69pt}
				\begin{document}$${\text{Similarity}}\;{\text{matrix}}\;{\text{between}}\;{\text{D}}\_{\text{A}}\;{\text{and}}\;{\text{D}}\_{\text{B}} = \left[ {\begin{array}{*{20}c} {{\text{DDS}}\_{\text{S}}_{{{\text{D}}\_{\text{A}}\_{\text{a}},{\text{D}}\_{\text{B}}}} } \\ {{\text{DDS}}\_{\text{T}}_{{{\text{D}}\_{\text{A}}\_{\text{b}},{\text{D}}\_{\text{B}}}} } \\ \end{array} } \right]$$\end{document}</tex-math><mml:math id="M110" display="block"><mml:mrow><mml:mtext>Similarity</mml:mtext><mml:mspace width="0.277778em"/><mml:mtext>matrix</mml:mtext><mml:mspace width="0.277778em"/><mml:mtext>between</mml:mtext><mml:mspace width="0.277778em"/><mml:mtext>D</mml:mtext><mml:mi>_</mml:mi><mml:mtext>A</mml:mtext><mml:mspace width="0.277778em"/><mml:mtext>and</mml:mtext><mml:mspace width="0.277778em"/><mml:mtext>D</mml:mtext><mml:mi>_</mml:mi><mml:mtext>B</mml:mtext><mml:mo>=</mml:mo><mml:mfenced close="]" open="["><mml:mrow><mml:mtable><mml:mtr><mml:mtd><mml:mrow><mml:mtext>DDS</mml:mtext><mml:mi>_</mml:mi><mml:msub><mml:mtext>S</mml:mtext><mml:mrow><mml:mtext>D</mml:mtext><mml:mi>_</mml:mi><mml:mtext>A</mml:mtext><mml:mi>_</mml:mi><mml:mtext>a</mml:mtext><mml:mo>,</mml:mo><mml:mtext>D</mml:mtext><mml:mi>_</mml:mi><mml:mtext>B</mml:mtext></mml:mrow></mml:msub></mml:mrow></mml:mtd></mml:mtr><mml:mtr><mml:mtd><mml:mrow><mml:mrow/><mml:mrow><mml:mtext>DDS</mml:mtext><mml:mi>_</mml:mi><mml:msub><mml:mtext>T</mml:mtext><mml:mrow><mml:mtext>D</mml:mtext><mml:mi>_</mml:mi><mml:mtext>A</mml:mtext><mml:mi>_</mml:mi><mml:mtext>b</mml:mtext><mml:mo>,</mml:mo><mml:mtext>D</mml:mtext><mml:mi>_</mml:mi><mml:mtext>B</mml:mtext></mml:mrow></mml:msub></mml:mrow></mml:mrow></mml:mtd></mml:mtr></mml:mtable></mml:mrow></mml:mfenced></mml:mrow></mml:math><graphic xlink:href="12859_2021_4522_Article_Equ10.gif" position="anchor"/></alternatives></disp-formula></p>
      <p id="Par25">To ensure the symmetry of <inline-formula id="IEq44"><alternatives><tex-math id="M111">\documentclass[12pt]{minimal}
				\usepackage{amsmath}
				\usepackage{wasysym} 
				\usepackage{amsfonts} 
				\usepackage{amssymb} 
				\usepackage{amsbsy}
				\usepackage{mathrsfs}
				\usepackage{upgreek}
				\setlength{\oddsidemargin}{-69pt}
				\begin{document}$${\text{DDS}}$$\end{document}</tex-math><mml:math id="M112"><mml:mtext>DDS</mml:mtext></mml:math><inline-graphic xlink:href="12859_2021_4522_Article_IEq44.gif"/></alternatives></inline-formula>, the <inline-formula id="IEq45"><alternatives><tex-math id="M113">\documentclass[12pt]{minimal}
				\usepackage{amsmath}
				\usepackage{wasysym} 
				\usepackage{amsfonts} 
				\usepackage{amssymb} 
				\usepackage{amsbsy}
				\usepackage{mathrsfs}
				\usepackage{upgreek}
				\setlength{\oddsidemargin}{-69pt}
				\begin{document}$${\text{similarity matrix between D}}\_{\text{B and }} {\text{D}}\_{\text{A}}$$\end{document}</tex-math><mml:math id="M114"><mml:mrow><mml:mrow><mml:mtext>similarity matrix between D</mml:mtext></mml:mrow><mml:mi>_</mml:mi><mml:mrow><mml:mtext>B and</mml:mtext><mml:mspace width="0.333333em"/></mml:mrow><mml:mtext>D</mml:mtext><mml:mi>_</mml:mi><mml:mtext>A</mml:mtext></mml:mrow></mml:math><inline-graphic xlink:href="12859_2021_4522_Article_IEq45.gif"/></alternatives></inline-formula> was set as the transpose of <inline-formula id="IEq46"><alternatives><tex-math id="M115">\documentclass[12pt]{minimal}
				\usepackage{amsmath}
				\usepackage{wasysym} 
				\usepackage{amsfonts} 
				\usepackage{amssymb} 
				\usepackage{amsbsy}
				\usepackage{mathrsfs}
				\usepackage{upgreek}
				\setlength{\oddsidemargin}{-69pt}
				\begin{document}$${\text{similarity}}\;{\text{matrix}}\;{\text{between}}\;{\text{D}}\_{\text{A}}\;{\text{and}}\;{\text{D}}\_{\text{B}}$$\end{document}</tex-math><mml:math id="M116"><mml:mrow><mml:mtext>similarity</mml:mtext><mml:mspace width="0.277778em"/><mml:mtext>matrix</mml:mtext><mml:mspace width="0.277778em"/><mml:mtext>between</mml:mtext><mml:mspace width="0.277778em"/><mml:mtext>D</mml:mtext><mml:mi>_</mml:mi><mml:mtext>A</mml:mtext><mml:mspace width="0.277778em"/><mml:mtext>and</mml:mtext><mml:mspace width="0.277778em"/><mml:mtext>D</mml:mtext><mml:mi>_</mml:mi><mml:mtext>B</mml:mtext></mml:mrow></mml:math><inline-graphic xlink:href="12859_2021_4522_Article_IEq46.gif"/></alternatives></inline-formula>. Finally, <inline-formula id="IEq47"><alternatives><tex-math id="M117">\documentclass[12pt]{minimal}
				\usepackage{amsmath}
				\usepackage{wasysym} 
				\usepackage{amsfonts} 
				\usepackage{amssymb} 
				\usepackage{amsbsy}
				\usepackage{mathrsfs}
				\usepackage{upgreek}
				\setlength{\oddsidemargin}{-69pt}
				\begin{document}$${\text{DDS}}$$\end{document}</tex-math><mml:math id="M118"><mml:mtext>DDS</mml:mtext></mml:math><inline-graphic xlink:href="12859_2021_4522_Article_IEq47.gif"/></alternatives></inline-formula> could be obtained as below:<disp-formula id="Equ11"><label>11</label><alternatives><tex-math id="M119">\documentclass[12pt]{minimal}
				\usepackage{amsmath}
				\usepackage{wasysym} 
				\usepackage{amsfonts} 
				\usepackage{amssymb} 
				\usepackage{amsbsy}
				\usepackage{mathrsfs}
				\usepackage{upgreek}
				\setlength{\oddsidemargin}{-69pt}
				\begin{document}$${\text{DDS}} = \left[ {\begin{array}{*{20}c} {{\text{DDS}}\_{\text{S}}_{{{\text{D}}\_{\text{A}},{\text{D}}\_{\text{A}}}} } &amp; {\left[ {\begin{array}{*{20}c} {{\text{DDS}}\_{\text{S}}_{{{\text{D}}\_{\text{A}}\_{\text{a}},{\text{D}}\_{\text{B}}}} } \\ {{\text{DDS}}\_{\text{T}}_{{{\text{D}}\_{\text{A}}\_{\text{b}},{\text{D}}\_{\text{B}}}} } \\ \end{array} } \right]} \\ {\left[ {\begin{array}{*{20}c} {{\text{DDS}}\_{\text{S}}_{{{\text{D}}\_{\text{A}}\_{\text{a}},{\text{D}}\_{\text{B}}}} } \\ {{\text{DDS}}\_{\text{T}}_{{{\text{D}}\_{\text{A}}\_{\text{b}},{\text{D}}\_{\text{B}}}} } \\ \end{array} } \right]^{T} } &amp; {{\text{DDS}}\_{\text{T}}_{{{\text{D}}\_{\text{B}},{\text{D}}\_{\text{B}}}} } \\ \end{array} } \right]$$\end{document}</tex-math><mml:math id="M120" display="block"><mml:mrow><mml:mtext>DDS</mml:mtext><mml:mo>=</mml:mo><mml:mfenced close="]" open="["><mml:mrow><mml:mtable><mml:mtr><mml:mtd><mml:mrow><mml:mtext>DDS</mml:mtext><mml:mi>_</mml:mi><mml:msub><mml:mtext>S</mml:mtext><mml:mrow><mml:mtext>D</mml:mtext><mml:mi>_</mml:mi><mml:mtext>A</mml:mtext><mml:mo>,</mml:mo><mml:mtext>D</mml:mtext><mml:mi>_</mml:mi><mml:mtext>A</mml:mtext></mml:mrow></mml:msub></mml:mrow></mml:mtd><mml:mtd><mml:mfenced close="]" open="["><mml:mrow><mml:mtable><mml:mtr><mml:mtd><mml:mrow><mml:mtext>DDS</mml:mtext><mml:mi>_</mml:mi><mml:msub><mml:mtext>S</mml:mtext><mml:mrow><mml:mtext>D</mml:mtext><mml:mi>_</mml:mi><mml:mtext>A</mml:mtext><mml:mi>_</mml:mi><mml:mtext>a</mml:mtext><mml:mo>,</mml:mo><mml:mtext>D</mml:mtext><mml:mi>_</mml:mi><mml:mtext>B</mml:mtext></mml:mrow></mml:msub></mml:mrow></mml:mtd></mml:mtr><mml:mtr><mml:mtd><mml:mrow><mml:mrow/><mml:mrow><mml:mtext>DDS</mml:mtext><mml:mi>_</mml:mi><mml:msub><mml:mtext>T</mml:mtext><mml:mrow><mml:mtext>D</mml:mtext><mml:mi>_</mml:mi><mml:mtext>A</mml:mtext><mml:mi>_</mml:mi><mml:mtext>b</mml:mtext><mml:mo>,</mml:mo><mml:mtext>D</mml:mtext><mml:mi>_</mml:mi><mml:mtext>B</mml:mtext></mml:mrow></mml:msub></mml:mrow></mml:mrow></mml:mtd></mml:mtr></mml:mtable></mml:mrow></mml:mfenced></mml:mtd></mml:mtr><mml:mtr><mml:mtd><mml:mrow><mml:mrow/><mml:msup><mml:mfenced close="]" open="["><mml:mrow><mml:mtable><mml:mtr><mml:mtd><mml:mrow><mml:mtext>DDS</mml:mtext><mml:mi>_</mml:mi><mml:msub><mml:mtext>S</mml:mtext><mml:mrow><mml:mtext>D</mml:mtext><mml:mi>_</mml:mi><mml:mtext>A</mml:mtext><mml:mi>_</mml:mi><mml:mtext>a</mml:mtext><mml:mo>,</mml:mo><mml:mtext>D</mml:mtext><mml:mi>_</mml:mi><mml:mtext>B</mml:mtext></mml:mrow></mml:msub></mml:mrow></mml:mtd></mml:mtr><mml:mtr><mml:mtd><mml:mrow><mml:mrow/><mml:mrow><mml:mtext>DDS</mml:mtext><mml:mi>_</mml:mi><mml:msub><mml:mtext>T</mml:mtext><mml:mrow><mml:mtext>D</mml:mtext><mml:mi>_</mml:mi><mml:mtext>A</mml:mtext><mml:mi>_</mml:mi><mml:mtext>b</mml:mtext><mml:mo>,</mml:mo><mml:mtext>D</mml:mtext><mml:mi>_</mml:mi><mml:mtext>B</mml:mtext></mml:mrow></mml:msub></mml:mrow></mml:mrow></mml:mtd></mml:mtr></mml:mtable></mml:mrow></mml:mfenced><mml:mi>T</mml:mi></mml:msup></mml:mrow></mml:mtd><mml:mtd><mml:mrow><mml:mtext>DDS</mml:mtext><mml:mi>_</mml:mi><mml:msub><mml:mtext>T</mml:mtext><mml:mrow><mml:mtext>D</mml:mtext><mml:mi>_</mml:mi><mml:mtext>B</mml:mtext><mml:mo>,</mml:mo><mml:mtext>D</mml:mtext><mml:mi>_</mml:mi><mml:mtext>B</mml:mtext></mml:mrow></mml:msub></mml:mrow></mml:mtd></mml:mtr></mml:mtable></mml:mrow></mml:mfenced></mml:mrow></mml:math><graphic xlink:href="12859_2021_4522_Article_Equ11.gif" position="anchor"/></alternatives></disp-formula></p>
      <p id="Par26">(2) The target-target similarity network. We calculated the target proteins’ amino acid sequences similarity from the KEGG database [<xref ref-type="bibr" rid="CR29">29</xref>] by the Smith-Waterman algorithm [<xref ref-type="bibr" rid="CR30">30</xref>] and the protein functional similarity by Chen et al.’s method [<xref ref-type="bibr" rid="CR31">31</xref>], respectively. For a target-target pair, the mean value of the two similarities was calculated to construct the similarity matrix <inline-formula id="IEq48"><alternatives><tex-math id="M121">\documentclass[12pt]{minimal}
				\usepackage{amsmath}
				\usepackage{wasysym} 
				\usepackage{amsfonts} 
				\usepackage{amssymb} 
				\usepackage{amsbsy}
				\usepackage{mathrsfs}
				\usepackage{upgreek}
				\setlength{\oddsidemargin}{-69pt}
				\begin{document}$${\text{TTS}}\_{\text{S}}^{{{\text{nT}} \times {\text{nT}}}}$$\end{document}</tex-math><mml:math id="M122"><mml:mrow><mml:mtext>TTS</mml:mtext><mml:mi>_</mml:mi><mml:msup><mml:mrow><mml:mtext>S</mml:mtext></mml:mrow><mml:mrow><mml:mtext>nT</mml:mtext><mml:mo>×</mml:mo><mml:mtext>nT</mml:mtext></mml:mrow></mml:msup></mml:mrow></mml:math><inline-graphic xlink:href="12859_2021_4522_Article_IEq48.gif"/></alternatives></inline-formula>. Then, targets’ topological structure similarity matrix <inline-formula id="IEq49"><alternatives><tex-math id="M123">\documentclass[12pt]{minimal}
				\usepackage{amsmath}
				\usepackage{wasysym} 
				\usepackage{amsfonts} 
				\usepackage{amssymb} 
				\usepackage{amsbsy}
				\usepackage{mathrsfs}
				\usepackage{upgreek}
				\setlength{\oddsidemargin}{-69pt}
				\begin{document}$${\text{TTS}}\_{\text{T}}^{{{\text{nT}} \times {\text{nT}}}}$$\end{document}</tex-math><mml:math id="M124"><mml:mrow><mml:mtext>TTS</mml:mtext><mml:mi>_</mml:mi><mml:msup><mml:mrow><mml:mtext>T</mml:mtext></mml:mrow><mml:mrow><mml:mtext>nT</mml:mtext><mml:mo>×</mml:mo><mml:mtext>nT</mml:mtext></mml:mrow></mml:msup></mml:mrow></mml:math><inline-graphic xlink:href="12859_2021_4522_Article_IEq49.gif"/></alternatives></inline-formula> was computed as below:<disp-formula id="Equ12"><label>12</label><alternatives><tex-math id="M125">\documentclass[12pt]{minimal}
				\usepackage{amsmath}
				\usepackage{wasysym} 
				\usepackage{amsfonts} 
				\usepackage{amssymb} 
				\usepackage{amsbsy}
				\usepackage{mathrsfs}
				\usepackage{upgreek}
				\setlength{\oddsidemargin}{-69pt}
				\begin{document}$${\text{TTS}}\_{\text{T}}_{i,j} = {\text{exp}}\left( { - \beta ||TDA_{i,} - TDA_{j,}||^{2} } \right)$$\end{document}</tex-math><mml:math id="M126" display="block"><mml:mrow><mml:mtext>TTS</mml:mtext><mml:mi>_</mml:mi><mml:msub><mml:mtext>T</mml:mtext><mml:mrow><mml:mi>i</mml:mi><mml:mo>,</mml:mo><mml:mi>j</mml:mi></mml:mrow></mml:msub><mml:mo>=</mml:mo><mml:mtext>exp</mml:mtext><mml:mfenced close=")" open="("><mml:mrow><mml:mo>-</mml:mo><mml:mrow><mml:mi>β</mml:mi><mml:mo stretchy="false">|</mml:mo><mml:mo stretchy="false">|</mml:mo><mml:mi>T</mml:mi><mml:mi>D</mml:mi></mml:mrow><mml:msub><mml:mi>A</mml:mi><mml:mrow><mml:mi>i</mml:mi><mml:mo>,</mml:mo></mml:mrow></mml:msub><mml:mo>-</mml:mo><mml:mi>T</mml:mi><mml:mi>D</mml:mi><mml:msub><mml:mi>A</mml:mi><mml:mrow><mml:mi>j</mml:mi><mml:mo>,</mml:mo></mml:mrow></mml:msub><mml:msup><mml:mrow><mml:mo stretchy="false">|</mml:mo><mml:mo stretchy="false">|</mml:mo></mml:mrow><mml:mn>2</mml:mn></mml:msup></mml:mrow></mml:mfenced></mml:mrow></mml:math><graphic xlink:href="12859_2021_4522_Article_Equ12.gif" position="anchor"/></alternatives></disp-formula><disp-formula id="Equc"><alternatives><tex-math id="M127">\documentclass[12pt]{minimal}
				\usepackage{amsmath}
				\usepackage{wasysym} 
				\usepackage{amsfonts} 
				\usepackage{amssymb} 
				\usepackage{amsbsy}
				\usepackage{mathrsfs}
				\usepackage{upgreek}
				\setlength{\oddsidemargin}{-69pt}
				\begin{document}$$\beta = {{\beta ^{\prime } } \mathord{\left/ {\vphantom {{\beta ^{\prime } } {\frac{1}{{nT}}\sum\limits_{{k = 1}}^{{nT}} | |TDA_{{k,}} ||^{2} }}} \right. \kern-\nulldelimiterspace} {\frac{1}{{nT}}\sum\limits_{{k = 1}}^{{nT}} | |TDA_{{k,}} ||^{2} }}$$\end{document}</tex-math><mml:math id="M128" display="block"><mml:mrow><mml:mi>β</mml:mi><mml:mo>=</mml:mo><mml:mrow><mml:msup><mml:mi>β</mml:mi><mml:mo>′</mml:mo></mml:msup><mml:mrow><mml:mo stretchy="true">/</mml:mo></mml:mrow><mml:mrow><mml:mfrac><mml:mn>1</mml:mn><mml:mrow><mml:mi mathvariant="italic">nT</mml:mi></mml:mrow></mml:mfrac><mml:munderover><mml:mo movablelimits="false">∑</mml:mo><mml:mrow><mml:mrow><mml:mi>k</mml:mi><mml:mo>=</mml:mo><mml:mn>1</mml:mn></mml:mrow></mml:mrow><mml:mrow><mml:mi mathvariant="italic">nT</mml:mi></mml:mrow></mml:munderover><mml:mrow><mml:mo stretchy="false">|</mml:mo><mml:mo stretchy="false">|</mml:mo><mml:mi>T</mml:mi><mml:mi>D</mml:mi></mml:mrow><mml:msub><mml:mi>A</mml:mi><mml:mrow><mml:mi>k</mml:mi><mml:mo>,</mml:mo></mml:mrow></mml:msub><mml:msup><mml:mrow><mml:mo stretchy="false">|</mml:mo><mml:mo stretchy="false">|</mml:mo></mml:mrow><mml:mn>2</mml:mn></mml:msup></mml:mrow></mml:mrow></mml:mrow></mml:math><graphic xlink:href="12859_2021_4522_Article_Equc.gif" position="anchor"/></alternatives></disp-formula>where <inline-formula id="IEq50"><alternatives><tex-math id="M129">\documentclass[12pt]{minimal}
				\usepackage{amsmath}
				\usepackage{wasysym} 
				\usepackage{amsfonts} 
				\usepackage{amssymb} 
				\usepackage{amsbsy}
				\usepackage{mathrsfs}
				\usepackage{upgreek}
				\setlength{\oddsidemargin}{-69pt}
				\begin{document}$$1 \le {\text{i}},{\text{j}} \le {\text{nT}}$$\end{document}</tex-math><mml:math id="M130"><mml:mrow><mml:mn>1</mml:mn><mml:mo>≤</mml:mo><mml:mtext>i</mml:mtext><mml:mo>,</mml:mo><mml:mtext>j</mml:mtext><mml:mo>≤</mml:mo><mml:mtext>nT</mml:mtext></mml:mrow></mml:math><inline-graphic xlink:href="12859_2021_4522_Article_IEq50.gif"/></alternatives></inline-formula>; <inline-formula id="IEq51"><alternatives><tex-math id="M131">\documentclass[12pt]{minimal}
				\usepackage{amsmath}
				\usepackage{wasysym} 
				\usepackage{amsfonts} 
				\usepackage{amssymb} 
				\usepackage{amsbsy}
				\usepackage{mathrsfs}
				\usepackage{upgreek}
				\setlength{\oddsidemargin}{-69pt}
				\begin{document}$$TDA_{i,}$$\end{document}</tex-math><mml:math id="M132"><mml:mrow><mml:mi>T</mml:mi><mml:mi>D</mml:mi><mml:msub><mml:mi>A</mml:mi><mml:mrow><mml:mi>i</mml:mi><mml:mo>,</mml:mo></mml:mrow></mml:msub></mml:mrow></mml:math><inline-graphic xlink:href="12859_2021_4522_Article_IEq51.gif"/></alternatives></inline-formula> was the <italic>i</italic>th row of <inline-formula id="IEq52"><alternatives><tex-math id="M133">\documentclass[12pt]{minimal}
				\usepackage{amsmath}
				\usepackage{wasysym} 
				\usepackage{amsfonts} 
				\usepackage{amssymb} 
				\usepackage{amsbsy}
				\usepackage{mathrsfs}
				\usepackage{upgreek}
				\setlength{\oddsidemargin}{-69pt}
				\begin{document}$$TDA$$\end{document}</tex-math><mml:math id="M134"><mml:mrow><mml:mi mathvariant="italic">TDA</mml:mi></mml:mrow></mml:math><inline-graphic xlink:href="12859_2021_4522_Article_IEq52.gif"/></alternatives></inline-formula>; <inline-formula id="IEq53"><alternatives><tex-math id="M135">\documentclass[12pt]{minimal}
				\usepackage{amsmath}
				\usepackage{wasysym} 
				\usepackage{amsfonts} 
				\usepackage{amssymb} 
				\usepackage{amsbsy}
				\usepackage{mathrsfs}
				\usepackage{upgreek}
				\setlength{\oddsidemargin}{-69pt}
				\begin{document}$$\beta^{\prime} = 1$$\end{document}</tex-math><mml:math id="M136"><mml:mrow><mml:msup><mml:mi>β</mml:mi><mml:mo>′</mml:mo></mml:msup><mml:mo>=</mml:mo><mml:mn>1</mml:mn></mml:mrow></mml:math><inline-graphic xlink:href="12859_2021_4522_Article_IEq53.gif"/></alternatives></inline-formula>.</p>
      <p id="Par27">The target subset <inline-formula id="IEq54"><alternatives><tex-math id="M137">\documentclass[12pt]{minimal}
				\usepackage{amsmath}
				\usepackage{wasysym} 
				\usepackage{amsfonts} 
				\usepackage{amssymb} 
				\usepackage{amsbsy}
				\usepackage{mathrsfs}
				\usepackage{upgreek}
				\setlength{\oddsidemargin}{-69pt}
				\begin{document}$${\text{T}}\_{\text{A}}$$\end{document}</tex-math><mml:math id="M138"><mml:mrow><mml:mtext>T</mml:mtext><mml:mi>_</mml:mi><mml:mtext>A</mml:mtext></mml:mrow></mml:math><inline-graphic xlink:href="12859_2021_4522_Article_IEq54.gif"/></alternatives></inline-formula>, <inline-formula id="IEq55"><alternatives><tex-math id="M139">\documentclass[12pt]{minimal}
				\usepackage{amsmath}
				\usepackage{wasysym} 
				\usepackage{amsfonts} 
				\usepackage{amssymb} 
				\usepackage{amsbsy}
				\usepackage{mathrsfs}
				\usepackage{upgreek}
				\setlength{\oddsidemargin}{-69pt}
				\begin{document}$${\text{T}}\_{\text{B}}$$\end{document}</tex-math><mml:math id="M140"><mml:mrow><mml:mtext>T</mml:mtext><mml:mi>_</mml:mi><mml:mtext>B</mml:mtext></mml:mrow></mml:math><inline-graphic xlink:href="12859_2021_4522_Article_IEq55.gif"/></alternatives></inline-formula>, <inline-formula id="IEq56"><alternatives><tex-math id="M141">\documentclass[12pt]{minimal}
				\usepackage{amsmath}
				\usepackage{wasysym} 
				\usepackage{amsfonts} 
				\usepackage{amssymb} 
				\usepackage{amsbsy}
				\usepackage{mathrsfs}
				\usepackage{upgreek}
				\setlength{\oddsidemargin}{-69pt}
				\begin{document}$${\text{T}}\_{\text{A}}\_{\text{a}}$$\end{document}</tex-math><mml:math id="M142"><mml:mrow><mml:mtext>T</mml:mtext><mml:mi>_</mml:mi><mml:mtext>A</mml:mtext><mml:mi>_</mml:mi><mml:mtext>a</mml:mtext></mml:mrow></mml:math><inline-graphic xlink:href="12859_2021_4522_Article_IEq56.gif"/></alternatives></inline-formula> and <inline-formula id="IEq57"><alternatives><tex-math id="M143">\documentclass[12pt]{minimal}
				\usepackage{amsmath}
				\usepackage{wasysym} 
				\usepackage{amsfonts} 
				\usepackage{amssymb} 
				\usepackage{amsbsy}
				\usepackage{mathrsfs}
				\usepackage{upgreek}
				\setlength{\oddsidemargin}{-69pt}
				\begin{document}$${\text{T}}\_{\text{A}}\_{\text{b}}$$\end{document}</tex-math><mml:math id="M144"><mml:mrow><mml:mtext>T</mml:mtext><mml:mi>_</mml:mi><mml:mtext>A</mml:mtext><mml:mi>_</mml:mi><mml:mtext>b</mml:mtext></mml:mrow></mml:math><inline-graphic xlink:href="12859_2021_4522_Article_IEq57.gif"/></alternatives></inline-formula> were defined as below:<disp-formula id="Equ13"><label>13</label><alternatives><tex-math id="M145">\documentclass[12pt]{minimal}
				\usepackage{amsmath}
				\usepackage{wasysym} 
				\usepackage{amsfonts} 
				\usepackage{amssymb} 
				\usepackage{amsbsy}
				\usepackage{mathrsfs}
				\usepackage{upgreek}
				\setlength{\oddsidemargin}{-69pt}
				\begin{document}$${\text{T}}\_{\text{A}} = \left\{ {{\text{t}}_{{\text{i}}} {\text{|E}}_{i}^{{{\text{TTS}}\_{\text{S }}}} \le {\text{E}}_{i}^{{{\text{TTS}}\_{\text{T }}}} ,1 \le {\text{i}} \le {\text{nT}}} \right\}$$\end{document}</tex-math><mml:math id="M146" display="block"><mml:mrow><mml:mtext>T</mml:mtext><mml:mi>_</mml:mi><mml:mtext>A</mml:mtext><mml:mo>=</mml:mo><mml:mfenced close="}" open="{"><mml:mrow><mml:msub><mml:mtext>t</mml:mtext><mml:mtext>i</mml:mtext></mml:msub><mml:msubsup><mml:mtext>|E</mml:mtext><mml:mrow><mml:mi>i</mml:mi></mml:mrow><mml:mrow><mml:mtext>TTS</mml:mtext><mml:mi>_</mml:mi><mml:mrow><mml:mtext>S</mml:mtext><mml:mspace width="0.333333em"/></mml:mrow></mml:mrow></mml:msubsup><mml:mo>≤</mml:mo><mml:msubsup><mml:mtext>E</mml:mtext><mml:mrow><mml:mi>i</mml:mi></mml:mrow><mml:mrow><mml:mtext>TTS</mml:mtext><mml:mi>_</mml:mi><mml:mrow><mml:mtext>T</mml:mtext><mml:mspace width="0.333333em"/></mml:mrow></mml:mrow></mml:msubsup><mml:mo>,</mml:mo><mml:mn>1</mml:mn><mml:mo>≤</mml:mo><mml:mtext>i</mml:mtext><mml:mo>≤</mml:mo><mml:mtext>nT</mml:mtext></mml:mrow></mml:mfenced></mml:mrow></mml:math><graphic xlink:href="12859_2021_4522_Article_Equ13.gif" position="anchor"/></alternatives></disp-formula><disp-formula id="Equ14"><label>14</label><alternatives><tex-math id="M147">\documentclass[12pt]{minimal}
				\usepackage{amsmath}
				\usepackage{wasysym} 
				\usepackage{amsfonts} 
				\usepackage{amssymb} 
				\usepackage{amsbsy}
				\usepackage{mathrsfs}
				\usepackage{upgreek}
				\setlength{\oddsidemargin}{-69pt}
				\begin{document}$${\text{T}}\_{\text{B}} = \left\{ {{\text{t}}_{{\text{j}}} {\text{|E}}_{j}^{{{\text{TTS}}\_{\text{T }}}} &lt; {\text{E}}_{j}^{{{\text{TTS}}\_{\text{S }}}} ,1 \le {\text{j}} \le {\text{nT}}} \right\}$$\end{document}</tex-math><mml:math id="M148" display="block"><mml:mrow><mml:mtext>T</mml:mtext><mml:mi>_</mml:mi><mml:mtext>B</mml:mtext><mml:mo>=</mml:mo><mml:mfenced close="}" open="{"><mml:mrow><mml:msub><mml:mtext>t</mml:mtext><mml:mtext>j</mml:mtext></mml:msub><mml:msubsup><mml:mtext>|E</mml:mtext><mml:mrow><mml:mi>j</mml:mi></mml:mrow><mml:mrow><mml:mtext>TTS</mml:mtext><mml:mi>_</mml:mi><mml:mrow><mml:mtext>T</mml:mtext><mml:mspace width="0.333333em"/></mml:mrow></mml:mrow></mml:msubsup><mml:mo>&lt;</mml:mo><mml:msubsup><mml:mtext>E</mml:mtext><mml:mrow><mml:mi>j</mml:mi></mml:mrow><mml:mrow><mml:mtext>TTS</mml:mtext><mml:mi>_</mml:mi><mml:mrow><mml:mtext>S</mml:mtext><mml:mspace width="0.333333em"/></mml:mrow></mml:mrow></mml:msubsup><mml:mo>,</mml:mo><mml:mn>1</mml:mn><mml:mo>≤</mml:mo><mml:mtext>j</mml:mtext><mml:mo>≤</mml:mo><mml:mtext>nT</mml:mtext></mml:mrow></mml:mfenced></mml:mrow></mml:math><graphic xlink:href="12859_2021_4522_Article_Equ14.gif" position="anchor"/></alternatives></disp-formula><disp-formula id="Equ15"><label>15</label><alternatives><tex-math id="M149">\documentclass[12pt]{minimal}
				\usepackage{amsmath}
				\usepackage{wasysym} 
				\usepackage{amsfonts} 
				\usepackage{amssymb} 
				\usepackage{amsbsy}
				\usepackage{mathrsfs}
				\usepackage{upgreek}
				\setlength{\oddsidemargin}{-69pt}
				\begin{document}$${\text{T}}\_{\text{A}}\_{\text{a}} = \left\{ {{\text{t}}_{{\text{i}}} {\text{|E}}_{i}^{{{\text{TTS}}\_{\text{S}}_{{{\text{T}}\_{\text{A}},{\text{T}}\_{\text{B}}}} { }}} \le {\text{E}}_{i}^{{{\text{TTS}}\_{\text{T}}_{{{\text{T}}\_{\text{A}},{\text{T}}\_{\text{B}}}} { }}} ,1 \le {\text{i}} \le \left| {{\text{T}}\_{\text{A}}} \right|} \right\}$$\end{document}</tex-math><mml:math id="M150" display="block"><mml:mrow><mml:mtext>T</mml:mtext><mml:mi>_</mml:mi><mml:mtext>A</mml:mtext><mml:mi>_</mml:mi><mml:mtext>a</mml:mtext><mml:mo>=</mml:mo><mml:mfenced close="}" open="{"><mml:mrow><mml:msub><mml:mtext>t</mml:mtext><mml:mtext>i</mml:mtext></mml:msub><mml:msubsup><mml:mtext>|E</mml:mtext><mml:mrow><mml:mi>i</mml:mi></mml:mrow><mml:mrow><mml:mtext>TTS</mml:mtext><mml:mi>_</mml:mi><mml:msub><mml:mtext>S</mml:mtext><mml:mrow><mml:mtext>T</mml:mtext><mml:mi>_</mml:mi><mml:mtext>A</mml:mtext><mml:mo>,</mml:mo><mml:mtext>T</mml:mtext><mml:mi>_</mml:mi><mml:mtext>B</mml:mtext></mml:mrow></mml:msub><mml:mrow/></mml:mrow></mml:msubsup><mml:mo>≤</mml:mo><mml:msubsup><mml:mtext>E</mml:mtext><mml:mrow><mml:mi>i</mml:mi></mml:mrow><mml:mrow><mml:mtext>TTS</mml:mtext><mml:mi>_</mml:mi><mml:msub><mml:mtext>T</mml:mtext><mml:mrow><mml:mtext>T</mml:mtext><mml:mi>_</mml:mi><mml:mtext>A</mml:mtext><mml:mo>,</mml:mo><mml:mtext>T</mml:mtext><mml:mi>_</mml:mi><mml:mtext>B</mml:mtext></mml:mrow></mml:msub><mml:mrow/></mml:mrow></mml:msubsup><mml:mo>,</mml:mo><mml:mn>1</mml:mn><mml:mo>≤</mml:mo><mml:mtext>i</mml:mtext><mml:mo>≤</mml:mo><mml:mfenced close="|" open="|"><mml:mrow><mml:mtext>T</mml:mtext><mml:mi>_</mml:mi><mml:mtext>A</mml:mtext></mml:mrow></mml:mfenced></mml:mrow></mml:mfenced></mml:mrow></mml:math><graphic xlink:href="12859_2021_4522_Article_Equ15.gif" position="anchor"/></alternatives></disp-formula><disp-formula id="Equ16"><label>16</label><alternatives><tex-math id="M151">\documentclass[12pt]{minimal}
				\usepackage{amsmath}
				\usepackage{wasysym} 
				\usepackage{amsfonts} 
				\usepackage{amssymb} 
				\usepackage{amsbsy}
				\usepackage{mathrsfs}
				\usepackage{upgreek}
				\setlength{\oddsidemargin}{-69pt}
				\begin{document}$${\text{T}}\_{\text{A}}\_{\text{b}} = \left\{ {{\text{t}}_{{\text{j}}} {\text{|E}}_{j}^{{{\text{TTS}}\_{\text{T}}_{{{\text{T}}\_{\text{A}},{\text{T}}\_{\text{B}}}} { }}} &lt; {\text{E}}_{j}^{{{\text{TTS}}\_{\text{S}}_{{{\text{T}}\_{\text{A}},{\text{T}}\_{\text{B}}}} { }}} ,1 \le {\text{j}} \le \left| {{\text{T}}\_{\text{A}}} \right|} \right\}$$\end{document}</tex-math><mml:math id="M152" display="block"><mml:mrow><mml:mtext>T</mml:mtext><mml:mi>_</mml:mi><mml:mtext>A</mml:mtext><mml:mi>_</mml:mi><mml:mtext>b</mml:mtext><mml:mo>=</mml:mo><mml:mfenced close="}" open="{"><mml:mrow><mml:msub><mml:mtext>t</mml:mtext><mml:mtext>j</mml:mtext></mml:msub><mml:msubsup><mml:mtext>|E</mml:mtext><mml:mrow><mml:mi>j</mml:mi></mml:mrow><mml:mrow><mml:mtext>TTS</mml:mtext><mml:mi>_</mml:mi><mml:msub><mml:mtext>T</mml:mtext><mml:mrow><mml:mtext>T</mml:mtext><mml:mi>_</mml:mi><mml:mtext>A</mml:mtext><mml:mo>,</mml:mo><mml:mtext>T</mml:mtext><mml:mi>_</mml:mi><mml:mtext>B</mml:mtext></mml:mrow></mml:msub><mml:mrow/></mml:mrow></mml:msubsup><mml:mo>&lt;</mml:mo><mml:msubsup><mml:mtext>E</mml:mtext><mml:mrow><mml:mi>j</mml:mi></mml:mrow><mml:mrow><mml:mtext>TTS</mml:mtext><mml:mi>_</mml:mi><mml:msub><mml:mtext>S</mml:mtext><mml:mrow><mml:mtext>T</mml:mtext><mml:mi>_</mml:mi><mml:mtext>A</mml:mtext><mml:mo>,</mml:mo><mml:mtext>T</mml:mtext><mml:mi>_</mml:mi><mml:mtext>B</mml:mtext></mml:mrow></mml:msub><mml:mrow/></mml:mrow></mml:msubsup><mml:mo>,</mml:mo><mml:mn>1</mml:mn><mml:mo>≤</mml:mo><mml:mtext>j</mml:mtext><mml:mo>≤</mml:mo><mml:mfenced close="|" open="|"><mml:mrow><mml:mtext>T</mml:mtext><mml:mi>_</mml:mi><mml:mtext>A</mml:mtext></mml:mrow></mml:mfenced></mml:mrow></mml:mfenced></mml:mrow></mml:math><graphic xlink:href="12859_2021_4522_Article_Equ16.gif" position="anchor"/></alternatives></disp-formula></p>
      <p id="Par28">Finally, <inline-formula id="IEq58"><alternatives><tex-math id="M153">\documentclass[12pt]{minimal}
				\usepackage{amsmath}
				\usepackage{wasysym} 
				\usepackage{amsfonts} 
				\usepackage{amssymb} 
				\usepackage{amsbsy}
				\usepackage{mathrsfs}
				\usepackage{upgreek}
				\setlength{\oddsidemargin}{-69pt}
				\begin{document}$${\text{TTS}}\_{\text{S}}$$\end{document}</tex-math><mml:math id="M154"><mml:mrow><mml:mtext>TTS</mml:mtext><mml:mi>_</mml:mi><mml:mtext>S</mml:mtext></mml:mrow></mml:math><inline-graphic xlink:href="12859_2021_4522_Article_IEq58.gif"/></alternatives></inline-formula> and <inline-formula id="IEq59"><alternatives><tex-math id="M155">\documentclass[12pt]{minimal}
				\usepackage{amsmath}
				\usepackage{wasysym} 
				\usepackage{amsfonts} 
				\usepackage{amssymb} 
				\usepackage{amsbsy}
				\usepackage{mathrsfs}
				\usepackage{upgreek}
				\setlength{\oddsidemargin}{-69pt}
				\begin{document}$${\text{TTS}}\_{\text{T}}$$\end{document}</tex-math><mml:math id="M156"><mml:mrow><mml:mtext>TTS</mml:mtext><mml:mi>_</mml:mi><mml:mtext>T</mml:mtext></mml:mrow></mml:math><inline-graphic xlink:href="12859_2021_4522_Article_IEq59.gif"/></alternatives></inline-formula> were integrated into the final target similarity matrix <inline-formula id="IEq60"><alternatives><tex-math id="M157">\documentclass[12pt]{minimal}
				\usepackage{amsmath}
				\usepackage{wasysym} 
				\usepackage{amsfonts} 
				\usepackage{amssymb} 
				\usepackage{amsbsy}
				\usepackage{mathrsfs}
				\usepackage{upgreek}
				\setlength{\oddsidemargin}{-69pt}
				\begin{document}$${\text{TTS}}^{nT \times nT}$$\end{document}</tex-math><mml:math id="M158"><mml:msup><mml:mrow><mml:mtext>TTS</mml:mtext></mml:mrow><mml:mrow><mml:mi>n</mml:mi><mml:mi>T</mml:mi><mml:mo>×</mml:mo><mml:mi>n</mml:mi><mml:mi>T</mml:mi></mml:mrow></mml:msup></mml:math><inline-graphic xlink:href="12859_2021_4522_Article_IEq60.gif"/></alternatives></inline-formula>:<disp-formula id="Equ17"><label>17</label><alternatives><tex-math id="M159">\documentclass[12pt]{minimal}
				\usepackage{amsmath}
				\usepackage{wasysym} 
				\usepackage{amsfonts} 
				\usepackage{amssymb} 
				\usepackage{amsbsy}
				\usepackage{mathrsfs}
				\usepackage{upgreek}
				\setlength{\oddsidemargin}{-69pt}
				\begin{document}$${\text{TTS}} = \left[ {\begin{array}{*{20}c} {{\text{TTS}}\_{\text{S}}_{{{\text{T}}\_{\text{A}},{\text{T}}\_{\text{A}}}} } &amp; {\left[ {\begin{array}{*{20}c} {{\text{TTS}}\_{\text{S}}_{{{\text{T}}\_{\text{A}}\_{\text{a}},{\text{T}}\_{\text{B}}}} } \\ {{\text{TTS}}\_{\text{T}}_{{{\text{T}}\_{\text{A}}\_{\text{b}},{\text{T}}\_{\text{B}}}} } \\ \end{array} } \right]} \\ {\left[ {\begin{array}{*{20}c} {{\text{TTS}}\_{\text{S}}_{{{\text{T}}\_{\text{A}}\_{\text{a}},{\text{T}}\_{\text{B}}}} } \\ {{\text{TTS}}\_{\text{T}}_{{{\text{T}}\_{\text{A}}\_{\text{b}},{\text{T}}\_{\text{B}}}} } \\ \end{array} } \right]^{T} } &amp; {{\text{TTS}}\_{\text{T}}_{{{\text{T}}\_{\text{B}},{\text{T}}\_{\text{B}}}} } \\ \end{array} } \right]$$\end{document}</tex-math><mml:math id="M160" display="block"><mml:mrow><mml:mtext>TTS</mml:mtext><mml:mo>=</mml:mo><mml:mfenced close="]" open="["><mml:mrow><mml:mtable><mml:mtr><mml:mtd><mml:mrow><mml:mtext>TTS</mml:mtext><mml:mi>_</mml:mi><mml:msub><mml:mtext>S</mml:mtext><mml:mrow><mml:mtext>T</mml:mtext><mml:mi>_</mml:mi><mml:mtext>A</mml:mtext><mml:mo>,</mml:mo><mml:mtext>T</mml:mtext><mml:mi>_</mml:mi><mml:mtext>A</mml:mtext></mml:mrow></mml:msub></mml:mrow></mml:mtd><mml:mtd><mml:mfenced close="]" open="["><mml:mrow><mml:mtable><mml:mtr><mml:mtd><mml:mrow><mml:mtext>TTS</mml:mtext><mml:mi>_</mml:mi><mml:msub><mml:mtext>S</mml:mtext><mml:mrow><mml:mtext>T</mml:mtext><mml:mi>_</mml:mi><mml:mtext>A</mml:mtext><mml:mi>_</mml:mi><mml:mtext>a</mml:mtext><mml:mo>,</mml:mo><mml:mtext>T</mml:mtext><mml:mi>_</mml:mi><mml:mtext>B</mml:mtext></mml:mrow></mml:msub></mml:mrow></mml:mtd></mml:mtr><mml:mtr><mml:mtd><mml:mrow><mml:mrow/><mml:mrow><mml:mtext>TTS</mml:mtext><mml:mi>_</mml:mi><mml:msub><mml:mtext>T</mml:mtext><mml:mrow><mml:mtext>T</mml:mtext><mml:mi>_</mml:mi><mml:mtext>A</mml:mtext><mml:mi>_</mml:mi><mml:mtext>b</mml:mtext><mml:mo>,</mml:mo><mml:mtext>T</mml:mtext><mml:mi>_</mml:mi><mml:mtext>B</mml:mtext></mml:mrow></mml:msub></mml:mrow></mml:mrow></mml:mtd></mml:mtr></mml:mtable></mml:mrow></mml:mfenced></mml:mtd></mml:mtr><mml:mtr><mml:mtd><mml:mrow><mml:mrow/><mml:msup><mml:mfenced close="]" open="["><mml:mrow><mml:mtable><mml:mtr><mml:mtd><mml:mrow><mml:mtext>TTS</mml:mtext><mml:mi>_</mml:mi><mml:msub><mml:mtext>S</mml:mtext><mml:mrow><mml:mtext>T</mml:mtext><mml:mi>_</mml:mi><mml:mtext>A</mml:mtext><mml:mi>_</mml:mi><mml:mtext>a</mml:mtext><mml:mo>,</mml:mo><mml:mtext>T</mml:mtext><mml:mi>_</mml:mi><mml:mtext>B</mml:mtext></mml:mrow></mml:msub></mml:mrow></mml:mtd></mml:mtr><mml:mtr><mml:mtd><mml:mrow><mml:mrow/><mml:mrow><mml:mtext>TTS</mml:mtext><mml:mi>_</mml:mi><mml:msub><mml:mtext>T</mml:mtext><mml:mrow><mml:mtext>T</mml:mtext><mml:mi>_</mml:mi><mml:mtext>A</mml:mtext><mml:mi>_</mml:mi><mml:mtext>b</mml:mtext><mml:mo>,</mml:mo><mml:mtext>T</mml:mtext><mml:mi>_</mml:mi><mml:mtext>B</mml:mtext></mml:mrow></mml:msub></mml:mrow></mml:mrow></mml:mtd></mml:mtr></mml:mtable></mml:mrow></mml:mfenced><mml:mi>T</mml:mi></mml:msup></mml:mrow></mml:mtd><mml:mtd><mml:mrow><mml:mtext>TTS</mml:mtext><mml:mi>_</mml:mi><mml:msub><mml:mtext>T</mml:mtext><mml:mrow><mml:mtext>T</mml:mtext><mml:mi>_</mml:mi><mml:mtext>B</mml:mtext><mml:mo>,</mml:mo><mml:mtext>T</mml:mtext><mml:mi>_</mml:mi><mml:mtext>B</mml:mtext></mml:mrow></mml:msub></mml:mrow></mml:mtd></mml:mtr></mml:mtable></mml:mrow></mml:mfenced></mml:mrow></mml:math><graphic xlink:href="12859_2021_4522_Article_Equ17.gif" position="anchor"/></alternatives></disp-formula></p>
      <p id="Par29">(3) The drug-drug topological structure similarity networks. We calculated drugs’ topological structure similarities in the target-drug interaction network and the disease-drug association network, respectively. They were represented as <inline-formula id="IEq61"><alternatives><tex-math id="M161">\documentclass[12pt]{minimal}
				\usepackage{amsmath}
				\usepackage{wasysym} 
				\usepackage{amsfonts} 
				\usepackage{amssymb} 
				\usepackage{amsbsy}
				\usepackage{mathrsfs}
				\usepackage{upgreek}
				\setlength{\oddsidemargin}{-69pt}
				\begin{document}$${\text{MMS}}\_{\text{T}}^{{{\text{nM}} \times {\text{nM}}}}$$\end{document}</tex-math><mml:math id="M162"><mml:mrow><mml:mtext>MMS</mml:mtext><mml:mi>_</mml:mi><mml:msup><mml:mrow><mml:mtext>T</mml:mtext></mml:mrow><mml:mrow><mml:mtext>nM</mml:mtext><mml:mo>×</mml:mo><mml:mtext>nM</mml:mtext></mml:mrow></mml:msup></mml:mrow></mml:math><inline-graphic xlink:href="12859_2021_4522_Article_IEq61.gif"/></alternatives></inline-formula> and <inline-formula id="IEq62"><alternatives><tex-math id="M163">\documentclass[12pt]{minimal}
				\usepackage{amsmath}
				\usepackage{wasysym} 
				\usepackage{amsfonts} 
				\usepackage{amssymb} 
				\usepackage{amsbsy}
				\usepackage{mathrsfs}
				\usepackage{upgreek}
				\setlength{\oddsidemargin}{-69pt}
				\begin{document}$${\text{ MMS}}\_{\text{D}}^{{{\text{nM}} \times {\text{nM}}}}$$\end{document}</tex-math><mml:math id="M164"><mml:mrow><mml:mrow><mml:mspace width="0.333333em"/><mml:mtext>MMS</mml:mtext></mml:mrow><mml:mi>_</mml:mi><mml:msup><mml:mrow><mml:mtext>D</mml:mtext></mml:mrow><mml:mrow><mml:mtext>nM</mml:mtext><mml:mo>×</mml:mo><mml:mtext>nM</mml:mtext></mml:mrow></mml:msup></mml:mrow></mml:math><inline-graphic xlink:href="12859_2021_4522_Article_IEq62.gif"/></alternatives></inline-formula>, respectively:<disp-formula id="Equ18"><label>18</label><alternatives><tex-math id="M165">\documentclass[12pt]{minimal}
				\usepackage{amsmath}
				\usepackage{wasysym} 
				\usepackage{amsfonts} 
				\usepackage{amssymb} 
				\usepackage{amsbsy}
				\usepackage{mathrsfs}
				\usepackage{upgreek}
				\setlength{\oddsidemargin}{-69pt}
				\begin{document}$${\text{MMS}}\_{\text{T}}_{{i,j}} = {\text{exp}}\left( { - \gamma ||TDI_{{,i}} - TDI_{{,j}} ||^{2} } \right)$$\end{document}</tex-math><mml:math id="M166" display="block"><mml:mrow><mml:mtext>MMS</mml:mtext><mml:mi>_</mml:mi><mml:msub><mml:mtext>T</mml:mtext><mml:mrow><mml:mi>i</mml:mi><mml:mo>,</mml:mo><mml:mi>j</mml:mi></mml:mrow></mml:msub><mml:mo>=</mml:mo><mml:mtext>exp</mml:mtext><mml:mfenced close=")" open="("><mml:mrow><mml:mo>-</mml:mo><mml:mrow><mml:mi>γ</mml:mi><mml:mo stretchy="false">|</mml:mo><mml:mo stretchy="false">|</mml:mo><mml:mi>T</mml:mi><mml:mi>D</mml:mi></mml:mrow><mml:msub><mml:mi>I</mml:mi><mml:mrow><mml:mo>,</mml:mo><mml:mi>i</mml:mi></mml:mrow></mml:msub><mml:mo>-</mml:mo><mml:mi>T</mml:mi><mml:mi>D</mml:mi><mml:msub><mml:mi>I</mml:mi><mml:mrow><mml:mo>,</mml:mo><mml:mi>j</mml:mi></mml:mrow></mml:msub><mml:msup><mml:mrow><mml:mo stretchy="false">|</mml:mo><mml:mo stretchy="false">|</mml:mo></mml:mrow><mml:mn>2</mml:mn></mml:msup></mml:mrow></mml:mfenced></mml:mrow></mml:math><graphic xlink:href="12859_2021_4522_Article_Equ18.gif" position="anchor"/></alternatives></disp-formula><disp-formula id="Equd"><alternatives><tex-math id="M167">\documentclass[12pt]{minimal}
				\usepackage{amsmath}
				\usepackage{wasysym} 
				\usepackage{amsfonts} 
				\usepackage{amssymb} 
				\usepackage{amsbsy}
				\usepackage{mathrsfs}
				\usepackage{upgreek}
				\setlength{\oddsidemargin}{-69pt}
				\begin{document}$$\gamma = {{\gamma ^{\prime } } \mathord{\left/ {\vphantom {{\gamma ^{\prime } } {\frac{1}{{nM}}\sum\limits_{{k = 1}}^{{nM}} {||TDI_{{,k}} ||^{2} } }}} \right. \kern-\nulldelimiterspace} {\frac{1}{{nM}}\sum\limits_{{k = 1}}^{{nM}} {||TDI_{{,k}} ||^{2} } }}$$\end{document}</tex-math><mml:math id="M168" display="block"><mml:mrow><mml:mi>γ</mml:mi><mml:mo>=</mml:mo><mml:mrow><mml:msup><mml:mi>γ</mml:mi><mml:mo>′</mml:mo></mml:msup><mml:mrow><mml:mo stretchy="true">/</mml:mo></mml:mrow><mml:mrow><mml:mfrac><mml:mn>1</mml:mn><mml:mrow><mml:mi mathvariant="italic">nM</mml:mi></mml:mrow></mml:mfrac><mml:munderover><mml:mo movablelimits="false">∑</mml:mo><mml:mrow><mml:mrow><mml:mi>k</mml:mi><mml:mo>=</mml:mo><mml:mn>1</mml:mn></mml:mrow></mml:mrow><mml:mrow><mml:mi mathvariant="italic">nM</mml:mi></mml:mrow></mml:munderover><mml:mrow><mml:mrow><mml:mo stretchy="false">|</mml:mo><mml:mo stretchy="false">|</mml:mo><mml:mi>T</mml:mi><mml:mi>D</mml:mi></mml:mrow><mml:msub><mml:mi>I</mml:mi><mml:mrow><mml:mo>,</mml:mo><mml:mi>k</mml:mi></mml:mrow></mml:msub><mml:msup><mml:mrow><mml:mo stretchy="false">|</mml:mo><mml:mo stretchy="false">|</mml:mo></mml:mrow><mml:mn>2</mml:mn></mml:msup></mml:mrow></mml:mrow></mml:mrow></mml:mrow></mml:math><graphic xlink:href="12859_2021_4522_Article_Equd.gif" position="anchor"/></alternatives></disp-formula><disp-formula id="Equ19"><label>19</label><alternatives><tex-math id="M169">\documentclass[12pt]{minimal}
				\usepackage{amsmath}
				\usepackage{wasysym} 
				\usepackage{amsfonts} 
				\usepackage{amssymb} 
				\usepackage{amsbsy}
				\usepackage{mathrsfs}
				\usepackage{upgreek}
				\setlength{\oddsidemargin}{-69pt}
				\begin{document}$${\text{MMS}}\_{\text{D}}_{{i,j}} = {\text{exp}}\left( { - \delta ||DDA_{{,i}} - DDA_{{,j}} ||^{2} } \right)$$\end{document}</tex-math><mml:math id="M170" display="block"><mml:mrow><mml:mtext>MMS</mml:mtext><mml:mi>_</mml:mi><mml:msub><mml:mtext>D</mml:mtext><mml:mrow><mml:mi>i</mml:mi><mml:mo>,</mml:mo><mml:mi>j</mml:mi></mml:mrow></mml:msub><mml:mo>=</mml:mo><mml:mtext>exp</mml:mtext><mml:mfenced close=")" open="("><mml:mrow><mml:mo>-</mml:mo><mml:mrow><mml:mi>δ</mml:mi><mml:mo stretchy="false">|</mml:mo><mml:mo stretchy="false">|</mml:mo><mml:mi>D</mml:mi><mml:mi>D</mml:mi></mml:mrow><mml:msub><mml:mi>A</mml:mi><mml:mrow><mml:mo>,</mml:mo><mml:mi>i</mml:mi></mml:mrow></mml:msub><mml:mo>-</mml:mo><mml:mi>D</mml:mi><mml:mi>D</mml:mi><mml:msub><mml:mi>A</mml:mi><mml:mrow><mml:mo>,</mml:mo><mml:mi>j</mml:mi></mml:mrow></mml:msub><mml:msup><mml:mrow><mml:mo stretchy="false">|</mml:mo><mml:mo stretchy="false">|</mml:mo></mml:mrow><mml:mn>2</mml:mn></mml:msup></mml:mrow></mml:mfenced></mml:mrow></mml:math><graphic xlink:href="12859_2021_4522_Article_Equ19.gif" position="anchor"/></alternatives></disp-formula><disp-formula id="Eque"><alternatives><tex-math id="M171">\documentclass[12pt]{minimal}
				\usepackage{amsmath}
				\usepackage{wasysym} 
				\usepackage{amsfonts} 
				\usepackage{amssymb} 
				\usepackage{amsbsy}
				\usepackage{mathrsfs}
				\usepackage{upgreek}
				\setlength{\oddsidemargin}{-69pt}
				\begin{document}$$\delta = {{\delta ^{\prime } } \mathord{\left/ {\vphantom {{\delta ^{\prime } } {\frac{1}{{nM}}\sum\limits_{{k = 1}}^{{nM}} {||DDA_{{,k}} ||^{2} } }}} \right. \kern-\nulldelimiterspace} {\frac{1}{{nM}}\sum\limits_{{k = 1}}^{{nM}} {||DDA_{{,k}} ||^{2} } }}$$\end{document}</tex-math><mml:math id="M172" display="block"><mml:mrow><mml:mi>δ</mml:mi><mml:mo>=</mml:mo><mml:mrow><mml:msup><mml:mi>δ</mml:mi><mml:mo>′</mml:mo></mml:msup><mml:mrow><mml:mo stretchy="true">/</mml:mo></mml:mrow><mml:mrow><mml:mfrac><mml:mn>1</mml:mn><mml:mrow><mml:mi mathvariant="italic">nM</mml:mi></mml:mrow></mml:mfrac><mml:munderover><mml:mo movablelimits="false">∑</mml:mo><mml:mrow><mml:mrow><mml:mi>k</mml:mi><mml:mo>=</mml:mo><mml:mn>1</mml:mn></mml:mrow></mml:mrow><mml:mrow><mml:mi mathvariant="italic">nM</mml:mi></mml:mrow></mml:munderover><mml:mrow><mml:mrow><mml:mo stretchy="false">|</mml:mo><mml:mo stretchy="false">|</mml:mo><mml:mi>D</mml:mi><mml:mi>D</mml:mi></mml:mrow><mml:msub><mml:mi>A</mml:mi><mml:mrow><mml:mo>,</mml:mo><mml:mi>k</mml:mi></mml:mrow></mml:msub><mml:msup><mml:mrow><mml:mo stretchy="false">|</mml:mo><mml:mo stretchy="false">|</mml:mo></mml:mrow><mml:mn>2</mml:mn></mml:msup></mml:mrow></mml:mrow></mml:mrow></mml:mrow></mml:math><graphic xlink:href="12859_2021_4522_Article_Eque.gif" position="anchor"/></alternatives></disp-formula>where <inline-formula id="IEq63"><alternatives><tex-math id="M173">\documentclass[12pt]{minimal}
				\usepackage{amsmath}
				\usepackage{wasysym} 
				\usepackage{amsfonts} 
				\usepackage{amssymb} 
				\usepackage{amsbsy}
				\usepackage{mathrsfs}
				\usepackage{upgreek}
				\setlength{\oddsidemargin}{-69pt}
				\begin{document}$$1 \le {\text{i}},{\text{j}} \le {\text{nM}}$$\end{document}</tex-math><mml:math id="M174"><mml:mrow><mml:mn>1</mml:mn><mml:mo>≤</mml:mo><mml:mtext>i</mml:mtext><mml:mo>,</mml:mo><mml:mtext>j</mml:mtext><mml:mo>≤</mml:mo><mml:mtext>nM</mml:mtext></mml:mrow></mml:math><inline-graphic xlink:href="12859_2021_4522_Article_IEq63.gif"/></alternatives></inline-formula>; <inline-formula id="IEq64"><alternatives><tex-math id="M175">\documentclass[12pt]{minimal}
				\usepackage{amsmath}
				\usepackage{wasysym} 
				\usepackage{amsfonts} 
				\usepackage{amssymb} 
				\usepackage{amsbsy}
				\usepackage{mathrsfs}
				\usepackage{upgreek}
				\setlength{\oddsidemargin}{-69pt}
				\begin{document}$$TDI_{,i}$$\end{document}</tex-math><mml:math id="M176"><mml:mrow><mml:mi>T</mml:mi><mml:mi>D</mml:mi><mml:msub><mml:mi>I</mml:mi><mml:mrow><mml:mo>,</mml:mo><mml:mi>i</mml:mi></mml:mrow></mml:msub></mml:mrow></mml:math><inline-graphic xlink:href="12859_2021_4522_Article_IEq64.gif"/></alternatives></inline-formula> and <inline-formula id="IEq65"><alternatives><tex-math id="M177">\documentclass[12pt]{minimal}
				\usepackage{amsmath}
				\usepackage{wasysym} 
				\usepackage{amsfonts} 
				\usepackage{amssymb} 
				\usepackage{amsbsy}
				\usepackage{mathrsfs}
				\usepackage{upgreek}
				\setlength{\oddsidemargin}{-69pt}
				\begin{document}$$DDA_{,i}$$\end{document}</tex-math><mml:math id="M178"><mml:mrow><mml:mi>D</mml:mi><mml:mi>D</mml:mi><mml:msub><mml:mi>A</mml:mi><mml:mrow><mml:mo>,</mml:mo><mml:mi>i</mml:mi></mml:mrow></mml:msub></mml:mrow></mml:math><inline-graphic xlink:href="12859_2021_4522_Article_IEq65.gif"/></alternatives></inline-formula> was the <italic>i</italic>th column of <inline-formula id="IEq66"><alternatives><tex-math id="M179">\documentclass[12pt]{minimal}
				\usepackage{amsmath}
				\usepackage{wasysym} 
				\usepackage{amsfonts} 
				\usepackage{amssymb} 
				\usepackage{amsbsy}
				\usepackage{mathrsfs}
				\usepackage{upgreek}
				\setlength{\oddsidemargin}{-69pt}
				\begin{document}$$TDI$$\end{document}</tex-math><mml:math id="M180"><mml:mrow><mml:mi mathvariant="italic">TDI</mml:mi></mml:mrow></mml:math><inline-graphic xlink:href="12859_2021_4522_Article_IEq66.gif"/></alternatives></inline-formula> and <inline-formula id="IEq67"><alternatives><tex-math id="M181">\documentclass[12pt]{minimal}
				\usepackage{amsmath}
				\usepackage{wasysym} 
				\usepackage{amsfonts} 
				\usepackage{amssymb} 
				\usepackage{amsbsy}
				\usepackage{mathrsfs}
				\usepackage{upgreek}
				\setlength{\oddsidemargin}{-69pt}
				\begin{document}$$DDA$$\end{document}</tex-math><mml:math id="M182"><mml:mrow><mml:mi mathvariant="italic">DDA</mml:mi></mml:mrow></mml:math><inline-graphic xlink:href="12859_2021_4522_Article_IEq67.gif"/></alternatives></inline-formula>, respectively; <inline-formula id="IEq68"><alternatives><tex-math id="M183">\documentclass[12pt]{minimal}
				\usepackage{amsmath}
				\usepackage{wasysym} 
				\usepackage{amsfonts} 
				\usepackage{amssymb} 
				\usepackage{amsbsy}
				\usepackage{mathrsfs}
				\usepackage{upgreek}
				\setlength{\oddsidemargin}{-69pt}
				\begin{document}$$\gamma^{\prime} = 1$$\end{document}</tex-math><mml:math id="M184"><mml:mrow><mml:msup><mml:mi>γ</mml:mi><mml:mo>′</mml:mo></mml:msup><mml:mo>=</mml:mo><mml:mn>1</mml:mn></mml:mrow></mml:math><inline-graphic xlink:href="12859_2021_4522_Article_IEq68.gif"/></alternatives></inline-formula>;<inline-formula id="IEq69"><alternatives><tex-math id="M185">\documentclass[12pt]{minimal}
				\usepackage{amsmath}
				\usepackage{wasysym} 
				\usepackage{amsfonts} 
				\usepackage{amssymb} 
				\usepackage{amsbsy}
				\usepackage{mathrsfs}
				\usepackage{upgreek}
				\setlength{\oddsidemargin}{-69pt}
				\begin{document}$$\delta^{\prime} = 1$$\end{document}</tex-math><mml:math id="M186"><mml:mrow><mml:msup><mml:mi>δ</mml:mi><mml:mo>′</mml:mo></mml:msup><mml:mo>=</mml:mo><mml:mn>1</mml:mn></mml:mrow></mml:math><inline-graphic xlink:href="12859_2021_4522_Article_IEq69.gif"/></alternatives></inline-formula>.</p>
      <p id="Par30">Finally, the heterogeneous network was constructed as shown in (Fig. <xref rid="Fig1" ref-type="fig">1</xref>b)). The characteristics of data in these networks were summarized in Table <xref rid="Tab1" ref-type="table">1</xref>, where the sparsity was the ratio of edges to the network size. Obviously, our objective network (the target-disease association network) was the most imbalanced.<table-wrap id="Tab1"><label>Table 1</label><caption><p>The instruction of the five networks’ characteristics</p></caption><table frame="hsides" rules="groups"><thead><tr><th align="left">Network</th><th align="left">Size of the network</th><th align="left">Number of the edges</th><th align="left">Range of the edges’ weight</th><th align="left">Sparsity</th></tr></thead><tbody><tr><td align="left">The target-disease association network</td><td align="left">1002*1035</td><td align="left">7342</td><td align="left">0 or 1</td><td align="left">0.007</td></tr><tr><td align="left">The target-drug interaction network</td><td align="left">1002*1095</td><td align="left">38,871</td><td align="left">0 or 1</td><td align="left">0.035</td></tr><tr><td align="left">The disease-drug association network</td><td align="left">1035*1095</td><td align="left">35,319</td><td align="left">0 or 1</td><td align="left">0.031</td></tr><tr><td align="left">The disease-disease similarity network</td><td align="left">1035*1035</td><td align="left">1,071,225</td><td align="left">[0,1]</td><td align="left">1</td></tr><tr><td align="left">The target-target similarity network</td><td align="left">1002*1002</td><td align="left">1,004,004</td><td align="left">[0,1]</td><td align="left">1</td></tr><tr><td align="left">The drug-drug topological structure similarity network</td><td align="left">1095*1095</td><td align="left">1,199,025</td><td align="left">[0,1]</td><td align="left">1</td></tr></tbody></table></table-wrap></p>
    </sec>
    <sec id="Sec5">
      <title>Feature construction for model training to score unconfirmed target-disease pairs</title>
      <p id="Par31">For target-disease pair <inline-formula id="IEq70"><alternatives><tex-math id="M187">\documentclass[12pt]{minimal}
				\usepackage{amsmath}
				\usepackage{wasysym} 
				\usepackage{amsfonts} 
				\usepackage{amssymb} 
				\usepackage{amsbsy}
				\usepackage{mathrsfs}
				\usepackage{upgreek}
				\setlength{\oddsidemargin}{-69pt}
				\begin{document}$${\text{ t}}_{{\text{i}}}$$\end{document}</tex-math><mml:math id="M188"><mml:msub><mml:mrow><mml:mspace width="0.333333em"/><mml:mtext>t</mml:mtext></mml:mrow><mml:mtext>i</mml:mtext></mml:msub></mml:math><inline-graphic xlink:href="12859_2021_4522_Article_IEq70.gif"/></alternatives></inline-formula>-<inline-formula id="IEq71"><alternatives><tex-math id="M189">\documentclass[12pt]{minimal}
				\usepackage{amsmath}
				\usepackage{wasysym} 
				\usepackage{amsfonts} 
				\usepackage{amssymb} 
				\usepackage{amsbsy}
				\usepackage{mathrsfs}
				\usepackage{upgreek}
				\setlength{\oddsidemargin}{-69pt}
				\begin{document}$${\text{ d}}_{{\text{j}}}$$\end{document}</tex-math><mml:math id="M190"><mml:msub><mml:mrow><mml:mspace width="0.333333em"/><mml:mtext>d</mml:mtext></mml:mrow><mml:mtext>j</mml:mtext></mml:msub></mml:math><inline-graphic xlink:href="12859_2021_4522_Article_IEq71.gif"/></alternatives></inline-formula> (<inline-formula id="IEq72"><alternatives><tex-math id="M191">\documentclass[12pt]{minimal}
				\usepackage{amsmath}
				\usepackage{wasysym} 
				\usepackage{amsfonts} 
				\usepackage{amssymb} 
				\usepackage{amsbsy}
				\usepackage{mathrsfs}
				\usepackage{upgreek}
				\setlength{\oddsidemargin}{-69pt}
				\begin{document}$$1 \le {\text{i}} \le {\text{nT}},{ }1 \le {\text{j}} \le {\text{nD}}$$\end{document}</tex-math><mml:math id="M192"><mml:mrow><mml:mn>1</mml:mn><mml:mo>≤</mml:mo><mml:mtext>i</mml:mtext><mml:mo>≤</mml:mo><mml:mtext>nT</mml:mtext><mml:mo>,</mml:mo><mml:mrow/><mml:mn>1</mml:mn><mml:mo>≤</mml:mo><mml:mtext>j</mml:mtext><mml:mo>≤</mml:mo><mml:mtext>nD</mml:mtext></mml:mrow></mml:math><inline-graphic xlink:href="12859_2021_4522_Article_IEq72.gif"/></alternatives></inline-formula>), we constructed a 9-dimension feature based on its neighborhood similarity information, drug-inferred information and path information (Fig. <xref rid="Fig1" ref-type="fig">1</xref>c)), shown in the following formulas:<disp-formula id="Equ20"><label>20</label><alternatives><tex-math id="M193">\documentclass[12pt]{minimal}
				\usepackage{amsmath}
				\usepackage{wasysym} 
				\usepackage{amsfonts} 
				\usepackage{amssymb} 
				\usepackage{amsbsy}
				\usepackage{mathrsfs}
				\usepackage{upgreek}
				\setlength{\oddsidemargin}{-69pt}
				\begin{document}$${\text{Fea}}1 = {\text{mean}}\left( {{\text{DDS}}_{{{\text{P}},{\text{j}}}} } \right)$$\end{document}</tex-math><mml:math id="M194" display="block"><mml:mrow><mml:mtext>Fea</mml:mtext><mml:mn>1</mml:mn><mml:mo>=</mml:mo><mml:mtext>mean</mml:mtext><mml:mfenced close=")" open="("><mml:msub><mml:mtext>DDS</mml:mtext><mml:mrow><mml:mtext>P</mml:mtext><mml:mo>,</mml:mo><mml:mtext>j</mml:mtext></mml:mrow></mml:msub></mml:mfenced></mml:mrow></mml:math><graphic xlink:href="12859_2021_4522_Article_Equ20.gif" position="anchor"/></alternatives></disp-formula><disp-formula id="Equf"><alternatives><tex-math id="M195">\documentclass[12pt]{minimal}
				\usepackage{amsmath}
				\usepackage{wasysym} 
				\usepackage{amsfonts} 
				\usepackage{amssymb} 
				\usepackage{amsbsy}
				\usepackage{mathrsfs}
				\usepackage{upgreek}
				\setlength{\oddsidemargin}{-69pt}
				\begin{document}$${\text{P}} = \left\{ {{\text{y| TDA}}_{{{\text{i}},{\text{y}}}} = 0,{ }1 \le {\text{y}} \le {\text{nD}}} \right\}$$\end{document}</tex-math><mml:math id="M196" display="block"><mml:mrow><mml:mtext>P</mml:mtext><mml:mo>=</mml:mo><mml:mfenced close="}" open="{"><mml:mrow><mml:msub><mml:mrow><mml:mtext>y| TDA</mml:mtext></mml:mrow><mml:mrow><mml:mtext>i</mml:mtext><mml:mo>,</mml:mo><mml:mtext>y</mml:mtext></mml:mrow></mml:msub><mml:mo>=</mml:mo><mml:mn>0</mml:mn><mml:mo>,</mml:mo><mml:mrow/><mml:mn>1</mml:mn><mml:mo>≤</mml:mo><mml:mtext>y</mml:mtext><mml:mo>≤</mml:mo><mml:mtext>nD</mml:mtext></mml:mrow></mml:mfenced></mml:mrow></mml:math><graphic xlink:href="12859_2021_4522_Article_Equf.gif" position="anchor"/></alternatives></disp-formula><disp-formula id="Equ21"><label>21</label><alternatives><tex-math id="M197">\documentclass[12pt]{minimal}
				\usepackage{amsmath}
				\usepackage{wasysym} 
				\usepackage{amsfonts} 
				\usepackage{amssymb} 
				\usepackage{amsbsy}
				\usepackage{mathrsfs}
				\usepackage{upgreek}
				\setlength{\oddsidemargin}{-69pt}
				\begin{document}$${\text{Fea}}2 = {\text{mean}}\left( {{\text{TTS}}_{{{\text{i}},{\text{Q}}}} } \right)$$\end{document}</tex-math><mml:math id="M198" display="block"><mml:mrow><mml:mtext>Fea</mml:mtext><mml:mn>2</mml:mn><mml:mo>=</mml:mo><mml:mtext>mean</mml:mtext><mml:mfenced close=")" open="("><mml:msub><mml:mtext>TTS</mml:mtext><mml:mrow><mml:mtext>i</mml:mtext><mml:mo>,</mml:mo><mml:mtext>Q</mml:mtext></mml:mrow></mml:msub></mml:mfenced></mml:mrow></mml:math><graphic xlink:href="12859_2021_4522_Article_Equ21.gif" position="anchor"/></alternatives></disp-formula><disp-formula id="Equg"><alternatives><tex-math id="M199">\documentclass[12pt]{minimal}
				\usepackage{amsmath}
				\usepackage{wasysym} 
				\usepackage{amsfonts} 
				\usepackage{amssymb} 
				\usepackage{amsbsy}
				\usepackage{mathrsfs}
				\usepackage{upgreek}
				\setlength{\oddsidemargin}{-69pt}
				\begin{document}$${\text{Q}} = \left\{ {{\text{x| TDA}}_{{{\text{x}},{\text{j}}}} = 0,{ }1 \le {\text{x}} \le {\text{nT}}} \right\}$$\end{document}</tex-math><mml:math id="M200" display="block"><mml:mrow><mml:mtext>Q</mml:mtext><mml:mo>=</mml:mo><mml:mfenced close="}" open="{"><mml:mrow><mml:msub><mml:mrow><mml:mtext>x| TDA</mml:mtext></mml:mrow><mml:mrow><mml:mtext>x</mml:mtext><mml:mo>,</mml:mo><mml:mtext>j</mml:mtext></mml:mrow></mml:msub><mml:mo>=</mml:mo><mml:mn>0</mml:mn><mml:mo>,</mml:mo><mml:mrow/><mml:mn>1</mml:mn><mml:mo>≤</mml:mo><mml:mtext>x</mml:mtext><mml:mo>≤</mml:mo><mml:mtext>nT</mml:mtext></mml:mrow></mml:mfenced></mml:mrow></mml:math><graphic xlink:href="12859_2021_4522_Article_Equg.gif" position="anchor"/></alternatives></disp-formula><disp-formula id="Equ22"><label>22</label><alternatives><tex-math id="M201">\documentclass[12pt]{minimal}
				\usepackage{amsmath}
				\usepackage{wasysym} 
				\usepackage{amsfonts} 
				\usepackage{amssymb} 
				\usepackage{amsbsy}
				\usepackage{mathrsfs}
				\usepackage{upgreek}
				\setlength{\oddsidemargin}{-69pt}
				\begin{document}$${\text{Fea}}3 = {\text{TTS}}_{{{\text{i}},{\text{a}}}} \times {\text{TDA}}_{{{\text{a}},{\text{j}}}} + {\text{TDA}}_{{{\text{i}},{\text{b}}}} \times {\text{DDS}}_{{{\text{b}},{\text{j}}}} + {\text{TTS}}_{{{\text{i}},{\text{a}}}} \times {\text{TDA}}_{{{\text{a}},{\text{b}}}} \times {\text{DDS}}_{{{\text{b}},{\text{j}}}}$$\end{document}</tex-math><mml:math id="M202" display="block"><mml:mrow><mml:mtext>Fea</mml:mtext><mml:mn>3</mml:mn><mml:mo>=</mml:mo><mml:msub><mml:mtext>TTS</mml:mtext><mml:mrow><mml:mtext>i</mml:mtext><mml:mo>,</mml:mo><mml:mtext>a</mml:mtext></mml:mrow></mml:msub><mml:mo>×</mml:mo><mml:msub><mml:mtext>TDA</mml:mtext><mml:mrow><mml:mtext>a</mml:mtext><mml:mo>,</mml:mo><mml:mtext>j</mml:mtext></mml:mrow></mml:msub><mml:mo>+</mml:mo><mml:msub><mml:mtext>TDA</mml:mtext><mml:mrow><mml:mtext>i</mml:mtext><mml:mo>,</mml:mo><mml:mtext>b</mml:mtext></mml:mrow></mml:msub><mml:mo>×</mml:mo><mml:msub><mml:mtext>DDS</mml:mtext><mml:mrow><mml:mtext>b</mml:mtext><mml:mo>,</mml:mo><mml:mtext>j</mml:mtext></mml:mrow></mml:msub><mml:mo>+</mml:mo><mml:msub><mml:mtext>TTS</mml:mtext><mml:mrow><mml:mtext>i</mml:mtext><mml:mo>,</mml:mo><mml:mtext>a</mml:mtext></mml:mrow></mml:msub><mml:mo>×</mml:mo><mml:msub><mml:mtext>TDA</mml:mtext><mml:mrow><mml:mtext>a</mml:mtext><mml:mo>,</mml:mo><mml:mtext>b</mml:mtext></mml:mrow></mml:msub><mml:mo>×</mml:mo><mml:msub><mml:mtext>DDS</mml:mtext><mml:mrow><mml:mtext>b</mml:mtext><mml:mo>,</mml:mo><mml:mtext>j</mml:mtext></mml:mrow></mml:msub></mml:mrow></mml:math><graphic xlink:href="12859_2021_4522_Article_Equ22.gif" position="anchor"/></alternatives></disp-formula><disp-formula id="Equh"><alternatives><tex-math id="M203">\documentclass[12pt]{minimal}
				\usepackage{amsmath}
				\usepackage{wasysym} 
				\usepackage{amsfonts} 
				\usepackage{amssymb} 
				\usepackage{amsbsy}
				\usepackage{mathrsfs}
				\usepackage{upgreek}
				\setlength{\oddsidemargin}{-69pt}
				\begin{document}$${\text{ a}} = \mathop {\text{arg max}}\limits_{{\text{x}}} {\text{TTS}}_{{{\text{i}},{\text{x}} = \left\{ {1,2, \ldots {\text{nT}}} \right\}\backslash {\text{i}}}}$$\end{document}</tex-math><mml:math id="M204" display="block"><mml:mrow><mml:mrow><mml:mspace width="0.333333em"/><mml:mtext>a</mml:mtext></mml:mrow><mml:mo>=</mml:mo><mml:munder><mml:mrow><mml:mtext>arg max</mml:mtext></mml:mrow><mml:mtext>x</mml:mtext></mml:munder><mml:msub><mml:mtext>TTS</mml:mtext><mml:mrow><mml:mtext>i</mml:mtext><mml:mo>,</mml:mo><mml:mtext>x</mml:mtext><mml:mo>=</mml:mo><mml:mfenced close="}" open="{"><mml:mrow><mml:mn>1</mml:mn><mml:mo>,</mml:mo><mml:mn>2</mml:mn><mml:mo>,</mml:mo><mml:mo>…</mml:mo><mml:mtext>nT</mml:mtext></mml:mrow></mml:mfenced><mml:mrow><mml:mo stretchy="true">\</mml:mo><mml:mtext>i</mml:mtext></mml:mrow></mml:mrow></mml:msub></mml:mrow></mml:math><graphic xlink:href="12859_2021_4522_Article_Equh.gif" position="anchor"/></alternatives></disp-formula><disp-formula id="Equi"><alternatives><tex-math id="M205">\documentclass[12pt]{minimal}
				\usepackage{amsmath}
				\usepackage{wasysym} 
				\usepackage{amsfonts} 
				\usepackage{amssymb} 
				\usepackage{amsbsy}
				\usepackage{mathrsfs}
				\usepackage{upgreek}
				\setlength{\oddsidemargin}{-69pt}
				\begin{document}$${\text{ b}} = \mathop {\text{arg max}}\limits_{{\text{y}}} {\text{DDS}}_{{{\text{y}} = \left\{ {1,2, \ldots {\text{nD}}} \right\}\backslash {\text{j}},{\text{j}}}}$$\end{document}</tex-math><mml:math id="M206" display="block"><mml:mrow><mml:mrow><mml:mspace width="0.333333em"/><mml:mtext>b</mml:mtext></mml:mrow><mml:mo>=</mml:mo><mml:munder><mml:mrow><mml:mtext>arg max</mml:mtext></mml:mrow><mml:mtext>y</mml:mtext></mml:munder><mml:msub><mml:mtext>DDS</mml:mtext><mml:mrow><mml:mtext>y</mml:mtext><mml:mo>=</mml:mo><mml:mfenced close="}" open="{"><mml:mrow><mml:mn>1</mml:mn><mml:mo>,</mml:mo><mml:mn>2</mml:mn><mml:mo>,</mml:mo><mml:mo>…</mml:mo><mml:mtext>nD</mml:mtext></mml:mrow></mml:mfenced><mml:mrow><mml:mo stretchy="true">\</mml:mo><mml:mtext>j</mml:mtext><mml:mo>,</mml:mo><mml:mtext>j</mml:mtext></mml:mrow></mml:mrow></mml:msub></mml:mrow></mml:math><graphic xlink:href="12859_2021_4522_Article_Equi.gif" position="anchor"/></alternatives></disp-formula><disp-formula id="Equ23"><label>23</label><alternatives><tex-math id="M207">\documentclass[12pt]{minimal}
				\usepackage{amsmath}
				\usepackage{wasysym} 
				\usepackage{amsfonts} 
				\usepackage{amssymb} 
				\usepackage{amsbsy}
				\usepackage{mathrsfs}
				\usepackage{upgreek}
				\setlength{\oddsidemargin}{-69pt}
				\begin{document}$${\text{Fea}}4 = \mathop {\max }\limits_{{{\text{k}} \in {\text{K}}}} \left( {{\text{L}}_{{{\text{j}},{\text{k}}}} /{\text{H}}_{{{\text{i}},{\text{k}}}} } \right)$$\end{document}</tex-math><mml:math id="M208" display="block"><mml:mrow><mml:mtext>Fea</mml:mtext><mml:mn>4</mml:mn><mml:mo>=</mml:mo><mml:munder><mml:mo movablelimits="false">max</mml:mo><mml:mrow><mml:mtext>k</mml:mtext><mml:mo>∈</mml:mo><mml:mtext>K</mml:mtext></mml:mrow></mml:munder><mml:mfenced close=")" open="("><mml:mrow><mml:msub><mml:mtext>L</mml:mtext><mml:mrow><mml:mtext>j</mml:mtext><mml:mo>,</mml:mo><mml:mtext>k</mml:mtext></mml:mrow></mml:msub><mml:mo stretchy="false">/</mml:mo><mml:msub><mml:mtext>H</mml:mtext><mml:mrow><mml:mtext>i</mml:mtext><mml:mo>,</mml:mo><mml:mtext>k</mml:mtext></mml:mrow></mml:msub></mml:mrow></mml:mfenced></mml:mrow></mml:math><graphic xlink:href="12859_2021_4522_Article_Equ23.gif" position="anchor"/></alternatives></disp-formula><disp-formula id="Equj"><alternatives><tex-math id="M209">\documentclass[12pt]{minimal}
				\usepackage{amsmath}
				\usepackage{wasysym} 
				\usepackage{amsfonts} 
				\usepackage{amssymb} 
				\usepackage{amsbsy}
				\usepackage{mathrsfs}
				\usepackage{upgreek}
				\setlength{\oddsidemargin}{-69pt}
				\begin{document}$${\text{K}} = \left\{ {{\text{z| TDI}}_{{{\text{i}},{\text{z}}}} = 1,{\text{DDA}}_{{{\text{j}},{\text{z}}}} = 1,{ }1 \le {\text{z}} \le {\text{nM}}} \right\}$$\end{document}</tex-math><mml:math id="M210" display="block"><mml:mrow><mml:mtext>K</mml:mtext><mml:mo>=</mml:mo><mml:mfenced close="}" open="{"><mml:mrow><mml:msub><mml:mrow><mml:mtext>z| TDI</mml:mtext></mml:mrow><mml:mrow><mml:mtext>i</mml:mtext><mml:mo>,</mml:mo><mml:mtext>z</mml:mtext></mml:mrow></mml:msub><mml:mo>=</mml:mo><mml:mn>1</mml:mn><mml:mo>,</mml:mo><mml:msub><mml:mtext>DDA</mml:mtext><mml:mrow><mml:mtext>j</mml:mtext><mml:mo>,</mml:mo><mml:mtext>z</mml:mtext></mml:mrow></mml:msub><mml:mo>=</mml:mo><mml:mn>1</mml:mn><mml:mo>,</mml:mo><mml:mrow/><mml:mn>1</mml:mn><mml:mo>≤</mml:mo><mml:mtext>z</mml:mtext><mml:mo>≤</mml:mo><mml:mtext>nM</mml:mtext></mml:mrow></mml:mfenced></mml:mrow></mml:math><graphic xlink:href="12859_2021_4522_Article_Equj.gif" position="anchor"/></alternatives></disp-formula><disp-formula id="Equk"><alternatives><tex-math id="M211">\documentclass[12pt]{minimal}
				\usepackage{amsmath}
				\usepackage{wasysym} 
				\usepackage{amsfonts} 
				\usepackage{amssymb} 
				\usepackage{amsbsy}
				\usepackage{mathrsfs}
				\usepackage{upgreek}
				\setlength{\oddsidemargin}{-69pt}
				\begin{document}$${\text{ H}}_{{{\text{i}},{\text{k}}}} = \left( {{\text{TDI}} \times {\text{MMS}}\_{\text{T}}} \right)_{{{\text{i}},{\text{k}}}} /\left| {\left\{ {{\text{x|TDI}}_{{{\text{i}},{\text{x}}}} = 1,{\text{ MMS}}\_{\text{T}}_{{{\text{x}},{\text{k}}}} \ne 0,{ }1 \le {\text{x}} \le {\text{nM}}} \right\}} \right|$$\end{document}</tex-math><mml:math id="M212" display="block"><mml:mrow><mml:msub><mml:mrow><mml:mspace width="0.333333em"/><mml:mtext>H</mml:mtext></mml:mrow><mml:mrow><mml:mtext>i</mml:mtext><mml:mo>,</mml:mo><mml:mtext>k</mml:mtext></mml:mrow></mml:msub><mml:mo>=</mml:mo><mml:msub><mml:mfenced close=")" open="("><mml:mrow><mml:mtext>TDI</mml:mtext><mml:mo>×</mml:mo><mml:mtext>MMS</mml:mtext><mml:mi>_</mml:mi><mml:mtext>T</mml:mtext></mml:mrow></mml:mfenced><mml:mrow><mml:mtext>i</mml:mtext><mml:mo>,</mml:mo><mml:mtext>k</mml:mtext></mml:mrow></mml:msub><mml:mo stretchy="false">/</mml:mo><mml:mfenced close="|" open="|"><mml:mfenced close="}" open="{"><mml:mrow><mml:msub><mml:mtext>x|TDI</mml:mtext><mml:mrow><mml:mtext>i</mml:mtext><mml:mo>,</mml:mo><mml:mtext>x</mml:mtext></mml:mrow></mml:msub><mml:mo>=</mml:mo><mml:mn>1</mml:mn><mml:mo>,</mml:mo><mml:mrow><mml:mspace width="0.333333em"/><mml:mtext>MMS</mml:mtext></mml:mrow><mml:mi>_</mml:mi><mml:msub><mml:mtext>T</mml:mtext><mml:mrow><mml:mtext>x</mml:mtext><mml:mo>,</mml:mo><mml:mtext>k</mml:mtext></mml:mrow></mml:msub><mml:mo>≠</mml:mo><mml:mn>0</mml:mn><mml:mo>,</mml:mo><mml:mrow/><mml:mn>1</mml:mn><mml:mo>≤</mml:mo><mml:mtext>x</mml:mtext><mml:mo>≤</mml:mo><mml:mtext>nM</mml:mtext></mml:mrow></mml:mfenced></mml:mfenced></mml:mrow></mml:math><graphic xlink:href="12859_2021_4522_Article_Equk.gif" position="anchor"/></alternatives></disp-formula><disp-formula id="Equl"><alternatives><tex-math id="M213">\documentclass[12pt]{minimal}
				\usepackage{amsmath}
				\usepackage{wasysym} 
				\usepackage{amsfonts} 
				\usepackage{amssymb} 
				\usepackage{amsbsy}
				\usepackage{mathrsfs}
				\usepackage{upgreek}
				\setlength{\oddsidemargin}{-69pt}
				\begin{document}$${\text{ L}}_{{{\text{j}},{\text{k}}}} = \left( {{\text{DDA}} \times {\text{MMS}}\_{\text{D}}} \right)_{{{\text{j}},{\text{k}}}} /\left| {\left\{ {{\text{y|DDA}}_{{{\text{j}},{\text{y}}}} = 1,{\text{ MMS}}\_{\text{D}}_{{{\text{y}},{\text{k}}}} \ne 0,{ }1 \le {\text{y}} \le {\text{nM}}} \right\}} \right|$$\end{document}</tex-math><mml:math id="M214" display="block"><mml:mrow><mml:msub><mml:mrow><mml:mspace width="0.333333em"/><mml:mtext>L</mml:mtext></mml:mrow><mml:mrow><mml:mtext>j</mml:mtext><mml:mo>,</mml:mo><mml:mtext>k</mml:mtext></mml:mrow></mml:msub><mml:mo>=</mml:mo><mml:msub><mml:mfenced close=")" open="("><mml:mrow><mml:mtext>DDA</mml:mtext><mml:mo>×</mml:mo><mml:mtext>MMS</mml:mtext><mml:mi>_</mml:mi><mml:mtext>D</mml:mtext></mml:mrow></mml:mfenced><mml:mrow><mml:mtext>j</mml:mtext><mml:mo>,</mml:mo><mml:mtext>k</mml:mtext></mml:mrow></mml:msub><mml:mo stretchy="false">/</mml:mo><mml:mfenced close="|" open="|"><mml:mfenced close="}" open="{"><mml:mrow><mml:msub><mml:mtext>y|DDA</mml:mtext><mml:mrow><mml:mtext>j</mml:mtext><mml:mo>,</mml:mo><mml:mtext>y</mml:mtext></mml:mrow></mml:msub><mml:mo>=</mml:mo><mml:mn>1</mml:mn><mml:mo>,</mml:mo><mml:mrow><mml:mspace width="0.333333em"/><mml:mtext>MMS</mml:mtext></mml:mrow><mml:mi>_</mml:mi><mml:msub><mml:mtext>D</mml:mtext><mml:mrow><mml:mtext>y</mml:mtext><mml:mo>,</mml:mo><mml:mtext>k</mml:mtext></mml:mrow></mml:msub><mml:mo>≠</mml:mo><mml:mn>0</mml:mn><mml:mo>,</mml:mo><mml:mrow/><mml:mn>1</mml:mn><mml:mo>≤</mml:mo><mml:mtext>y</mml:mtext><mml:mo>≤</mml:mo><mml:mtext>nM</mml:mtext></mml:mrow></mml:mfenced></mml:mfenced></mml:mrow></mml:math><graphic xlink:href="12859_2021_4522_Article_Equl.gif" position="anchor"/></alternatives></disp-formula><disp-formula id="Equ24"><label>24</label><alternatives><tex-math id="M215">\documentclass[12pt]{minimal}
				\usepackage{amsmath}
				\usepackage{wasysym} 
				\usepackage{amsfonts} 
				\usepackage{amssymb} 
				\usepackage{amsbsy}
				\usepackage{mathrsfs}
				\usepackage{upgreek}
				\setlength{\oddsidemargin}{-69pt}
				\begin{document}$${\text{Fea}}5 = \left( {{\text{TTS}} \times {\text{TDA}}} \right)_{{{\text{i}},{\text{j}}}} /\left| {\left\{ {{\text{x|TTS}}_{{{\text{i}},{\text{x}}}} \ne 0,{\text{ TDA}}_{{{\text{x}},{\text{j}}}} = 1,{ }1 \le {\text{x}} \le {\text{nT}}} \right\}} \right|$$\end{document}</tex-math><mml:math id="M216" display="block"><mml:mrow><mml:mtext>Fea</mml:mtext><mml:mn>5</mml:mn><mml:mo>=</mml:mo><mml:msub><mml:mfenced close=")" open="("><mml:mrow><mml:mtext>TTS</mml:mtext><mml:mo>×</mml:mo><mml:mtext>TDA</mml:mtext></mml:mrow></mml:mfenced><mml:mrow><mml:mtext>i</mml:mtext><mml:mo>,</mml:mo><mml:mtext>j</mml:mtext></mml:mrow></mml:msub><mml:mo stretchy="false">/</mml:mo><mml:mfenced close="|" open="|"><mml:mfenced close="}" open="{"><mml:mrow><mml:msub><mml:mtext>x|TTS</mml:mtext><mml:mrow><mml:mtext>i</mml:mtext><mml:mo>,</mml:mo><mml:mtext>x</mml:mtext></mml:mrow></mml:msub><mml:mo>≠</mml:mo><mml:mn>0</mml:mn><mml:mo>,</mml:mo><mml:msub><mml:mrow><mml:mspace width="0.333333em"/><mml:mtext>TDA</mml:mtext></mml:mrow><mml:mrow><mml:mtext>x</mml:mtext><mml:mo>,</mml:mo><mml:mtext>j</mml:mtext></mml:mrow></mml:msub><mml:mo>=</mml:mo><mml:mn>1</mml:mn><mml:mo>,</mml:mo><mml:mrow/><mml:mn>1</mml:mn><mml:mo>≤</mml:mo><mml:mtext>x</mml:mtext><mml:mo>≤</mml:mo><mml:mtext>nT</mml:mtext></mml:mrow></mml:mfenced></mml:mfenced></mml:mrow></mml:math><graphic xlink:href="12859_2021_4522_Article_Equ24.gif" position="anchor"/></alternatives></disp-formula><disp-formula id="Equ25"><label>25</label><alternatives><tex-math id="M217">\documentclass[12pt]{minimal}
				\usepackage{amsmath}
				\usepackage{wasysym} 
				\usepackage{amsfonts} 
				\usepackage{amssymb} 
				\usepackage{amsbsy}
				\usepackage{mathrsfs}
				\usepackage{upgreek}
				\setlength{\oddsidemargin}{-69pt}
				\begin{document}$${\text{Fea}}6 = \left( {{\text{TDA}} \times {\text{DDS}}} \right)_{{{\text{i}},{\text{j}}}} /\left| {\left\{ {{\text{y|TDA}}_{{{\text{i}},{\text{y}}}} = 1,{\text{ DDS}}_{{{\text{y}},{\text{j}}}} \ne 0,{ }1 \le {\text{y}} \le {\text{nD}}} \right\}} \right|$$\end{document}</tex-math><mml:math id="M218" display="block"><mml:mrow><mml:mtext>Fea</mml:mtext><mml:mn>6</mml:mn><mml:mo>=</mml:mo><mml:msub><mml:mfenced close=")" open="("><mml:mrow><mml:mtext>TDA</mml:mtext><mml:mo>×</mml:mo><mml:mtext>DDS</mml:mtext></mml:mrow></mml:mfenced><mml:mrow><mml:mtext>i</mml:mtext><mml:mo>,</mml:mo><mml:mtext>j</mml:mtext></mml:mrow></mml:msub><mml:mo stretchy="false">/</mml:mo><mml:mfenced close="|" open="|"><mml:mfenced close="}" open="{"><mml:mrow><mml:msub><mml:mtext>y|TDA</mml:mtext><mml:mrow><mml:mtext>i</mml:mtext><mml:mo>,</mml:mo><mml:mtext>y</mml:mtext></mml:mrow></mml:msub><mml:mo>=</mml:mo><mml:mn>1</mml:mn><mml:mo>,</mml:mo><mml:msub><mml:mrow><mml:mspace width="0.333333em"/><mml:mtext>DDS</mml:mtext></mml:mrow><mml:mrow><mml:mtext>y</mml:mtext><mml:mo>,</mml:mo><mml:mtext>j</mml:mtext></mml:mrow></mml:msub><mml:mo>≠</mml:mo><mml:mn>0</mml:mn><mml:mo>,</mml:mo><mml:mrow/><mml:mn>1</mml:mn><mml:mo>≤</mml:mo><mml:mtext>y</mml:mtext><mml:mo>≤</mml:mo><mml:mtext>nD</mml:mtext></mml:mrow></mml:mfenced></mml:mfenced></mml:mrow></mml:math><graphic xlink:href="12859_2021_4522_Article_Equ25.gif" position="anchor"/></alternatives></disp-formula><disp-formula id="Equ26"><label>26</label><alternatives><tex-math id="M219">\documentclass[12pt]{minimal}
				\usepackage{amsmath}
				\usepackage{wasysym} 
				\usepackage{amsfonts} 
				\usepackage{amssymb} 
				\usepackage{amsbsy}
				\usepackage{mathrsfs}
				\usepackage{upgreek}
				\setlength{\oddsidemargin}{-69pt}
				\begin{document}$${\text{Fea}}7 = \frac{{\left( {{\text{TTS}} \times {\text{TTS}} \times {\text{TDA}}} \right)_{{{\text{i}},{\text{j}}}} }}{{\left| {\left\{ {\left( {{\text{x}},{\text{s}}} \right){\text{|TTS}}_{{{\text{i}},{\text{x}}}} \ne 0,{\text{ TTS}}_{{{\text{x}},{\text{s}}}} \ne 0,{\text{ TDA}}_{{{\text{s}},{\text{j}}}} = 1,{ }1 \le {\text{x}},{\text{s}} \le {\text{nT}}} \right\}} \right|}}$$\end{document}</tex-math><mml:math id="M220" display="block"><mml:mrow><mml:mtext>Fea</mml:mtext><mml:mn>7</mml:mn><mml:mo>=</mml:mo><mml:mfrac><mml:msub><mml:mfenced close=")" open="("><mml:mrow><mml:mtext>TTS</mml:mtext><mml:mo>×</mml:mo><mml:mtext>TTS</mml:mtext><mml:mo>×</mml:mo><mml:mtext>TDA</mml:mtext></mml:mrow></mml:mfenced><mml:mrow><mml:mtext>i</mml:mtext><mml:mo>,</mml:mo><mml:mtext>j</mml:mtext></mml:mrow></mml:msub><mml:mfenced close="|" open="|"><mml:mfenced close="}" open="{"><mml:mrow><mml:mfenced close=")" open="("><mml:mrow><mml:mtext>x</mml:mtext><mml:mo>,</mml:mo><mml:mtext>s</mml:mtext></mml:mrow></mml:mfenced><mml:msub><mml:mtext>|TTS</mml:mtext><mml:mrow><mml:mtext>i</mml:mtext><mml:mo>,</mml:mo><mml:mtext>x</mml:mtext></mml:mrow></mml:msub><mml:mo>≠</mml:mo><mml:mn>0</mml:mn><mml:mo>,</mml:mo><mml:msub><mml:mrow><mml:mspace width="0.333333em"/><mml:mtext>TTS</mml:mtext></mml:mrow><mml:mrow><mml:mtext>x</mml:mtext><mml:mo>,</mml:mo><mml:mtext>s</mml:mtext></mml:mrow></mml:msub><mml:mo>≠</mml:mo><mml:mn>0</mml:mn><mml:mo>,</mml:mo><mml:msub><mml:mrow><mml:mspace width="0.333333em"/><mml:mtext>TDA</mml:mtext></mml:mrow><mml:mrow><mml:mtext>s</mml:mtext><mml:mo>,</mml:mo><mml:mtext>j</mml:mtext></mml:mrow></mml:msub><mml:mo>=</mml:mo><mml:mn>1</mml:mn><mml:mo>,</mml:mo><mml:mrow/><mml:mn>1</mml:mn><mml:mo>≤</mml:mo><mml:mtext>x</mml:mtext><mml:mo>,</mml:mo><mml:mtext>s</mml:mtext><mml:mo>≤</mml:mo><mml:mtext>nT</mml:mtext></mml:mrow></mml:mfenced></mml:mfenced></mml:mfrac></mml:mrow></mml:math><graphic xlink:href="12859_2021_4522_Article_Equ26.gif" position="anchor"/></alternatives></disp-formula><disp-formula id="Equ27"><label>27</label><alternatives><tex-math id="M221">\documentclass[12pt]{minimal}
				\usepackage{amsmath}
				\usepackage{wasysym} 
				\usepackage{amsfonts} 
				\usepackage{amssymb} 
				\usepackage{amsbsy}
				\usepackage{mathrsfs}
				\usepackage{upgreek}
				\setlength{\oddsidemargin}{-69pt}
				\begin{document}$${\text{Fea}}8 = \frac{{\left( {{\text{TTS}} \times {\text{TDA}} \times {\text{DDS}}} \right)_{{{\text{i}},{\text{j}}}} }}{{\left| {\left\{ {\left( {{\text{x}},{\text{y}}} \right){\text{|TTS}}_{{{\text{i}},{\text{x}}}} \ne 0,{\text{ TDA}}_{{{\text{x}},{\text{y}}}} = 1,{\text{ DDS}}_{{{\text{y}},{\text{j}}}} \ne 0,{ }1 \le {\text{x}} \le {\text{nT}},1 \le {\text{y}} \le {\text{nD}}} \right\}} \right|}}$$\end{document}</tex-math><mml:math id="M222" display="block"><mml:mrow><mml:mtext>Fea</mml:mtext><mml:mn>8</mml:mn><mml:mo>=</mml:mo><mml:mfrac><mml:msub><mml:mfenced close=")" open="("><mml:mrow><mml:mtext>TTS</mml:mtext><mml:mo>×</mml:mo><mml:mtext>TDA</mml:mtext><mml:mo>×</mml:mo><mml:mtext>DDS</mml:mtext></mml:mrow></mml:mfenced><mml:mrow><mml:mtext>i</mml:mtext><mml:mo>,</mml:mo><mml:mtext>j</mml:mtext></mml:mrow></mml:msub><mml:mfenced close="|" open="|"><mml:mfenced close="}" open="{"><mml:mrow><mml:mfenced close=")" open="("><mml:mrow><mml:mtext>x</mml:mtext><mml:mo>,</mml:mo><mml:mtext>y</mml:mtext></mml:mrow></mml:mfenced><mml:msub><mml:mtext>|TTS</mml:mtext><mml:mrow><mml:mtext>i</mml:mtext><mml:mo>,</mml:mo><mml:mtext>x</mml:mtext></mml:mrow></mml:msub><mml:mo>≠</mml:mo><mml:mn>0</mml:mn><mml:mo>,</mml:mo><mml:msub><mml:mrow><mml:mspace width="0.333333em"/><mml:mtext>TDA</mml:mtext></mml:mrow><mml:mrow><mml:mtext>x</mml:mtext><mml:mo>,</mml:mo><mml:mtext>y</mml:mtext></mml:mrow></mml:msub><mml:mo>=</mml:mo><mml:mn>1</mml:mn><mml:mo>,</mml:mo><mml:msub><mml:mrow><mml:mspace width="0.333333em"/><mml:mtext>DDS</mml:mtext></mml:mrow><mml:mrow><mml:mtext>y</mml:mtext><mml:mo>,</mml:mo><mml:mtext>j</mml:mtext></mml:mrow></mml:msub><mml:mo>≠</mml:mo><mml:mn>0</mml:mn><mml:mo>,</mml:mo><mml:mrow/><mml:mn>1</mml:mn><mml:mo>≤</mml:mo><mml:mtext>x</mml:mtext><mml:mo>≤</mml:mo><mml:mtext>nT</mml:mtext><mml:mo>,</mml:mo><mml:mn>1</mml:mn><mml:mo>≤</mml:mo><mml:mtext>y</mml:mtext><mml:mo>≤</mml:mo><mml:mtext>nD</mml:mtext></mml:mrow></mml:mfenced></mml:mfenced></mml:mfrac></mml:mrow></mml:math><graphic xlink:href="12859_2021_4522_Article_Equ27.gif" position="anchor"/></alternatives></disp-formula><disp-formula id="Equ28"><label>28</label><alternatives><tex-math id="M223">\documentclass[12pt]{minimal}
				\usepackage{amsmath}
				\usepackage{wasysym} 
				\usepackage{amsfonts} 
				\usepackage{amssymb} 
				\usepackage{amsbsy}
				\usepackage{mathrsfs}
				\usepackage{upgreek}
				\setlength{\oddsidemargin}{-69pt}
				\begin{document}$${\text{Fea}}9 = \frac{{\left( {{\text{TDA}} \times {\text{DDS}} \times {\text{DDS}}} \right)_{{{\text{i}},{\text{j}}}} }}{{\left| {\left\{ {\left( {{\text{y}},{\text{t}}} \right){\text{|TDA}}_{{{\text{i}},{\text{y}}}} = 1,{\text{ DDS}}_{{{\text{y}},{\text{t}}}} \ne 0,{\text{DDS}}_{{{\text{t}},{\text{j}}}} \ne 0,{ }1 \le {\text{y}},{\text{t}} \le {\text{nD}}} \right\}} \right|}}$$\end{document}</tex-math><mml:math id="M224" display="block"><mml:mrow><mml:mtext>Fea</mml:mtext><mml:mn>9</mml:mn><mml:mo>=</mml:mo><mml:mfrac><mml:msub><mml:mfenced close=")" open="("><mml:mrow><mml:mtext>TDA</mml:mtext><mml:mo>×</mml:mo><mml:mtext>DDS</mml:mtext><mml:mo>×</mml:mo><mml:mtext>DDS</mml:mtext></mml:mrow></mml:mfenced><mml:mrow><mml:mtext>i</mml:mtext><mml:mo>,</mml:mo><mml:mtext>j</mml:mtext></mml:mrow></mml:msub><mml:mfenced close="|" open="|"><mml:mfenced close="}" open="{"><mml:mrow><mml:mfenced close=")" open="("><mml:mrow><mml:mtext>y</mml:mtext><mml:mo>,</mml:mo><mml:mtext>t</mml:mtext></mml:mrow></mml:mfenced><mml:msub><mml:mtext>|TDA</mml:mtext><mml:mrow><mml:mtext>i</mml:mtext><mml:mo>,</mml:mo><mml:mtext>y</mml:mtext></mml:mrow></mml:msub><mml:mo>=</mml:mo><mml:mn>1</mml:mn><mml:mo>,</mml:mo><mml:msub><mml:mrow><mml:mspace width="0.333333em"/><mml:mtext>DDS</mml:mtext></mml:mrow><mml:mrow><mml:mtext>y</mml:mtext><mml:mo>,</mml:mo><mml:mtext>t</mml:mtext></mml:mrow></mml:msub><mml:mo>≠</mml:mo><mml:mn>0</mml:mn><mml:mo>,</mml:mo><mml:msub><mml:mtext>DDS</mml:mtext><mml:mrow><mml:mtext>t</mml:mtext><mml:mo>,</mml:mo><mml:mtext>j</mml:mtext></mml:mrow></mml:msub><mml:mo>≠</mml:mo><mml:mn>0</mml:mn><mml:mo>,</mml:mo><mml:mrow/><mml:mn>1</mml:mn><mml:mo>≤</mml:mo><mml:mtext>y</mml:mtext><mml:mo>,</mml:mo><mml:mtext>t</mml:mtext><mml:mo>≤</mml:mo><mml:mtext>nD</mml:mtext></mml:mrow></mml:mfenced></mml:mfenced></mml:mfrac></mml:mrow></mml:math><graphic xlink:href="12859_2021_4522_Article_Equ28.gif" position="anchor"/></alternatives></disp-formula></p>
      <p id="Par32">The analysis of these features were summarized in Table <xref rid="Tab2" ref-type="table">2</xref>, including each feature’s type, description, content and information source. Considering each target-disease pair in the training set as a sample, the pair with known associations was regarded as a positive sample which was labelled as 1, while the pair which did not have known associations was regarded as a negative sample labelled as 0. After constructing features for each sample, the training set was used to train the random forest regression model [<xref ref-type="bibr" rid="CR32">32</xref>], then the prediction model was used to score the unconfirmed target-disease pairs (Fig. <xref rid="Fig1" ref-type="fig">1</xref>d)). A higher score represented a larger possibility that the unconfirmed pair was associated. Parameters of mtry and ntree in the random forest model were set to 3 (the number of features/3) and 500 according to the default settings in R package, respectively.<table-wrap id="Tab2"><label>Table 2</label><caption><p>Information summary of the constructed features and their influence coefficient</p></caption><table frame="hsides" rules="groups"><thead><tr><th align="left">Type</th><th align="left">Description</th><th align="left">Feature</th><th align="left">Content</th><th align="left">Information source</th><th align="left">Influence coefficient</th></tr></thead><tbody><tr><td align="left">The neighborhood similarity information</td><td align="left">Information based on the similarities between the specific disease (target) and its neighborhoods</td><td align="left"><inline-formula id="IEq79"><alternatives><tex-math id="M225">\documentclass[12pt]{minimal}
				\usepackage{amsmath}
				\usepackage{wasysym} 
				\usepackage{amsfonts} 
				\usepackage{amssymb} 
				\usepackage{amsbsy}
				\usepackage{mathrsfs}
				\usepackage{upgreek}
				\setlength{\oddsidemargin}{-69pt}
				\begin{document}$$\mathrm{Fea}1$$\end{document}</tex-math><mml:math id="M226"><mml:mrow><mml:mi mathvariant="normal">Fea</mml:mi><mml:mn>1</mml:mn></mml:mrow></mml:math><inline-graphic xlink:href="12859_2021_4522_Article_IEq79.gif"/></alternatives></inline-formula></td><td align="left">The average similarity between the specific disease and its neighborhoods which did not have known associations with the specific target</td><td align="left"><inline-formula id="IEq80"><alternatives><tex-math id="M227">\documentclass[12pt]{minimal}
				\usepackage{amsmath}
				\usepackage{wasysym} 
				\usepackage{amsfonts} 
				\usepackage{amssymb} 
				\usepackage{amsbsy}
				\usepackage{mathrsfs}
				\usepackage{upgreek}
				\setlength{\oddsidemargin}{-69pt}
				\begin{document}$$\text{DDS TDA}$$\end{document}</tex-math><mml:math id="M228"><mml:mrow><mml:mtext>DDS TDA</mml:mtext></mml:mrow></mml:math><inline-graphic xlink:href="12859_2021_4522_Article_IEq80.gif"/></alternatives></inline-formula></td><td char="." align="char">0.58</td></tr><tr><td align="left"/><td align="left"/><td align="left"><inline-formula id="IEq81"><alternatives><tex-math id="M229">\documentclass[12pt]{minimal}
				\usepackage{amsmath}
				\usepackage{wasysym} 
				\usepackage{amsfonts} 
				\usepackage{amssymb} 
				\usepackage{amsbsy}
				\usepackage{mathrsfs}
				\usepackage{upgreek}
				\setlength{\oddsidemargin}{-69pt}
				\begin{document}$$\mathrm{Fea}2$$\end{document}</tex-math><mml:math id="M230"><mml:mrow><mml:mi mathvariant="normal">Fea</mml:mi><mml:mn>2</mml:mn></mml:mrow></mml:math><inline-graphic xlink:href="12859_2021_4522_Article_IEq81.gif"/></alternatives></inline-formula></td><td align="left">The average similarity between the specific target and its neighborhoods which did not have known associations with the specific disease</td><td align="left"><inline-formula id="IEq82"><alternatives><tex-math id="M231">\documentclass[12pt]{minimal}
				\usepackage{amsmath}
				\usepackage{wasysym} 
				\usepackage{amsfonts} 
				\usepackage{amssymb} 
				\usepackage{amsbsy}
				\usepackage{mathrsfs}
				\usepackage{upgreek}
				\setlength{\oddsidemargin}{-69pt}
				\begin{document}$$\text{TTS TDA}$$\end{document}</tex-math><mml:math id="M232"><mml:mrow><mml:mtext>TTS TDA</mml:mtext></mml:mrow></mml:math><inline-graphic xlink:href="12859_2021_4522_Article_IEq82.gif"/></alternatives></inline-formula></td><td char="." align="char">0.576</td></tr><tr><td align="left"/><td align="left"/><td align="left"><inline-formula id="IEq83"><alternatives><tex-math id="M233">\documentclass[12pt]{minimal}
				\usepackage{amsmath}
				\usepackage{wasysym} 
				\usepackage{amsfonts} 
				\usepackage{amssymb} 
				\usepackage{amsbsy}
				\usepackage{mathrsfs}
				\usepackage{upgreek}
				\setlength{\oddsidemargin}{-69pt}
				\begin{document}$$\mathrm{Fea}3$$\end{document}</tex-math><mml:math id="M234"><mml:mrow><mml:mi mathvariant="normal">Fea</mml:mi><mml:mn>3</mml:mn></mml:mrow></mml:math><inline-graphic xlink:href="12859_2021_4522_Article_IEq83.gif"/></alternatives></inline-formula></td><td align="left">The sum of weights for paths which connected by the nearest neighborhood of the specific target and the nearest neighborhood of the specific disease</td><td align="left"><inline-formula id="IEq84"><alternatives><tex-math id="M235">\documentclass[12pt]{minimal}
				\usepackage{amsmath}
				\usepackage{wasysym} 
				\usepackage{amsfonts} 
				\usepackage{amssymb} 
				\usepackage{amsbsy}
				\usepackage{mathrsfs}
				\usepackage{upgreek}
				\setlength{\oddsidemargin}{-69pt}
				\begin{document}$$\text{TTS DDS }$$\end{document}</tex-math><mml:math id="M236"><mml:mrow><mml:mtext>TTS DDS</mml:mtext><mml:mspace width="0.333333em"/></mml:mrow></mml:math><inline-graphic xlink:href="12859_2021_4522_Article_IEq84.gif"/></alternatives></inline-formula><inline-formula id="IEq85"><alternatives><tex-math id="M237">\documentclass[12pt]{minimal}
				\usepackage{amsmath}
				\usepackage{wasysym} 
				\usepackage{amsfonts} 
				\usepackage{amssymb} 
				\usepackage{amsbsy}
				\usepackage{mathrsfs}
				\usepackage{upgreek}
				\setlength{\oddsidemargin}{-69pt}
				\begin{document}$$\mathrm{TDA}$$\end{document}</tex-math><mml:math id="M238"><mml:mi mathvariant="normal">TDA</mml:mi></mml:math><inline-graphic xlink:href="12859_2021_4522_Article_IEq85.gif"/></alternatives></inline-formula></td><td char="." align="char">0.638</td></tr><tr><td align="left">The drug-inferred information</td><td align="left">Information inferred by drugs based on the drug-target-disease mechanism</td><td align="left"><inline-formula id="IEq86"><alternatives><tex-math id="M239">\documentclass[12pt]{minimal}
				\usepackage{amsmath}
				\usepackage{wasysym} 
				\usepackage{amsfonts} 
				\usepackage{amssymb} 
				\usepackage{amsbsy}
				\usepackage{mathrsfs}
				\usepackage{upgreek}
				\setlength{\oddsidemargin}{-69pt}
				\begin{document}$$\mathrm{Fea}4$$\end{document}</tex-math><mml:math id="M240"><mml:mrow><mml:mi mathvariant="normal">Fea</mml:mi><mml:mn>4</mml:mn></mml:mrow></mml:math><inline-graphic xlink:href="12859_2021_4522_Article_IEq86.gif"/></alternatives></inline-formula></td><td align="left">The maximum quotient of the average weight for the specific disease-drug paths divided by the average weight for the specific target-drug paths</td><td align="left"><inline-formula id="IEq87"><alternatives><tex-math id="M241">\documentclass[12pt]{minimal}
				\usepackage{amsmath}
				\usepackage{wasysym} 
				\usepackage{amsfonts} 
				\usepackage{amssymb} 
				\usepackage{amsbsy}
				\usepackage{mathrsfs}
				\usepackage{upgreek}
				\setlength{\oddsidemargin}{-69pt}
				\begin{document}$$\text{TDI DDA }{\mathrm{MMS}}\_{\mathrm{T}}\text{ MMS}\_\mathrm{D}$$\end{document}</tex-math><mml:math id="M242"><mml:mrow><mml:mtext>TDI DDA</mml:mtext><mml:mspace width="0.333333em"/><mml:mi mathvariant="normal">MMS</mml:mi><mml:mi>_</mml:mi><mml:mi mathvariant="normal">T</mml:mi><mml:mspace width="0.333333em"/><mml:mtext>MMS</mml:mtext><mml:mi>_</mml:mi><mml:mi mathvariant="normal">D</mml:mi></mml:mrow></mml:math><inline-graphic xlink:href="12859_2021_4522_Article_IEq87.gif"/></alternatives></inline-formula></td><td char="." align="char">0.671</td></tr><tr><td align="left">The path information</td><td align="left">Information from paths (length = 2 and length = 3) between the specific target and the specific disease</td><td align="left"><inline-formula id="IEq88"><alternatives><tex-math id="M243">\documentclass[12pt]{minimal}
				\usepackage{amsmath}
				\usepackage{wasysym} 
				\usepackage{amsfonts} 
				\usepackage{amssymb} 
				\usepackage{amsbsy}
				\usepackage{mathrsfs}
				\usepackage{upgreek}
				\setlength{\oddsidemargin}{-69pt}
				\begin{document}$$\mathrm{Fea}5$$\end{document}</tex-math><mml:math id="M244"><mml:mrow><mml:mi mathvariant="normal">Fea</mml:mi><mml:mn>5</mml:mn></mml:mrow></mml:math><inline-graphic xlink:href="12859_2021_4522_Article_IEq88.gif"/></alternatives></inline-formula></td><td align="left">The average weight of paths from the specific target to the specific disease based on target-target-disease pattern</td><td align="left"><inline-formula id="IEq89"><alternatives><tex-math id="M245">\documentclass[12pt]{minimal}
				\usepackage{amsmath}
				\usepackage{wasysym} 
				\usepackage{amsfonts} 
				\usepackage{amssymb} 
				\usepackage{amsbsy}
				\usepackage{mathrsfs}
				\usepackage{upgreek}
				\setlength{\oddsidemargin}{-69pt}
				\begin{document}$$\text{TTS TDA}$$\end{document}</tex-math><mml:math id="M246"><mml:mrow><mml:mtext>TTS TDA</mml:mtext></mml:mrow></mml:math><inline-graphic xlink:href="12859_2021_4522_Article_IEq89.gif"/></alternatives></inline-formula></td><td char="." align="char">0.745</td></tr><tr><td align="left"/><td align="left"/><td align="left"><inline-formula id="IEq90"><alternatives><tex-math id="M247">\documentclass[12pt]{minimal}
				\usepackage{amsmath}
				\usepackage{wasysym} 
				\usepackage{amsfonts} 
				\usepackage{amssymb} 
				\usepackage{amsbsy}
				\usepackage{mathrsfs}
				\usepackage{upgreek}
				\setlength{\oddsidemargin}{-69pt}
				\begin{document}$$\mathrm{Fea}6$$\end{document}</tex-math><mml:math id="M248"><mml:mrow><mml:mi mathvariant="normal">Fea</mml:mi><mml:mn>6</mml:mn></mml:mrow></mml:math><inline-graphic xlink:href="12859_2021_4522_Article_IEq90.gif"/></alternatives></inline-formula></td><td align="left">The same as above but based on target-disease-disease pattern</td><td align="left"><inline-formula id="IEq91"><alternatives><tex-math id="M249">\documentclass[12pt]{minimal}
				\usepackage{amsmath}
				\usepackage{wasysym} 
				\usepackage{amsfonts} 
				\usepackage{amssymb} 
				\usepackage{amsbsy}
				\usepackage{mathrsfs}
				\usepackage{upgreek}
				\setlength{\oddsidemargin}{-69pt}
				\begin{document}$${\text{DDS TDA}}$$\end{document}</tex-math><mml:math id="M250"><mml:mrow><mml:mtext>DDS TDA</mml:mtext></mml:mrow></mml:math><inline-graphic xlink:href="12859_2021_4522_Article_IEq91.gif"/></alternatives></inline-formula></td><td char="." align="char">0.722</td></tr><tr><td align="left"/><td align="left"/><td align="left"><inline-formula id="IEq92"><alternatives><tex-math id="M251">\documentclass[12pt]{minimal}
				\usepackage{amsmath}
				\usepackage{wasysym} 
				\usepackage{amsfonts} 
				\usepackage{amssymb} 
				\usepackage{amsbsy}
				\usepackage{mathrsfs}
				\usepackage{upgreek}
				\setlength{\oddsidemargin}{-69pt}
				\begin{document}$${\text{Fea}}7$$\end{document}</tex-math><mml:math id="M252"><mml:mrow><mml:mtext>Fea</mml:mtext><mml:mn>7</mml:mn></mml:mrow></mml:math><inline-graphic xlink:href="12859_2021_4522_Article_IEq92.gif"/></alternatives></inline-formula></td><td align="left">The same as above but based on target-target-target-disease pattern</td><td align="left"><inline-formula id="IEq94"><alternatives><tex-math id="M253">\documentclass[12pt]{minimal}
				\usepackage{amsmath}
				\usepackage{wasysym} 
				\usepackage{amsfonts} 
				\usepackage{amssymb} 
				\usepackage{amsbsy}
				\usepackage{mathrsfs}
				\usepackage{upgreek}
				\setlength{\oddsidemargin}{-69pt}
				\begin{document}$${\text{TTS TDA}}$$\end{document}</tex-math><mml:math id="M254"><mml:mrow><mml:mtext>TTS TDA</mml:mtext></mml:mrow></mml:math><inline-graphic xlink:href="12859_2021_4522_Article_IEq94.gif"/></alternatives></inline-formula></td><td char="." align="char">0.671</td></tr><tr><td align="left"/><td align="left"/><td align="left"><inline-formula id="IEq95"><alternatives><tex-math id="M255">\documentclass[12pt]{minimal}
				\usepackage{amsmath}
				\usepackage{wasysym} 
				\usepackage{amsfonts} 
				\usepackage{amssymb} 
				\usepackage{amsbsy}
				\usepackage{mathrsfs}
				\usepackage{upgreek}
				\setlength{\oddsidemargin}{-69pt}
				\begin{document}$${\text{Fea}}8$$\end{document}</tex-math><mml:math id="M256"><mml:mrow><mml:mtext>Fea</mml:mtext><mml:mn>8</mml:mn></mml:mrow></mml:math><inline-graphic xlink:href="12859_2021_4522_Article_IEq95.gif"/></alternatives></inline-formula></td><td align="left">The same as above but based on target-target-disease-disease pattern</td><td align="left"><inline-formula id="IEq97"><alternatives><tex-math id="M257">\documentclass[12pt]{minimal}
				\usepackage{amsmath}
				\usepackage{wasysym} 
				\usepackage{amsfonts} 
				\usepackage{amssymb} 
				\usepackage{amsbsy}
				\usepackage{mathrsfs}
				\usepackage{upgreek}
				\setlength{\oddsidemargin}{-69pt}
				\begin{document}$${\text{TTS DDS TDA}}$$\end{document}</tex-math><mml:math id="M258"><mml:mrow><mml:mtext>TTS DDS TDA</mml:mtext></mml:mrow></mml:math><inline-graphic xlink:href="12859_2021_4522_Article_IEq97.gif"/></alternatives></inline-formula></td><td char="." align="char"> 0.654</td></tr><tr><td align="left"/><td align="left"/><td align="left"><inline-formula id="IEq99"><alternatives><tex-math id="M259">\documentclass[12pt]{minimal}
				\usepackage{amsmath}
				\usepackage{wasysym} 
				\usepackage{amsfonts} 
				\usepackage{amssymb} 
				\usepackage{amsbsy}
				\usepackage{mathrsfs}
				\usepackage{upgreek}
				\setlength{\oddsidemargin}{-69pt}
				\begin{document}$${\text{Fea}}9$$\end{document}</tex-math><mml:math id="M260"><mml:mrow><mml:mtext>Fea</mml:mtext><mml:mn>9</mml:mn></mml:mrow></mml:math><inline-graphic xlink:href="12859_2021_4522_Article_IEq99.gif"/></alternatives></inline-formula></td><td align="left">The same as above but based on target-disease-disease-disease pattern</td><td align="left"><inline-formula id="IEq101"><alternatives><tex-math id="M261">\documentclass[12pt]{minimal}
				\usepackage{amsmath}
				\usepackage{wasysym} 
				\usepackage{amsfonts} 
				\usepackage{amssymb} 
				\usepackage{amsbsy}
				\usepackage{mathrsfs}
				\usepackage{upgreek}
				\setlength{\oddsidemargin}{-69pt}
				\begin{document}$${\text{DDS TDA}}$$\end{document}</tex-math><mml:math id="M262"><mml:mrow><mml:mtext>DDS TDA</mml:mtext></mml:mrow></mml:math><inline-graphic xlink:href="12859_2021_4522_Article_IEq101.gif"/></alternatives></inline-formula></td><td char="." align="char">0.593</td></tr></tbody></table></table-wrap></p>
    </sec>
  </sec>
  <sec id="Sec6">
    <title>Results</title>
    <sec id="Sec7">
      <title>Evaluation metric</title>
      <p id="Par33">The fivefold cross-validation (CV) experiment was implemented to evaluate the performance of diverse prediction models. In the target-disease association network, there were 7342 known associations and 1,029,728 unconfirmed pairs. First, the 7342 target-disease associations and 7342 randomly selected unconfirmed pairs were considered as positive samples and negative samples, respectively. The remaining 1,022,386 unconfirmed pairs was unlabeled samples. Then, the positive samples and negative samples were evenly divided into 5 parts, where each part contained the same amount of positive and negative samples. In each CV, four parts were taken as training set in turn to train the model, while the remaining part and all unlabeled samples were taken as test set. For each test sample, the model could give a score representing the possibility that the pair was associated. We calculated the true positive rate (TPR) and false positive rate (FPR) for these scores under different thresholds to acquire the areas under the receiver operating characteristic curve (AUROC) and the areas under the precision–recall curve (AUPR). In fivefold CV, we obtained five AUROC/AUPR values and adopted the average AUROC/AUPR value to evaluate the performance of the model in this CV. To make the results more reliable, we repeated fivefold CV for 5 times to compute the mean and standard deviation (SD) values of the five average AUROC/AUPR values as the final evaluation metrics for prediction models.</p>
    </sec>
    <sec id="Sec8">
      <title>Feature analysis</title>
      <p id="Par34">M2PP acquired mean AUROC of 0.986 and mean AUPR of 0.417 under fivefold CV for 5 times. To detect the influence of features on model’s prediction performance, we removed each feature in turn to run M2PP with the remaining features under the same fold settings. After removing the investigated feature, the more reduced the prediction performance, the more effective the feature was. The AUROC and AUPR values via removing different feature were exhibited by boxplots in Fig. <xref rid="Fig2" ref-type="fig">2</xref>, where the mean values were represented by point in the box. It could be observed that the mean AUROC/AUPR values of using all features was better than removing any feature. The paired t-test [<xref ref-type="bibr" rid="CR33">33</xref>] was performed between AUROC (AUPR) values of using all features and values of removing any feature to check whether the average difference in their performance is significantly different from zero. All p-values were less than 0.05 as shown in Fig. <xref rid="Fig2" ref-type="fig">2</xref>, indicating that the performance of using all features is significantly better than removing any feature. This result demonstrated that each feature was indispensable. To further explore the influence of different feature on prediction performance, we defined an indicator named influence coefficient as below:<disp-formula id="Equ29"><label>29</label><alternatives><tex-math id="M263">\documentclass[12pt]{minimal}
				\usepackage{amsmath}
				\usepackage{wasysym} 
				\usepackage{amsfonts} 
				\usepackage{amssymb} 
				\usepackage{amsbsy}
				\usepackage{mathrsfs}
				\usepackage{upgreek}
				\setlength{\oddsidemargin}{-69pt}
				\begin{document}$${\text{Influence coefficient of Fea}}i = mean\left( {{\text{DifferenceAUROC}}_{i} ,{\text{DifferenceAUPR}}_{i} } \right)$$\end{document}</tex-math><mml:math id="M264" display="block"><mml:mrow><mml:mrow><mml:mtext>Influence coefficient of Fea</mml:mtext></mml:mrow><mml:mi>i</mml:mi><mml:mo>=</mml:mo><mml:mi>m</mml:mi><mml:mi>e</mml:mi><mml:mi>a</mml:mi><mml:mi>n</mml:mi><mml:mfenced close=")" open="("><mml:mrow><mml:msub><mml:mtext>DifferenceAUROC</mml:mtext><mml:mi>i</mml:mi></mml:msub><mml:mo>,</mml:mo><mml:msub><mml:mtext>DifferenceAUPR</mml:mtext><mml:mi>i</mml:mi></mml:msub></mml:mrow></mml:mfenced></mml:mrow></mml:math><graphic xlink:href="12859_2021_4522_Article_Equ29.gif" position="anchor"/></alternatives></disp-formula><disp-formula id="Equm"><alternatives><tex-math id="M265">\documentclass[12pt]{minimal}
				\usepackage{amsmath}
				\usepackage{wasysym} 
				\usepackage{amsfonts} 
				\usepackage{amssymb} 
				\usepackage{amsbsy}
				\usepackage{mathrsfs}
				\usepackage{upgreek}
				\setlength{\oddsidemargin}{-69pt}
				\begin{document}$${\text{DifferenceAUROC}}_{i} = 1/\left( {1 + e^{{ - sum\left( {AUROC_{all\, features} - AUROC_{all\, features\backslash Feai} } \right)}} } \right)$$\end{document}</tex-math><mml:math id="M266" display="block"><mml:mrow><mml:msub><mml:mtext>DifferenceAUROC</mml:mtext><mml:mi>i</mml:mi></mml:msub><mml:mo>=</mml:mo><mml:mn>1</mml:mn><mml:mo stretchy="false">/</mml:mo><mml:mfenced close=")" open="("><mml:mrow><mml:mn>1</mml:mn><mml:mo>+</mml:mo><mml:msup><mml:mi>e</mml:mi><mml:mrow><mml:mo>-</mml:mo><mml:mi>s</mml:mi><mml:mi>u</mml:mi><mml:mi>m</mml:mi><mml:mfenced close=")" open="("><mml:mrow><mml:mi>A</mml:mi><mml:mi>U</mml:mi><mml:mi>R</mml:mi><mml:mi>O</mml:mi><mml:msub><mml:mi>C</mml:mi><mml:mrow><mml:mi>a</mml:mi><mml:mi>l</mml:mi><mml:mi>l</mml:mi><mml:mspace width="0.166667em"/><mml:mi>f</mml:mi><mml:mi>e</mml:mi><mml:mi>a</mml:mi><mml:mi>t</mml:mi><mml:mi>u</mml:mi><mml:mi>r</mml:mi><mml:mi>e</mml:mi><mml:mi>s</mml:mi></mml:mrow></mml:msub><mml:mo>-</mml:mo><mml:mi>A</mml:mi><mml:mi>U</mml:mi><mml:mi>R</mml:mi><mml:mi>O</mml:mi><mml:msub><mml:mi>C</mml:mi><mml:mrow><mml:mi>a</mml:mi><mml:mi>l</mml:mi><mml:mi>l</mml:mi><mml:mspace width="0.166667em"/><mml:mi>f</mml:mi><mml:mi>e</mml:mi><mml:mi>a</mml:mi><mml:mi>t</mml:mi><mml:mi>u</mml:mi><mml:mi>r</mml:mi><mml:mi>e</mml:mi><mml:mi>s</mml:mi><mml:mo stretchy="true">\</mml:mo><mml:mi>F</mml:mi><mml:mi>e</mml:mi><mml:mi>a</mml:mi><mml:mi>i</mml:mi></mml:mrow></mml:msub></mml:mrow></mml:mfenced></mml:mrow></mml:msup></mml:mrow></mml:mfenced></mml:mrow></mml:math><graphic xlink:href="12859_2021_4522_Article_Equm.gif" position="anchor"/></alternatives></disp-formula><disp-formula id="Equn"><alternatives><tex-math id="M267">\documentclass[12pt]{minimal}
				\usepackage{amsmath}
				\usepackage{wasysym} 
				\usepackage{amsfonts} 
				\usepackage{amssymb} 
				\usepackage{amsbsy}
				\usepackage{mathrsfs}
				\usepackage{upgreek}
				\setlength{\oddsidemargin}{-69pt}
				\begin{document}$${\text{DifferenceAUPR}}_{i} = 1/\left( {1 + e^{{ - sum\left( {AUPR_{all\,features} - AUPR_{all\, features\backslash Feai} } \right)}} } \right)$$\end{document}</tex-math><mml:math id="M268" display="block"><mml:mrow><mml:msub><mml:mtext>DifferenceAUPR</mml:mtext><mml:mi>i</mml:mi></mml:msub><mml:mo>=</mml:mo><mml:mn>1</mml:mn><mml:mo stretchy="false">/</mml:mo><mml:mfenced close=")" open="("><mml:mrow><mml:mn>1</mml:mn><mml:mo>+</mml:mo><mml:msup><mml:mi>e</mml:mi><mml:mrow><mml:mo>-</mml:mo><mml:mi>s</mml:mi><mml:mi>u</mml:mi><mml:mi>m</mml:mi><mml:mfenced close=")" open="("><mml:mrow><mml:mi>A</mml:mi><mml:mi>U</mml:mi><mml:mi>P</mml:mi><mml:msub><mml:mi>R</mml:mi><mml:mrow><mml:mi>a</mml:mi><mml:mi>l</mml:mi><mml:mi>l</mml:mi><mml:mspace width="0.166667em"/><mml:mi>f</mml:mi><mml:mi>e</mml:mi><mml:mi>a</mml:mi><mml:mi>t</mml:mi><mml:mi>u</mml:mi><mml:mi>r</mml:mi><mml:mi>e</mml:mi><mml:mi>s</mml:mi></mml:mrow></mml:msub><mml:mo>-</mml:mo><mml:mi>A</mml:mi><mml:mi>U</mml:mi><mml:mi>P</mml:mi><mml:msub><mml:mi>R</mml:mi><mml:mrow><mml:mi>a</mml:mi><mml:mi>l</mml:mi><mml:mi>l</mml:mi><mml:mspace width="0.166667em"/><mml:mi>f</mml:mi><mml:mi>e</mml:mi><mml:mi>a</mml:mi><mml:mi>t</mml:mi><mml:mi>u</mml:mi><mml:mi>r</mml:mi><mml:mi>e</mml:mi><mml:mi>s</mml:mi><mml:mo stretchy="true">\</mml:mo><mml:mi>F</mml:mi><mml:mi>e</mml:mi><mml:mi>a</mml:mi><mml:mi>i</mml:mi></mml:mrow></mml:msub></mml:mrow></mml:mfenced></mml:mrow></mml:msup></mml:mrow></mml:mfenced></mml:mrow></mml:math><graphic xlink:href="12859_2021_4522_Article_Equn.gif" position="anchor"/></alternatives></disp-formula>where <inline-formula id="IEq73"><alternatives><tex-math id="M269">\documentclass[12pt]{minimal}
				\usepackage{amsmath}
				\usepackage{wasysym} 
				\usepackage{amsfonts} 
				\usepackage{amssymb} 
				\usepackage{amsbsy}
				\usepackage{mathrsfs}
				\usepackage{upgreek}
				\setlength{\oddsidemargin}{-69pt}
				\begin{document}$$1 \le {\text{i}} \le 9$$\end{document}</tex-math><mml:math id="M270"><mml:mrow><mml:mn>1</mml:mn><mml:mo>≤</mml:mo><mml:mtext>i</mml:mtext><mml:mo>≤</mml:mo><mml:mn>9</mml:mn></mml:mrow></mml:math><inline-graphic xlink:href="12859_2021_4522_Article_IEq73.gif"/></alternatives></inline-formula>; <inline-formula id="IEq74"><alternatives><tex-math id="M271">\documentclass[12pt]{minimal}
				\usepackage{amsmath}
				\usepackage{wasysym} 
				\usepackage{amsfonts} 
				\usepackage{amssymb} 
				\usepackage{amsbsy}
				\usepackage{mathrsfs}
				\usepackage{upgreek}
				\setlength{\oddsidemargin}{-69pt}
				\begin{document}$$AUROC_{all features}$$\end{document}</tex-math><mml:math id="M272"><mml:mrow><mml:mi>A</mml:mi><mml:mi>U</mml:mi><mml:mi>R</mml:mi><mml:mi>O</mml:mi><mml:msub><mml:mi>C</mml:mi><mml:mrow><mml:mi mathvariant="italic">allfeatures</mml:mi></mml:mrow></mml:msub></mml:mrow></mml:math><inline-graphic xlink:href="12859_2021_4522_Article_IEq74.gif"/></alternatives></inline-formula> and <inline-formula id="IEq75"><alternatives><tex-math id="M273">\documentclass[12pt]{minimal}
				\usepackage{amsmath}
				\usepackage{wasysym} 
				\usepackage{amsfonts} 
				\usepackage{amssymb} 
				\usepackage{amsbsy}
				\usepackage{mathrsfs}
				\usepackage{upgreek}
				\setlength{\oddsidemargin}{-69pt}
				\begin{document}$$AUPR_{all features}$$\end{document}</tex-math><mml:math id="M274"><mml:mrow><mml:mi>A</mml:mi><mml:mi>U</mml:mi><mml:mi>P</mml:mi><mml:msub><mml:mi>R</mml:mi><mml:mrow><mml:mi mathvariant="italic">allfeatures</mml:mi></mml:mrow></mml:msub></mml:mrow></mml:math><inline-graphic xlink:href="12859_2021_4522_Article_IEq75.gif"/></alternatives></inline-formula> represented the AUROC and AUPR values of five times fivefold CV by using all features, respectively;<inline-formula id="IEq76"><alternatives><tex-math id="M275">\documentclass[12pt]{minimal}
				\usepackage{amsmath}
				\usepackage{wasysym} 
				\usepackage{amsfonts} 
				\usepackage{amssymb} 
				\usepackage{amsbsy}
				\usepackage{mathrsfs}
				\usepackage{upgreek}
				\setlength{\oddsidemargin}{-69pt}
				\begin{document}$$AUROC_{all features\backslash Feai}$$\end{document}</tex-math><mml:math id="M276"><mml:mrow><mml:mi>A</mml:mi><mml:mi>U</mml:mi><mml:mi>R</mml:mi><mml:mi>O</mml:mi><mml:msub><mml:mi>C</mml:mi><mml:mrow><mml:mi>a</mml:mi><mml:mi>l</mml:mi><mml:mi>l</mml:mi><mml:mi>f</mml:mi><mml:mi>e</mml:mi><mml:mi>a</mml:mi><mml:mi>t</mml:mi><mml:mi>u</mml:mi><mml:mi>r</mml:mi><mml:mi>e</mml:mi><mml:mi>s</mml:mi><mml:mo stretchy="true">\</mml:mo><mml:mi>F</mml:mi><mml:mi>e</mml:mi><mml:mi>a</mml:mi><mml:mi>i</mml:mi></mml:mrow></mml:msub></mml:mrow></mml:math><inline-graphic xlink:href="12859_2021_4522_Article_IEq76.gif"/></alternatives></inline-formula> and <inline-formula id="IEq77"><alternatives><tex-math id="M277">\documentclass[12pt]{minimal}
				\usepackage{amsmath}
				\usepackage{wasysym} 
				\usepackage{amsfonts} 
				\usepackage{amssymb} 
				\usepackage{amsbsy}
				\usepackage{mathrsfs}
				\usepackage{upgreek}
				\setlength{\oddsidemargin}{-69pt}
				\begin{document}$$AUPR_{all features\backslash Feai}$$\end{document}</tex-math><mml:math id="M278"><mml:mrow><mml:mi>A</mml:mi><mml:mi>U</mml:mi><mml:mi>P</mml:mi><mml:msub><mml:mi>R</mml:mi><mml:mrow><mml:mi>a</mml:mi><mml:mi>l</mml:mi><mml:mi>l</mml:mi><mml:mi>f</mml:mi><mml:mi>e</mml:mi><mml:mi>a</mml:mi><mml:mi>t</mml:mi><mml:mi>u</mml:mi><mml:mi>r</mml:mi><mml:mi>e</mml:mi><mml:mi>s</mml:mi><mml:mo stretchy="true">\</mml:mo><mml:mi>F</mml:mi><mml:mi>e</mml:mi><mml:mi>a</mml:mi><mml:mi>i</mml:mi></mml:mrow></mml:msub></mml:mrow></mml:math><inline-graphic xlink:href="12859_2021_4522_Article_IEq77.gif"/></alternatives></inline-formula> represented the AUROC and AUPR values of five times fivefold CV by removing feature <inline-formula id="IEq78"><alternatives><tex-math id="M279">\documentclass[12pt]{minimal}
				\usepackage{amsmath}
				\usepackage{wasysym} 
				\usepackage{amsfonts} 
				\usepackage{amssymb} 
				\usepackage{amsbsy}
				\usepackage{mathrsfs}
				\usepackage{upgreek}
				\setlength{\oddsidemargin}{-69pt}
				\begin{document}$$Feai$$\end{document}</tex-math><mml:math id="M280"><mml:mrow><mml:mi mathvariant="italic">Feai</mml:mi></mml:mrow></mml:math><inline-graphic xlink:href="12859_2021_4522_Article_IEq78.gif"/></alternatives></inline-formula>, respectively. The larger the influence coefficient, the more effective the feature was. The influence coefficient of each feature were shown in Table <xref rid="Tab2" ref-type="table">2</xref>. In the neighborhood similarity information type, Fea3 got the largest influence coefficient, because Fea3 mainly utilized the nearest neighborhoods’ similarity, which was the most valid information in similarity networks. In the path information type, Fea5 and Fea6 obtained advantageous influence coefficients, because paths of length = 2 provided more basic, direct and non-redundant information than length = 3. The drug-inferred information type, Fea4, also acquired decent influence coefficient, indicating that drug indeed play an effective role in predicting target-disease associations because of the drug-target-disease mechanism. Hence, our constructed features were effective, reasonable and indispensable to achieve excellent prediction performance.<fig id="Fig2"><label>Fig. 2</label><caption><p>Analysis of features in M2PP. <bold>a</bold> AUROC values via all features and removing each feature with p-values of paired t-test, where the point in the box represent the mean value; <bold>b</bold> AUPR values via all features and removing each feature with p-values of paired t-test, where the point in the box represent the mean value</p></caption><graphic xlink:href="12859_2021_4522_Fig2_HTML" id="MO2"/></fig></p>
    </sec>
    <sec id="Sec9">
      <title>Comparison with existing prediction models</title>
      <p id="Par35">M2PP was compared with six state-of-the-art models, which were RFLDA [<xref ref-type="bibr" rid="CR34">34</xref>], DDR [<xref ref-type="bibr" rid="CR35">35</xref>], NEDD [<xref ref-type="bibr" rid="CR36">36</xref>], IRFMDA [<xref ref-type="bibr" rid="CR37">37</xref>], GCRFLDA [<xref ref-type="bibr" rid="CR38">38</xref>] and MFLDA [<xref ref-type="bibr" rid="CR39">39</xref>]. The first four methods were based on random forest algorithm, and the last two methods were based on the graph convolutional matrix completion and the matrix factorization, respectively. We performed fivefold CV for five times on each model, exhibiting the mean and SD of AUROC/AUPR values in Fig. <xref rid="Fig3" ref-type="fig">3</xref>a). The AUROC values were 0.986 ± 0.001 (M2PP), 0.918 ± 0.002 (MFLDA), 0.922 ± 0.001 (IRFMDA), 0.936 ± 0.001 (GCRFLDA), 0.936 ± 0.001 (NEDD), 0.97 ± 0.001 (DDR) and 0.979 ± 0.001 (RFLDA); the AUPR values were 0.417 ± 0.016 (M2PP), 0.301 ± 0.018 (MFLDA), 0.336 ± 0.017 (IRFMDA), 0.341 ± 0.018 (GCRFLDA), 0.353 ± 0.015 (NEDD), 0.39 ± 0.014 (DDR) and 0.402 ± 0.015 (RFLDA). Whether AUROC or AUPR values, M2PP always achieved the advantageous performance among all methods.<fig id="Fig3"><label>Fig. 3</label><caption><p>Model comparison. <bold>a</bold> Models’ prediction performance on 5-fold CV for five times, including the mean AUROC/AUPR values with SD marked at the top of each bar; <bold>b</bold> Statistics of disease categories, including the circular bar chart in the left side to exhibit the number and proportion of diseases in each category and the UpSet chart in the right side to exhibit the details of diseases in the top 5 category; <bold>c</bold> Models’ prediction performance for the top 5 category, including the mean AUROC/AUPR values with SD marked at the top of each bar</p></caption><graphic xlink:href="12859_2021_4522_Fig3_HTML" id="MO3"/></fig></p>
      <p id="Par36">Each disease belonged to at least one category provided by MESH, for example, disease “Lymphoma” belonged to three categories, which were “C04: Neoplasms”, “C15: Hemic and Lymphatic Diseases” and “C20: Immune System Diseases”. In our network, diseases involved 24 categories, where the number and proportion of diseases in each category were shown in the left graph in Fig. <xref rid="Fig3" ref-type="fig">3</xref>b). Proportion of the top 5 category “C23: Pathological Conditions, Signs and Symptoms”, “C10: Nervous System Diseases”, “C04: Neoplasms”, “C14: Cardiovascular Diseases” and “C16: Congenital, Hereditary, and Neonatal Diseases and Abnormalities” exceeded 10%, whose UpSet chart was shown in the right side in Fig. <xref rid="Fig3" ref-type="fig">3</xref>b) to exhibit the details of diseases in them. For these five categories, we detected models’ prediction performance for their diseases. First, we trained the model with a training sample set which included known target-disease (excluded diseases in the investigated category) associations as the positive samples and the randomly selected unconfirmed target-disease (excluded diseases in the investigated category) pairs as the negative samples, noting that the number of positive and negative samples were the same. Second, the pairs between all targets and each disease in the investigated category were considered as the test set in turn to acquire scores by the model. Then, we could compute the AUROC and AUPR values for each disease in the investigated category, and the average AUROC/AUPR value was considered as the prediction performance of the investigated category. The process was repeated for 5 times to get reliable results. Each model’s mean and SD of AUROC/AUPR values for the five categories were exhibited in Fig. <xref rid="Fig3" ref-type="fig">3</xref>c), where M2PP always achieved the best performance. These results indicated the excellent ability of our model.</p>
    </sec>
    <sec id="Sec10">
      <title>Case studies</title>
      <p id="Par37">We predicted new pathogenic proteins for five common diseases: lung cancer, breast cancer, colon cancer, leukemia and lymphoma. For one investigated disease, M2PP was trained with a training sample set, where the known target-disease (excluded the investigated disease) associations was the positive samples and the randomly selected unconfirmed target-disease (excluded the investigated disease) pairs of the same size was the negative samples. Then, M2PP could predict for the pairs between all targets and the investigated disease to acquire prediction scores. We repeated the process for 5 times, so the pair between one target and the investigated disease had five scores, and finally the average score was considered as the prediction score of the pair. We sorted the prediction score of all unconfirmed pairs between targets and the investigated disease, and manually searched the top 10 pairs in public biomedical literature to find the supporting evidence. All top 10 targets were successfully predicted for lung cancer, breast cancer and colon cancer, nine targets for leukemia and seven targets for lymphoma, shown in Table <xref rid="Tab3" ref-type="table">3</xref>. Here, we mainly introduced the top 1 predicted target for each disease. Researchers found that TNF played a key role in inducing resistance to epidermal growth factor receptor inhibition in lung cancer, and suggested that a concomitant inhibition of epidermal growth factor receptor and TNF maybe a potentially new treatment strategy for lung cancer patients [<xref ref-type="bibr" rid="CR40">40</xref>]. IL2 inhibited the growth of breast cancer cells through improving the proliferation of natural killer cells [<xref ref-type="bibr" rid="CR41">41</xref>]. Inhibiting or knocking MET down made colon cancer cells sensitive on cetuximab-mediated growth inhibition, implicating that targeting MET was a rational strategy for reversing cetuximab resistance in colon cancer [<xref ref-type="bibr" rid="CR42">42</xref>]. VEGFA was observed to have additive effect in inflating the risk of leukemia [<xref ref-type="bibr" rid="CR43">43</xref>]. CHKA possessed oncogenic activity and could be a potential therapeutic target in lymphoma [<xref ref-type="bibr" rid="CR44">44</xref>]. We also predicted target-disease association scores on the whole network and sorted all unconfirmed pairs’ scores. Seven associations in top 10 has been successfully predicted with public literature as evidences, shown in Table <xref rid="Tab4" ref-type="table">4</xref>. For example, researchers investigated the expression and functions of ALOX5 in breast cancer cells, and demonstrated that inhibiting ALOX5 had therapeutic potential in breast cancer [<xref ref-type="bibr" rid="CR45">45</xref>]. In addition to these literature evidences, we also found that no matter in Tables <xref rid="Tab3" ref-type="table">3</xref> or <xref rid="Tab4" ref-type="table">4</xref>, targets and diseases in all successful predictions had co-associated drugs (CDs), which were drugs simultaneously associated with the target and disease. The phenomenon further demonstrated that these high-rank predicted pairs were reasonable from the aspect of both computational data and biomedicine verification. Other drugs which interacted with the predicted target might be potential candidate therapeutic strategies for the investigated disease, needing to be explored in future clinical trials. These results indicated the ability of M2PP to provide conveniences for the future biological researches.<table-wrap id="Tab3"><label>Table 3</label><caption><p>Successfully predicted pathogenic targets in top 10 for common diseases</p></caption><table frame="hsides" rules="groups"><thead><tr><th align="left">Disease name</th><th align="left">Rank</th><th align="left">Target name</th><th align="left">Have CDs</th><th align="left">Evidence</th><th align="left">Disease name</th><th align="left">Rank</th><th align="left">Target name</th><th align="left">Have CDs</th><th align="left">Evidence</th></tr></thead><tbody><tr><td align="left">Lung cancer</td><td char="." align="char">1</td><td align="left">TNF</td><td align="left">Yes</td><td align="left">[<xref ref-type="bibr" rid="CR40">40</xref>]</td><td align="left">Colon cancer</td><td char="." align="char">4</td><td align="left">ESR1</td><td align="left">Yes</td><td align="left">[<xref ref-type="bibr" rid="CR46">46</xref>]</td></tr><tr><td align="left"/><td char="." align="char">2</td><td align="left">IL1B</td><td align="left">Yes</td><td align="left">[<xref ref-type="bibr" rid="CR47">47</xref>]</td><td align="left"/><td char="." align="char">5</td><td align="left">ACE</td><td align="left">Yes</td><td align="left">[<xref ref-type="bibr" rid="CR48">48</xref>, <xref ref-type="bibr" rid="CR49">49</xref>]</td></tr><tr><td align="left"/><td char="." align="char">3</td><td align="left">CTNNB1</td><td align="left">Yes</td><td align="left">[<xref ref-type="bibr" rid="CR50">50</xref>, <xref ref-type="bibr" rid="CR51">51</xref>]</td><td align="left"/><td char="." align="char">6</td><td align="left">CYP2A6</td><td align="left">Yes</td><td align="left">[<xref ref-type="bibr" rid="CR52">52</xref>]</td></tr><tr><td align="left"/><td char="." align="char">4</td><td align="left">ESR1</td><td align="left">Yes</td><td align="left">[<xref ref-type="bibr" rid="CR53">53</xref>]</td><td align="left"/><td char="." align="char">7</td><td align="left">CA1</td><td align="left">Yes</td><td align="left">[<xref ref-type="bibr" rid="CR54">54</xref>]</td></tr><tr><td align="left"/><td char="." align="char">5</td><td align="left">MMP9</td><td align="left">Yes</td><td align="left">[<xref ref-type="bibr" rid="CR55">55</xref>]</td><td align="left"/><td char="." align="char">8</td><td align="left">PIK3CA</td><td align="left">Yes</td><td align="left">[<xref ref-type="bibr" rid="CR56">56</xref>]</td></tr><tr><td align="left"/><td char="." align="char">6</td><td align="left">MAPK3</td><td align="left">Yes</td><td align="left">[<xref ref-type="bibr" rid="CR57">57</xref>]</td><td align="left"/><td char="." align="char">9</td><td align="left">PLAU</td><td align="left">Yes</td><td align="left">[<xref ref-type="bibr" rid="CR58">58</xref>]</td></tr><tr><td align="left"/><td char="." align="char">7</td><td align="left">SOD1</td><td align="left">Yes</td><td align="left">[<xref ref-type="bibr" rid="CR59">59</xref>]</td><td align="left"/><td char="." align="char">10</td><td align="left">CYP2E1</td><td align="left">Yes</td><td align="left">[<xref ref-type="bibr" rid="CR60">60</xref>]</td></tr><tr><td align="left"/><td char="." align="char">8</td><td align="left">AKT1</td><td align="left">Yes</td><td align="left">[<xref ref-type="bibr" rid="CR61">61</xref>]</td><td align="left">Leukemia</td><td char="." align="char">1</td><td align="left">VEGFA</td><td align="left">Yes</td><td align="left">[<xref ref-type="bibr" rid="CR43">43</xref>]</td></tr><tr><td align="left"/><td char="." align="char">9</td><td align="left">MAPK1</td><td align="left">Yes</td><td align="left">[<xref ref-type="bibr" rid="CR62">62</xref>]</td><td align="left"/><td char="." align="char">2</td><td align="left">HIF1A</td><td align="left">Yes</td><td align="left">[<xref ref-type="bibr" rid="CR63">63</xref>]</td></tr><tr><td align="left"/><td char="." align="char">10</td><td align="left">PTGS2</td><td align="left">Yes</td><td align="left">[<xref ref-type="bibr" rid="CR64">64</xref>]</td><td align="left"/><td char="." align="char">4</td><td align="left">TGM2</td><td align="left">Yes</td><td align="left">[<xref ref-type="bibr" rid="CR65">65</xref>]</td></tr><tr><td align="left">Breast cancer</td><td char="." align="char">1</td><td align="left">IL2</td><td align="left">Yes</td><td align="left">[<xref ref-type="bibr" rid="CR41">41</xref>]</td><td align="left"/><td char="." align="char">5</td><td align="left">JUN</td><td align="left">Yes</td><td align="left">[<xref ref-type="bibr" rid="CR66">66</xref>]</td></tr><tr><td align="left"/><td char="." align="char">2</td><td align="left">NR3C1</td><td align="left">Yes</td><td align="left">[<xref ref-type="bibr" rid="CR67">67</xref>]</td><td align="left"/><td char="." align="char">6</td><td align="left">TP53</td><td align="left">Yes</td><td align="left">[<xref ref-type="bibr" rid="CR68">68</xref>]</td></tr><tr><td align="left"/><td char="." align="char">3</td><td align="left">PON1</td><td align="left">Yes</td><td align="left">[<xref ref-type="bibr" rid="CR69">69</xref>, <xref ref-type="bibr" rid="CR70">70</xref>]</td><td align="left"/><td char="." align="char">7</td><td align="left">AKT1</td><td align="left">Yes</td><td align="left">[<xref ref-type="bibr" rid="CR71">71</xref>]</td></tr><tr><td align="left"/><td char="." align="char">4</td><td align="left">JAK2</td><td align="left">Yes</td><td align="left">[<xref ref-type="bibr" rid="CR72">72</xref>]</td><td align="left"/><td char="." align="char">8</td><td align="left">GSTP1</td><td align="left">Yes</td><td align="left">[<xref ref-type="bibr" rid="CR73">73</xref>, <xref ref-type="bibr" rid="CR74">74</xref>]</td></tr><tr><td align="left"/><td char="." align="char">5</td><td align="left">ICAM1</td><td align="left">Yes</td><td align="left">[<xref ref-type="bibr" rid="CR75">75</xref>]</td><td align="left"/><td char="." align="char">9</td><td align="left">CDK4</td><td align="left">Yes</td><td align="left">[<xref ref-type="bibr" rid="CR76">76</xref>]</td></tr><tr><td align="left"/><td char="." align="char">6</td><td align="left">VEGFA</td><td align="left">Yes</td><td align="left">[<xref ref-type="bibr" rid="CR77">77</xref>]</td><td align="left"/><td char="." align="char">10</td><td align="left">SMO</td><td align="left">Yes</td><td align="left">[<xref ref-type="bibr" rid="CR78">78</xref>]</td></tr><tr><td align="left"/><td char="." align="char">7</td><td align="left">CCL2</td><td align="left">Yes</td><td align="left">[<xref ref-type="bibr" rid="CR79">79</xref>]</td><td align="left">Lymphoma</td><td char="." align="char">1</td><td align="left">CHKA</td><td align="left">Yes</td><td align="left">[<xref ref-type="bibr" rid="CR44">44</xref>]</td></tr><tr><td align="left"/><td char="." align="char">8</td><td align="left">ADRB2</td><td align="left">Yes</td><td align="left">[<xref ref-type="bibr" rid="CR80">80</xref>]</td><td align="left"/><td char="." align="char">3</td><td align="left">BCL2</td><td align="left">Yes</td><td align="left">[<xref ref-type="bibr" rid="CR81">81</xref>]</td></tr><tr><td align="left"/><td char="." align="char">9</td><td align="left">PLAU</td><td align="left">Yes</td><td align="left">[<xref ref-type="bibr" rid="CR82">82</xref>, <xref ref-type="bibr" rid="CR83">83</xref>]</td><td align="left"/><td char="." align="char">4</td><td align="left">GSTP1</td><td align="left">Yes</td><td align="left">[<xref ref-type="bibr" rid="CR84">84</xref>, <xref ref-type="bibr" rid="CR85">85</xref>]</td></tr><tr><td align="left"/><td char="." align="char">10</td><td align="left">B2M</td><td align="left">Yes</td><td align="left">[<xref ref-type="bibr" rid="CR86">86</xref>]</td><td align="left"/><td char="." align="char">5</td><td align="left">HMOX1</td><td align="left">Yes</td><td align="left">[<xref ref-type="bibr" rid="CR87">87</xref>]</td></tr><tr><td align="left">Colon cancer</td><td char="." align="char">1</td><td align="left">MET</td><td align="left">Yes</td><td align="left">[<xref ref-type="bibr" rid="CR42">42</xref>]</td><td align="left"/><td char="." align="char">6</td><td align="left">ATP6V1B2</td><td align="left">Yes</td><td align="left">[<xref ref-type="bibr" rid="CR88">88</xref>]</td></tr><tr><td align="left"/><td char="." align="char">2</td><td align="left">NOS3</td><td align="left">Yes</td><td align="left">[<xref ref-type="bibr" rid="CR89">89</xref>]</td><td align="left"/><td char="." align="char">7</td><td align="left">TP53</td><td align="left">Yes</td><td align="left">[<xref ref-type="bibr" rid="CR90">90</xref>, <xref ref-type="bibr" rid="CR91">91</xref>]</td></tr><tr><td align="left"/><td char="." align="char">3</td><td align="left">ESR2</td><td align="left">Yes</td><td align="left">[<xref ref-type="bibr" rid="CR92">92</xref>]</td><td align="left"/><td char="." align="char">8</td><td align="left">VEGFA</td><td align="left">Yes</td><td align="left">[<xref ref-type="bibr" rid="CR93">93</xref>]</td></tr></tbody></table></table-wrap><table-wrap id="Tab4"><label>Table 4</label><caption><p>Successfully predicted target-disease associations on the whole network in top 10</p></caption><table frame="hsides" rules="groups"><thead><tr><th align="left">Target name</th><th align="left">Disease name</th><th align="left">Have CDs</th><th align="left">Rank</th><th align="left">Evidence</th></tr></thead><tbody><tr><td align="left">ALOX5</td><td align="left">Breast cancer</td><td align="left">Yes</td><td char="." align="char">1</td><td align="left">[<xref ref-type="bibr" rid="CR45">45</xref>]</td></tr><tr><td align="left">NQO1</td><td align="left">Lung cancer</td><td align="left">Yes</td><td char="." align="char">2</td><td align="left">[<xref ref-type="bibr" rid="CR94">94</xref>]</td></tr><tr><td align="left">MMP14</td><td align="left">Non-small-cell lung cancer</td><td align="left">Yes</td><td char="." align="char">3</td><td align="left">[<xref ref-type="bibr" rid="CR95">95</xref>, <xref ref-type="bibr" rid="CR96">96</xref>]</td></tr><tr><td align="left">BRAF</td><td align="left">Breast cancer</td><td align="left">Yes</td><td char="." align="char">5</td><td align="left">[<xref ref-type="bibr" rid="CR97">97</xref>]</td></tr><tr><td align="left">ERBB2</td><td align="left">Colon cancer</td><td align="left">Yes</td><td char="." align="char">6</td><td align="left">[<xref ref-type="bibr" rid="CR98">98</xref>, <xref ref-type="bibr" rid="CR99">99</xref>]</td></tr><tr><td align="left">MMP14</td><td align="left">Stomach cancer</td><td align="left">Yes</td><td char="." align="char">8</td><td align="left">[<xref ref-type="bibr" rid="CR100">100</xref>]</td></tr><tr><td align="left">ERBB2</td><td align="left">Hepatocellular Cancer</td><td align="left">Yes</td><td char="." align="char">10</td><td align="left">[<xref ref-type="bibr" rid="CR101">101</xref>, <xref ref-type="bibr" rid="CR102">102</xref>]</td></tr></tbody></table></table-wrap></p>
    </sec>
  </sec>
  <sec id="Sec11">
    <title>Conclusion</title>
    <p id="Par38">Predicting drug-targeted pathogenic proteins is crucial for understanding disease mechanism and implementing disease treatment. In this study, we presented a novel model M2PP to predict drug-targeted pathogenic proteins. First, we constructed a heterogeneous network, including the target-disease association network, target-drug interaction network, disease-drug association network, disease-disease similarity network, target-target similarity network and drug-drug topological structure similarity network. Then, we developed three types of features on the network, which were based on neighborhood similarity information, drug-inferred information and path information. Finally, we trained a random forest model with these features to score unconfirmed target-disease pairs. In the result section, we first analyzed our constructed features in detail. By removing each feature in turn to check the change of prediction performance, we found that each feature was indispensable. Three types of feature obtained the average influence coefficient of 0.598 (the neighborhood similarity information), 0.671 (the drug-inferred information type) and 0.677 (the path information type), respectively. The path information type acquired the highest value mainly benefited from paths of length = 2, which provided more basic, direct and non-redundant information than paths of length = 3. In addition, the drug-inferred information type also got decent value, indicating that drugs were effective in predicting target-disease associations because of the drug-target-disease mechanism. Then, we compared M2PP with several state-of-the-art models, where M2PP obtained advantageous performance among them. According to the disease category, we extracted sub-networks from the whole target-disease association network for the top 5 category to perform the prediction. Results showed that category of “C23”, “C04” and “C14” achieved better performance. This was because that diseases in “C23”, “C04” and “C14” have more associations with targets than in the other two categories “C10” and “C16”. The average degree of diseases in “C23”, “C04” and “C14” were 6.84 (1670 associations /244 diseases), 12.03 (1985/165) and 7.16 (960/134); while in “C10” and “C16”, the average degree of diseases were 5.06 (1057/209) and 2.95 (348/118). Finally, we predicted new target-disease associations using M2PP, where several high rank associations were successfully confirmed with public literature as evidence. These results demonstrated that M2PP was effective and accurate, which might be convenient for biological researches in the future.</p>
  </sec>
</body>
<back>
  <glossary>
    <title>Abbreviations</title>
    <def-list>
      <def-item>
        <term>PPI</term>
        <def>
          <p id="Par4">Protein–protein interaction</p>
        </def>
      </def-item>
      <def-item>
        <term>FDA</term>
        <def>
          <p id="Par5">Food and drug administration</p>
        </def>
      </def-item>
      <def-item>
        <term>CV</term>
        <def>
          <p id="Par6">Cross-validation</p>
        </def>
      </def-item>
      <def-item>
        <term>AUROC</term>
        <def>
          <p id="Par7">The areas under the receiver operating characteristic curve</p>
        </def>
      </def-item>
      <def-item>
        <term>AUPR</term>
        <def>
          <p id="Par8">The areas under the precision–recall curve</p>
        </def>
      </def-item>
      <def-item>
        <term>SD</term>
        <def>
          <p id="Par9">Standard deviation</p>
        </def>
      </def-item>
      <def-item>
        <term>CDs</term>
        <def>
          <p id="Par10">Co-associated drugs</p>
        </def>
      </def-item>
      <def-item>
        <term>CTD</term>
        <def>
          <p id="Par11">Comparative toxicogenomics database</p>
        </def>
      </def-item>
      <def-item>
        <term>DO</term>
        <def>
          <p id="Par12">Disease ontology</p>
        </def>
      </def-item>
    </def-list>
  </glossary>
  <fn-group>
    <fn>
      <p>
        <bold>Publisher's Note</bold>
      </p>
      <p>Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.</p>
    </fn>
  </fn-group>
  <ack>
    <title>Acknowledgements</title>
    <p>Not applicable.</p>
  </ack>
  <notes notes-type="author-contribution">
    <title>Authors' contributions</title>
    <p>SW implemented the model and wrote the main manuscript text. JL and YW revised the manuscript. All authors have read and approved the final manuscript.</p>
  </notes>
  <notes notes-type="funding-information">
    <title>Funding</title>
    <p>This work was supported by the National Key Research and Development Program of China [2016YFC0901905].</p>
  </notes>
  <notes notes-type="data-availability">
    <title>Availability of data and materials</title>
    <p>All data and materials in our manuscript were available on: DrugBank (<ext-link ext-link-type="uri" xlink:href="https://go.drugbank.com/">https://go.drugbank.com/</ext-link>), CTD (<ext-link ext-link-type="uri" xlink:href="http://ctdbase.org/">http://ctdbase.org/</ext-link>), MESH (<ext-link ext-link-type="uri" xlink:href="https://meshb.nlm.nih.gov/search">https://meshb.nlm.nih.gov/search</ext-link>), DO (<ext-link ext-link-type="uri" xlink:href="https://disease-ontology.org/">https://disease-ontology.org/</ext-link>) and KEGG (<ext-link ext-link-type="uri" xlink:href="https://www.kegg.jp/">https://www.kegg.jp/</ext-link>). The original data and code of M2PP is available at <ext-link ext-link-type="uri" xlink:href="https://github.com/shimingwang1994/M2PP.git">https://github.com/shimingwang1994/M2PP.git</ext-link></p>
  </notes>
  <notes>
    <title>Declarations</title>
    <notes id="FPar1">
      <title>Ethics approval and consent to participate</title>
      <p id="Par39">Not applicable.</p>
    </notes>
    <notes id="FPar2">
      <title>Consent for publication</title>
      <p id="Par40">Not applicable.</p>
    </notes>
    <notes id="FPar3" notes-type="COI-statement">
      <title>Competing interests</title>
      <p id="Par41">The authors declare that they have no competing interests.</p>
    </notes>
  </notes>
  <ref-list id="Bib1">
    <title>References</title>
    <ref id="CR1">
      <label>1.</label>
      <element-citation publication-type="journal">
        <person-group person-group-type="author">
          <name>
            <surname>Hong</surname>
            <given-names>K-W</given-names>
          </name>
          <name>
            <surname>Oh</surname>
            <given-names>B-S</given-names>
          </name>
        </person-group>
        <article-title>Overview of personalized medicine in the disease genomic era</article-title>
        <source>BMB Rep</source>
        <year>2010</year>
        <volume>43</volume>
        <issue>10</issue>
        <fpage>643</fpage>
        <lpage>648</lpage>
        <?supplied-pmid 21034525?>
        <pub-id pub-id-type="pmid">21034525</pub-id>
      </element-citation>
    </ref>
    <ref id="CR2">
      <label>2.</label>
      <element-citation publication-type="journal">
        <person-group person-group-type="author">
          <name>
            <surname>Giallourakis</surname>
            <given-names>C</given-names>
          </name>
          <name>
            <surname>Henson</surname>
            <given-names>C</given-names>
          </name>
          <name>
            <surname>Reich</surname>
            <given-names>M</given-names>
          </name>
          <name>
            <surname>Xie</surname>
            <given-names>X</given-names>
          </name>
          <name>
            <surname>Mootha</surname>
            <given-names>VK</given-names>
          </name>
        </person-group>
        <article-title>Disease gene discovery through integrative genomics</article-title>
        <source>Annu Rev Genomics Hum Genet</source>
        <year>2005</year>
        <volume>6</volume>
        <issue>1</issue>
        <fpage>381</fpage>
        <lpage>406</lpage>
        <?supplied-pmid 16124867?>
        <pub-id pub-id-type="pmid">16124867</pub-id>
      </element-citation>
    </ref>
    <ref id="CR3">
      <label>3.</label>
      <element-citation publication-type="journal">
        <person-group person-group-type="author">
          <name>
            <surname>Hurle</surname>
            <given-names>MR</given-names>
          </name>
          <name>
            <surname>Yang</surname>
            <given-names>L</given-names>
          </name>
          <name>
            <surname>Xie</surname>
            <given-names>Q</given-names>
          </name>
          <name>
            <surname>Rajpal</surname>
            <given-names>DK</given-names>
          </name>
          <name>
            <surname>Sanseau</surname>
            <given-names>P</given-names>
          </name>
          <name>
            <surname>Agarwal</surname>
            <given-names>P</given-names>
          </name>
        </person-group>
        <article-title>Computational drug repositioning: from data to therapeutics</article-title>
        <source>Clin Pharmacol Ther</source>
        <year>2013</year>
        <volume>93</volume>
        <issue>4</issue>
        <fpage>335</fpage>
        <lpage>341</lpage>
        <?supplied-pmid 23443757?>
        <pub-id pub-id-type="pmid">23443757</pub-id>
      </element-citation>
    </ref>
    <ref id="CR4">
      <label>4.</label>
      <element-citation publication-type="journal">
        <person-group person-group-type="author">
          <name>
            <surname>Köhler</surname>
            <given-names>S</given-names>
          </name>
          <name>
            <surname>Bauer</surname>
            <given-names>S</given-names>
          </name>
          <name>
            <surname>Horn</surname>
            <given-names>D</given-names>
          </name>
          <name>
            <surname>Robinson</surname>
            <given-names>PN</given-names>
          </name>
        </person-group>
        <article-title>Walking the interactome for prioritization of candidate disease genes</article-title>
        <source>The American Journal of Human Genetics</source>
        <year>2008</year>
        <volume>82</volume>
        <issue>4</issue>
        <fpage>949</fpage>
        <lpage>958</lpage>
        <?supplied-pmid 18371930?>
        <pub-id pub-id-type="pmid">18371930</pub-id>
      </element-citation>
    </ref>
    <ref id="CR5">
      <label>5.</label>
      <mixed-citation publication-type="other">Vanunu O, Magger O, Ruppin E, Shlomi T, Sharan R, Wasserman WW: Associating Genes and protein complexes with disease via network propagation. PLOSComput Biol 2010, 6.</mixed-citation>
    </ref>
    <ref id="CR6">
      <label>6.</label>
      <element-citation publication-type="journal">
        <person-group person-group-type="author">
          <name>
            <surname>Jia</surname>
            <given-names>P</given-names>
          </name>
          <name>
            <surname>Zheng</surname>
            <given-names>S</given-names>
          </name>
          <name>
            <surname>Long</surname>
            <given-names>J</given-names>
          </name>
          <name>
            <surname>Zheng</surname>
            <given-names>W</given-names>
          </name>
          <name>
            <surname>Zhao</surname>
            <given-names>Z</given-names>
          </name>
        </person-group>
        <article-title>dmGWAS: dense module searching for genome-wide association studies in protein–protein interaction networks</article-title>
        <source>Bioinformatics</source>
        <year>2011</year>
        <volume>27</volume>
        <issue>1</issue>
        <fpage>95</fpage>
        <lpage>102</lpage>
        <?supplied-pmid 21045073?>
        <pub-id pub-id-type="pmid">21045073</pub-id>
      </element-citation>
    </ref>
    <ref id="CR7">
      <label>7.</label>
      <mixed-citation publication-type="other">Wu M, Zeng W, Liu W, Zhang Y, Chen T, Jiang R: Integrating embeddings of multiple gene networks to prioritize complex disease-associated genes. In: 2017 IEEE International Conference on Bioinformatics and Biomedicine (BIBM): 2017. IEEE: 208–215.</mixed-citation>
    </ref>
    <ref id="CR8">
      <label>8.</label>
      <element-citation publication-type="journal">
        <person-group person-group-type="author">
          <name>
            <surname>Lee</surname>
            <given-names>I</given-names>
          </name>
          <name>
            <surname>Blom</surname>
            <given-names>UM</given-names>
          </name>
          <name>
            <surname>Wang</surname>
            <given-names>PI</given-names>
          </name>
          <name>
            <surname>Shim</surname>
            <given-names>JE</given-names>
          </name>
          <name>
            <surname>Marcotte</surname>
            <given-names>EM</given-names>
          </name>
        </person-group>
        <article-title>Prioritizing candidate disease genes by network-based boosting of genome-wide association data</article-title>
        <source>Genome Res</source>
        <year>2011</year>
        <volume>21</volume>
        <issue>7</issue>
        <fpage>1109</fpage>
        <lpage>1121</lpage>
        <?supplied-pmid 21536720?>
        <pub-id pub-id-type="pmid">21536720</pub-id>
      </element-citation>
    </ref>
    <ref id="CR9">
      <label>9.</label>
      <element-citation publication-type="journal">
        <person-group person-group-type="author">
          <name>
            <surname>Hou</surname>
            <given-names>L</given-names>
          </name>
          <name>
            <surname>Chen</surname>
            <given-names>M</given-names>
          </name>
          <name>
            <surname>Zhang</surname>
            <given-names>CK</given-names>
          </name>
          <name>
            <surname>Cho</surname>
            <given-names>J</given-names>
          </name>
          <name>
            <surname>Zhao</surname>
            <given-names>H</given-names>
          </name>
        </person-group>
        <article-title>Guilt by rewiring: gene prioritization through network rewiring in genome wide association studies</article-title>
        <source>Hum Mol Genet</source>
        <year>2014</year>
        <volume>23</volume>
        <issue>10</issue>
        <fpage>2780</fpage>
        <lpage>2790</lpage>
        <?supplied-pmid 24381306?>
        <pub-id pub-id-type="pmid">24381306</pub-id>
      </element-citation>
    </ref>
    <ref id="CR10">
      <label>10.</label>
      <element-citation publication-type="journal">
        <person-group person-group-type="author">
          <name>
            <surname>Luo</surname>
            <given-names>P</given-names>
          </name>
          <name>
            <surname>Tian</surname>
            <given-names>L-P</given-names>
          </name>
          <name>
            <surname>Ruan</surname>
            <given-names>J</given-names>
          </name>
          <name>
            <surname>Wu</surname>
            <given-names>F-X</given-names>
          </name>
        </person-group>
        <article-title>Disease gene prediction by integrating ppi networks, clinical rna-seq data and omim data</article-title>
        <source>IEEE/ACM Trans Comput Biol Bioinf</source>
        <year>2017</year>
        <volume>16</volume>
        <issue>1</issue>
        <fpage>222</fpage>
        <lpage>232</lpage>
      </element-citation>
    </ref>
    <ref id="CR11">
      <label>11.</label>
      <element-citation publication-type="journal">
        <person-group person-group-type="author">
          <name>
            <surname>Wang</surname>
            <given-names>Q</given-names>
          </name>
          <name>
            <surname>Yu</surname>
            <given-names>H</given-names>
          </name>
          <name>
            <surname>Zhao</surname>
            <given-names>Z</given-names>
          </name>
          <name>
            <surname>Jia</surname>
            <given-names>P</given-names>
          </name>
        </person-group>
        <article-title>EW_dmGWAS: edge-weighted dense module search for genome-wide association studies and gene expression profiles</article-title>
        <source>Bioinformatics</source>
        <year>2015</year>
        <volume>31</volume>
        <issue>15</issue>
        <fpage>2591</fpage>
        <lpage>2594</lpage>
        <?supplied-pmid 25805723?>
        <pub-id pub-id-type="pmid">25805723</pub-id>
      </element-citation>
    </ref>
    <ref id="CR12">
      <label>12.</label>
      <element-citation publication-type="journal">
        <person-group person-group-type="author">
          <name>
            <surname>Nam</surname>
            <given-names>Y</given-names>
          </name>
          <name>
            <surname>Jhee</surname>
            <given-names>JH</given-names>
          </name>
          <name>
            <surname>Cho</surname>
            <given-names>J</given-names>
          </name>
          <name>
            <surname>Lee</surname>
            <given-names>J-H</given-names>
          </name>
          <name>
            <surname>Shin</surname>
            <given-names>H</given-names>
          </name>
        </person-group>
        <article-title>Disease gene identification based on generic and disease-specific genome networks</article-title>
        <source>Bioinformatics</source>
        <year>2019</year>
        <volume>35</volume>
        <issue>11</issue>
        <fpage>1923</fpage>
        <lpage>1930</lpage>
        <?supplied-pmid 30335143?>
        <pub-id pub-id-type="pmid">30335143</pub-id>
      </element-citation>
    </ref>
    <ref id="CR13">
      <label>13.</label>
      <element-citation publication-type="journal">
        <person-group person-group-type="author">
          <name>
            <surname>Luo</surname>
            <given-names>P</given-names>
          </name>
          <name>
            <surname>Tian</surname>
            <given-names>L-P</given-names>
          </name>
          <name>
            <surname>Chen</surname>
            <given-names>B</given-names>
          </name>
          <name>
            <surname>Xiao</surname>
            <given-names>Q</given-names>
          </name>
          <name>
            <surname>Wu</surname>
            <given-names>F-X</given-names>
          </name>
        </person-group>
        <article-title>Ensemble disease gene prediction by clinical sample-based networks</article-title>
        <source>BMC Bioinformatics</source>
        <year>2020</year>
        <volume>21</volume>
        <issue>2</issue>
        <fpage>1</fpage>
        <lpage>12</lpage>
        <pub-id pub-id-type="pmid">31898485</pub-id>
      </element-citation>
    </ref>
    <ref id="CR14">
      <label>14.</label>
      <element-citation publication-type="journal">
        <person-group person-group-type="author">
          <name>
            <surname>Tomczak</surname>
            <given-names>K</given-names>
          </name>
          <name>
            <surname>Czerwińska</surname>
            <given-names>P</given-names>
          </name>
          <name>
            <surname>Wiznerowicz</surname>
            <given-names>M</given-names>
          </name>
        </person-group>
        <article-title>The Cancer genome atlas (TCGA): an immeasurable source of knowledge</article-title>
        <source>Contemp Oncol</source>
        <year>2015</year>
        <volume>19</volume>
        <issue>1A</issue>
        <fpage>A68</fpage>
      </element-citation>
    </ref>
    <ref id="CR15">
      <label>15.</label>
      <mixed-citation publication-type="other">Han P, Yang P, Zhao P, Shang S, Liu Y, Zhou J, Gao X, Kalnis P: GCN-MF: disease-gene association identification by graph convolutional networks and matrix factorization. In: P<italic>r</italic>oceedings of the 25th ACM SIGKDD international conference on knowledge discovery &amp; data mining<italic>: 2019</italic>. 705–713.</mixed-citation>
    </ref>
    <ref id="CR16">
      <label>16.</label>
      <element-citation publication-type="journal">
        <person-group person-group-type="author">
          <name>
            <surname>Natarajan</surname>
            <given-names>N</given-names>
          </name>
          <name>
            <surname>Dhillon</surname>
            <given-names>IS</given-names>
          </name>
        </person-group>
        <article-title>Inductive matrix completion for predicting gene–disease associations</article-title>
        <source>Bioinformatics</source>
        <year>2014</year>
        <volume>30</volume>
        <issue>12</issue>
        <fpage>i60</fpage>
        <lpage>i68</lpage>
        <?supplied-pmid 24932006?>
        <pub-id pub-id-type="pmid">24932006</pub-id>
      </element-citation>
    </ref>
    <ref id="CR17">
      <label>17.</label>
      <mixed-citation publication-type="other">Singh-Blom UM, Natarajan N, Tewari A, Woods JO, Dhillon IS, Marcotte EM: Prediction and validation of gene-disease associations using methods inspired by social network analyses. PloS one 2013, 8(5):e58977.</mixed-citation>
    </ref>
    <ref id="CR18">
      <label>18.</label>
      <element-citation publication-type="journal">
        <person-group person-group-type="author">
          <name>
            <surname>Zeng</surname>
            <given-names>X</given-names>
          </name>
          <name>
            <surname>Ding</surname>
            <given-names>N</given-names>
          </name>
          <name>
            <surname>Rodríguez-Patón</surname>
            <given-names>A</given-names>
          </name>
          <name>
            <surname>Zou</surname>
            <given-names>Q</given-names>
          </name>
        </person-group>
        <article-title>Probability-based collaborative filtering model for predicting gene–disease associations</article-title>
        <source>BMC Med Genomics</source>
        <year>2017</year>
        <volume>10</volume>
        <issue>5</issue>
        <fpage>45</fpage>
        <lpage>53</lpage>
        <pub-id pub-id-type="pmid">28786359</pub-id>
      </element-citation>
    </ref>
    <ref id="CR19">
      <label>19.</label>
      <element-citation publication-type="journal">
        <person-group person-group-type="author">
          <name>
            <surname>Luo</surname>
            <given-names>P</given-names>
          </name>
          <name>
            <surname>Li</surname>
            <given-names>Y</given-names>
          </name>
          <name>
            <surname>Tian</surname>
            <given-names>L-P</given-names>
          </name>
          <name>
            <surname>Wu</surname>
            <given-names>F-X</given-names>
          </name>
        </person-group>
        <article-title>Enhancing the prediction of disease–gene associations with multimodal deep learning</article-title>
        <source>Bioinformatics</source>
        <year>2019</year>
        <volume>35</volume>
        <issue>19</issue>
        <fpage>3735</fpage>
        <lpage>3742</lpage>
        <?supplied-pmid 30825303?>
        <pub-id pub-id-type="pmid">30825303</pub-id>
      </element-citation>
    </ref>
    <ref id="CR20">
      <label>20.</label>
      <mixed-citation publication-type="other">Wishart DS, Craig K, Guo AC, Cheng D, Savita S, Dan T, Bijaya G, Murtaza H: DrugBank: a knowledgebase for drugs, drug actions and drug targets. Nucleic Acids Res 2008, 36(suppl_1):D901-D906.</mixed-citation>
    </ref>
    <ref id="CR21">
      <label>21.</label>
      <mixed-citation publication-type="other">Paul SM, Mytelka DS, Dunwiddie CT, Persinger CC, Munos BH, Lindborg SR, Schacht AL: How to improve R&amp;D productivity: the pharmaceutical industry's grand challenge. Nat Rev Drug Discov 2010:203–214.</mixed-citation>
    </ref>
    <ref id="CR22">
      <label>22.</label>
      <element-citation publication-type="journal">
        <person-group person-group-type="author">
          <name>
            <surname>Peter</surname>
            <given-names>DA</given-names>
          </name>
          <name>
            <surname>Grondin</surname>
            <given-names>CJ</given-names>
          </name>
          <name>
            <surname>Kelley</surname>
            <given-names>LH</given-names>
          </name>
          <name>
            <surname>Cynthia</surname>
            <given-names>SR</given-names>
          </name>
          <name>
            <surname>Daniela</surname>
            <given-names>S</given-names>
          </name>
          <name>
            <surname>King</surname>
            <given-names>BL</given-names>
          </name>
          <name>
            <surname>Wiegers</surname>
            <given-names>TC</given-names>
          </name>
          <name>
            <surname>Mattingly</surname>
            <given-names>CJ</given-names>
          </name>
        </person-group>
        <article-title>The comparative toxicogenomics database's 10th year anniversary: update 2015</article-title>
        <source>Nucleic Acids Res</source>
        <year>2015</year>
        <volume>D1</volume>
        <fpage>914</fpage>
        <lpage>920</lpage>
      </element-citation>
    </ref>
    <ref id="CR23">
      <label>23.</label>
      <element-citation publication-type="journal">
        <person-group person-group-type="author">
          <name>
            <surname>Lipscomb</surname>
            <given-names>CE</given-names>
          </name>
        </person-group>
        <article-title>Medical subject headings (MeSH)</article-title>
        <source>Bull Med Libr Assoc</source>
        <year>2000</year>
        <volume>88</volume>
        <issue>3</issue>
        <fpage>265</fpage>
        <lpage>266</lpage>
        <?supplied-pmid 10928714?>
        <pub-id pub-id-type="pmid">10928714</pub-id>
      </element-citation>
    </ref>
    <ref id="CR24">
      <label>24.</label>
      <mixed-citation publication-type="other">Fan W, Shang J, Li F, Sun Y, Liu JX: IDSSIM: an lncRNA functional similarity calculation model based on an improved disease semantic similarity method. BMC Bioinform 2020, 21(1).</mixed-citation>
    </ref>
    <ref id="CR25">
      <label>25.</label>
      <mixed-citation publication-type="other">Kibbe WA, Arze C, Felix V, Mitraka E, Schriml LM: Disease Ontology 2015 update: An expanded and updated database of Human diseases for linking biomedical knowledge through disease data. Nucleic Acids Research 2014, 43(D1).</mixed-citation>
    </ref>
    <ref id="CR26">
      <label>26.</label>
      <element-citation publication-type="journal">
        <person-group person-group-type="author">
          <name>
            <surname>Wang</surname>
            <given-names>JZ</given-names>
          </name>
          <name>
            <surname>Du</surname>
            <given-names>Z</given-names>
          </name>
          <name>
            <surname>Payattakool</surname>
            <given-names>R</given-names>
          </name>
          <name>
            <surname>Yu</surname>
            <given-names>PS</given-names>
          </name>
          <name>
            <surname>Chen</surname>
            <given-names>C</given-names>
          </name>
        </person-group>
        <article-title>A new method to measure the semantic similarity of GO terms</article-title>
        <source>Bioinformatics</source>
        <year>2007</year>
        <volume>23</volume>
        <issue>10</issue>
        <fpage>1274</fpage>
        <lpage>1281</lpage>
        <?supplied-pmid 17344234?>
        <pub-id pub-id-type="pmid">17344234</pub-id>
      </element-citation>
    </ref>
    <ref id="CR27">
      <label>27.</label>
      <element-citation publication-type="journal">
        <person-group person-group-type="author">
          <name>
            <surname>Van Laarhoven</surname>
            <given-names>T</given-names>
          </name>
          <name>
            <surname>Nabuurs</surname>
            <given-names>SB</given-names>
          </name>
          <name>
            <surname>Marchiori</surname>
            <given-names>E</given-names>
          </name>
        </person-group>
        <article-title>Gaussian interaction profile kernels for predicting drug–target interaction</article-title>
        <source>Bioinformatics</source>
        <year>2011</year>
        <volume>27</volume>
        <issue>21</issue>
        <fpage>3036</fpage>
        <lpage>3043</lpage>
        <?supplied-pmid 21893517?>
        <pub-id pub-id-type="pmid">21893517</pub-id>
      </element-citation>
    </ref>
    <ref id="CR28">
      <label>28.</label>
      <element-citation publication-type="journal">
        <person-group person-group-type="author">
          <name>
            <surname>Zhao</surname>
            <given-names>Y</given-names>
          </name>
          <name>
            <surname>Chen</surname>
            <given-names>X</given-names>
          </name>
          <name>
            <surname>Yin</surname>
            <given-names>J</given-names>
          </name>
        </person-group>
        <article-title>Adaptive boosting-based computational model for predicting potential miRNA-disease associations</article-title>
        <source>Bioinformatics</source>
        <year>2019</year>
        <volume>35</volume>
        <issue>22</issue>
        <fpage>4730</fpage>
        <lpage>4738</lpage>
        <?supplied-pmid 31038664?>
        <pub-id pub-id-type="pmid">31038664</pub-id>
      </element-citation>
    </ref>
    <ref id="CR29">
      <label>29.</label>
      <mixed-citation publication-type="other">Kanehisa M, Goto S, Hattori M, Aoki-Kinoshita KF, Hirakawa M: From genomics to chemical genomics: new developments in KEGG. Nucleic Acids Research 2006, 34(Database issue):D354–357.</mixed-citation>
    </ref>
    <ref id="CR30">
      <label>30.</label>
      <element-citation publication-type="journal">
        <person-group person-group-type="author">
          <name>
            <surname>Smith</surname>
            <given-names>TF</given-names>
          </name>
          <name>
            <surname>Waterman</surname>
            <given-names>MS</given-names>
          </name>
        </person-group>
        <article-title>Identification of common molecular subsequences</article-title>
        <source>J Mol Biol</source>
        <year>1981</year>
        <volume>147</volume>
        <issue>1</issue>
        <fpage>195</fpage>
        <lpage>197</lpage>
        <?supplied-pmid 7265238?>
        <pub-id pub-id-type="pmid">7265238</pub-id>
      </element-citation>
    </ref>
    <ref id="CR31">
      <label>31.</label>
      <element-citation publication-type="journal">
        <person-group person-group-type="author">
          <name>
            <surname>Chen</surname>
            <given-names>X</given-names>
          </name>
          <name>
            <surname>Yan</surname>
            <given-names>C</given-names>
          </name>
          <name>
            <surname>Luo</surname>
            <given-names>C</given-names>
          </name>
          <name>
            <surname>Ji</surname>
            <given-names>W</given-names>
          </name>
          <name>
            <surname>Zhang</surname>
            <given-names>Y</given-names>
          </name>
          <name>
            <surname>Dai</surname>
            <given-names>Q</given-names>
          </name>
        </person-group>
        <article-title>Constructing lncRNA functional similarity network based on lncRNA-disease associations and disease semantic similarity</article-title>
        <source>Sci Rep</source>
        <year>2015</year>
        <volume>5</volume>
        <fpage>11338</fpage>
        <?supplied-pmid 26061969?>
        <pub-id pub-id-type="pmid">26061969</pub-id>
      </element-citation>
    </ref>
    <ref id="CR32">
      <label>32.</label>
      <mixed-citation publication-type="other">Ho TK: Random decision forests. In: Document Analysis and Recognition, 1995, Proceedings of the Third International Conference on: 1995.</mixed-citation>
    </ref>
    <ref id="CR33">
      <label>33.</label>
      <element-citation publication-type="journal">
        <person-group person-group-type="author">
          <name>
            <surname>Demšar</surname>
            <given-names>J</given-names>
          </name>
        </person-group>
        <article-title>Statistical comparisons of classifiers over multiple data sets</article-title>
        <source>J Mach Learn Res</source>
        <year>2006</year>
        <volume>7</volume>
        <fpage>1</fpage>
        <lpage>30</lpage>
      </element-citation>
    </ref>
    <ref id="CR34">
      <label>34.</label>
      <element-citation publication-type="journal">
        <person-group person-group-type="author">
          <name>
            <surname>Yao</surname>
            <given-names>D</given-names>
          </name>
          <name>
            <surname>Zhan</surname>
            <given-names>X</given-names>
          </name>
          <name>
            <surname>Zhan</surname>
            <given-names>X</given-names>
          </name>
          <name>
            <surname>Kwoh</surname>
            <given-names>CK</given-names>
          </name>
          <name>
            <surname>Li</surname>
            <given-names>P</given-names>
          </name>
          <name>
            <surname>Wang</surname>
            <given-names>J</given-names>
          </name>
        </person-group>
        <article-title>A random forest based computational model for predicting novel lncRNA-disease associations</article-title>
        <source>BMC Bioinform</source>
        <year>2020</year>
        <volume>21</volume>
        <fpage>1</fpage>
        <lpage>18</lpage>
      </element-citation>
    </ref>
    <ref id="CR35">
      <label>35.</label>
      <element-citation publication-type="journal">
        <person-group person-group-type="author">
          <name>
            <surname>Olayan</surname>
            <given-names>RS</given-names>
          </name>
          <name>
            <surname>Ashoor</surname>
            <given-names>H</given-names>
          </name>
          <name>
            <surname>Bajic</surname>
            <given-names>VB</given-names>
          </name>
        </person-group>
        <article-title>DDR: efficient computational method to predict drug–target interactions using graph mining and machine learning approaches</article-title>
        <source>Bioinformatics</source>
        <year>2018</year>
        <volume>34</volume>
        <issue>7</issue>
        <fpage>1164</fpage>
        <lpage>1173</lpage>
        <?supplied-pmid 29186331?>
        <pub-id pub-id-type="pmid">29186331</pub-id>
      </element-citation>
    </ref>
    <ref id="CR36">
      <label>36.</label>
      <element-citation publication-type="journal">
        <person-group person-group-type="author">
          <name>
            <surname>Zhou</surname>
            <given-names>R</given-names>
          </name>
          <name>
            <surname>Lu</surname>
            <given-names>Z</given-names>
          </name>
          <name>
            <surname>Luo</surname>
            <given-names>H</given-names>
          </name>
          <name>
            <surname>Xiang</surname>
            <given-names>J</given-names>
          </name>
          <name>
            <surname>Zeng</surname>
            <given-names>M</given-names>
          </name>
          <name>
            <surname>Li</surname>
            <given-names>M</given-names>
          </name>
        </person-group>
        <article-title>NEDD: a network embedding based method for predicting drug-disease associations</article-title>
        <source>BMC Bioinform</source>
        <year>2020</year>
        <volume>21</volume>
        <issue>13</issue>
        <fpage>1</fpage>
        <lpage>12</lpage>
      </element-citation>
    </ref>
    <ref id="CR37">
      <label>37.</label>
      <element-citation publication-type="journal">
        <person-group person-group-type="author">
          <name>
            <surname>Yao</surname>
            <given-names>D</given-names>
          </name>
          <name>
            <surname>Zhan</surname>
            <given-names>X</given-names>
          </name>
          <name>
            <surname>Kwoh</surname>
            <given-names>C-K</given-names>
          </name>
        </person-group>
        <article-title>An improved random forest-based computational model for predicting novel miRNA-disease associations</article-title>
        <source>BMC Bioinform</source>
        <year>2019</year>
        <volume>20</volume>
        <issue>1</issue>
        <fpage>1</fpage>
        <lpage>14</lpage>
      </element-citation>
    </ref>
    <ref id="CR38">
      <label>38.</label>
      <mixed-citation publication-type="other">Fan Y, Chen M, Pan X: GCRFLDA: scoring lncRNA-disease associations using graph convolution matrix completion with conditional random field. Briefings in Bioinformatics 2021.</mixed-citation>
    </ref>
    <ref id="CR39">
      <label>39.</label>
      <element-citation publication-type="journal">
        <person-group person-group-type="author">
          <name>
            <surname>Fu</surname>
            <given-names>G</given-names>
          </name>
          <name>
            <surname>Wang</surname>
            <given-names>J</given-names>
          </name>
          <name>
            <surname>Domeniconi</surname>
            <given-names>C</given-names>
          </name>
          <name>
            <surname>Yu</surname>
            <given-names>G</given-names>
          </name>
        </person-group>
        <article-title>Matrix factorization-based data fusion for the prediction of lncRNA–disease associations</article-title>
        <source>Bioinformatics</source>
        <year>2018</year>
        <volume>34</volume>
        <issue>9</issue>
        <fpage>1529</fpage>
        <lpage>1537</lpage>
        <?supplied-pmid 29228285?>
        <pub-id pub-id-type="pmid">29228285</pub-id>
      </element-citation>
    </ref>
    <ref id="CR40">
      <label>40.</label>
      <element-citation publication-type="journal">
        <person-group person-group-type="author">
          <name>
            <surname>Gong</surname>
            <given-names>K</given-names>
          </name>
          <name>
            <surname>Guo</surname>
            <given-names>G</given-names>
          </name>
          <name>
            <surname>Gerber</surname>
            <given-names>DE</given-names>
          </name>
          <name>
            <surname>Gao</surname>
            <given-names>B</given-names>
          </name>
          <name>
            <surname>Peyton</surname>
            <given-names>M</given-names>
          </name>
          <name>
            <surname>Huang</surname>
            <given-names>C</given-names>
          </name>
          <name>
            <surname>Minna</surname>
            <given-names>JD</given-names>
          </name>
          <name>
            <surname>Hatanpaa</surname>
            <given-names>KJ</given-names>
          </name>
          <name>
            <surname>Kernstine</surname>
            <given-names>K</given-names>
          </name>
          <name>
            <surname>Cai</surname>
            <given-names>L</given-names>
          </name>
        </person-group>
        <article-title>TNF-driven adaptive response mediates resistance to EGFR inhibition in lung cancer</article-title>
        <source>J Clin Investig</source>
        <year>2018</year>
        <volume>128</volume>
        <issue>6</issue>
        <fpage>2500</fpage>
        <lpage>2518</lpage>
        <?supplied-pmid 29613856?>
        <pub-id pub-id-type="pmid">29613856</pub-id>
      </element-citation>
    </ref>
    <ref id="CR41">
      <label>41.</label>
      <element-citation publication-type="journal">
        <person-group person-group-type="author">
          <name>
            <surname>Widowati</surname>
            <given-names>W</given-names>
          </name>
          <name>
            <surname>Jasaputra</surname>
            <given-names>DK</given-names>
          </name>
          <name>
            <surname>Sumitro</surname>
            <given-names>SB</given-names>
          </name>
          <name>
            <surname>Widodo</surname>
            <given-names>MA</given-names>
          </name>
          <name>
            <surname>Mozef</surname>
            <given-names>T</given-names>
          </name>
          <name>
            <surname>Rizal</surname>
            <given-names>R</given-names>
          </name>
          <name>
            <surname>Kusuma</surname>
            <given-names>HSW</given-names>
          </name>
          <name>
            <surname>Laksmitawati</surname>
            <given-names>DR</given-names>
          </name>
          <name>
            <surname>Murti</surname>
            <given-names>H</given-names>
          </name>
          <name>
            <surname>Bachtiar</surname>
            <given-names>I</given-names>
          </name>
        </person-group>
        <article-title>Effect of interleukins (IL-2, IL-15, IL-18) on receptors activation and cytotoxic activity of natural killer cells in breast cancer cell</article-title>
        <source>Afr Health Sci</source>
        <year>2020</year>
        <volume>20</volume>
        <issue>2</issue>
        <fpage>822</fpage>
        <lpage>832</lpage>
        <?supplied-pmid 33163049?>
        <pub-id pub-id-type="pmid">33163049</pub-id>
      </element-citation>
    </ref>
    <ref id="CR42">
      <label>42.</label>
      <element-citation publication-type="journal">
        <person-group person-group-type="author">
          <name>
            <surname>Song</surname>
            <given-names>N</given-names>
          </name>
          <name>
            <surname>Liu</surname>
            <given-names>S</given-names>
          </name>
          <name>
            <surname>Zhang</surname>
            <given-names>J</given-names>
          </name>
          <name>
            <surname>Liu</surname>
            <given-names>J</given-names>
          </name>
          <name>
            <surname>Xu</surname>
            <given-names>L</given-names>
          </name>
          <name>
            <surname>Liu</surname>
            <given-names>Y</given-names>
          </name>
          <name>
            <surname>Qu</surname>
            <given-names>X</given-names>
          </name>
        </person-group>
        <article-title>Cetuximab-induced MET activation acts as a novel resistance mechanism in colon cancer cells</article-title>
        <source>Int J Mol Sci</source>
        <year>2014</year>
        <volume>15</volume>
        <issue>4</issue>
        <fpage>5838</fpage>
        <lpage>5851</lpage>
        <?supplied-pmid 24714091?>
        <pub-id pub-id-type="pmid">24714091</pub-id>
      </element-citation>
    </ref>
    <ref id="CR43">
      <label>43.</label>
      <element-citation publication-type="journal">
        <person-group person-group-type="author">
          <name>
            <surname>Lakkireddy</surname>
            <given-names>S</given-names>
          </name>
          <name>
            <surname>Aula</surname>
            <given-names>S</given-names>
          </name>
          <name>
            <surname>Kapley</surname>
            <given-names>A</given-names>
          </name>
          <name>
            <surname>Swamy</surname>
            <given-names>A</given-names>
          </name>
          <name>
            <surname>Digumarti</surname>
            <given-names>RR</given-names>
          </name>
          <name>
            <surname>Kutala</surname>
            <given-names>VK</given-names>
          </name>
          <name>
            <surname>Jamil</surname>
            <given-names>K</given-names>
          </name>
        </person-group>
        <article-title>Association of vascular endothelial growth factor A (VEGFA) and its receptor (VEGFR2) gene polymorphisms with risk of chronic myeloid leukemia and influence on clinical outcome</article-title>
        <source>Mol Diagn Ther</source>
        <year>2016</year>
        <volume>20</volume>
        <issue>1</issue>
        <fpage>33</fpage>
        <lpage>44</lpage>
        <?supplied-pmid 26476544?>
        <pub-id pub-id-type="pmid">26476544</pub-id>
      </element-citation>
    </ref>
    <ref id="CR44">
      <label>44.</label>
      <element-citation publication-type="journal">
        <person-group person-group-type="author">
          <name>
            <surname>Xiong</surname>
            <given-names>J</given-names>
          </name>
          <name>
            <surname>Bian</surname>
            <given-names>J</given-names>
          </name>
          <name>
            <surname>Wang</surname>
            <given-names>L</given-names>
          </name>
          <name>
            <surname>Zhou</surname>
            <given-names>J</given-names>
          </name>
          <name>
            <surname>Wang</surname>
            <given-names>Y</given-names>
          </name>
          <name>
            <surname>Zhao</surname>
            <given-names>Y</given-names>
          </name>
          <name>
            <surname>Wu</surname>
            <given-names>L</given-names>
          </name>
          <name>
            <surname>Hu</surname>
            <given-names>J</given-names>
          </name>
          <name>
            <surname>Li</surname>
            <given-names>B</given-names>
          </name>
          <name>
            <surname>Chen</surname>
            <given-names>S</given-names>
          </name>
        </person-group>
        <article-title>Dysregulated choline metabolism in T-cell lymphoma: role of choline kinase-α and therapeutic targeting</article-title>
        <source>Blood Cancer J</source>
        <year>2015</year>
        <volume>5</volume>
        <issue>3</issue>
        <fpage>e287</fpage>
        <lpage>e287</lpage>
      </element-citation>
    </ref>
    <ref id="CR45">
      <label>45.</label>
      <mixed-citation publication-type="other">Zhou X, Jiang Y, Li Q, Huang Z, Yang H, Wei C: Aberrant ALOX5 Activation correlates with HER2 status and mediates breast cancer biological activities through multiple mechanisms. BioMed research international 2020, 2020.</mixed-citation>
    </ref>
    <ref id="CR46">
      <label>46.</label>
      <element-citation publication-type="journal">
        <person-group person-group-type="author">
          <name>
            <surname>Liu</surname>
            <given-names>S</given-names>
          </name>
          <name>
            <surname>Fan</surname>
            <given-names>W</given-names>
          </name>
          <name>
            <surname>Gao</surname>
            <given-names>X</given-names>
          </name>
          <name>
            <surname>Huang</surname>
            <given-names>K</given-names>
          </name>
          <name>
            <surname>Ding</surname>
            <given-names>C</given-names>
          </name>
          <name>
            <surname>Ma</surname>
            <given-names>G</given-names>
          </name>
          <name>
            <surname>Yan</surname>
            <given-names>L</given-names>
          </name>
          <name>
            <surname>Song</surname>
            <given-names>S</given-names>
          </name>
        </person-group>
        <article-title>Estrogen receptor alpha regulates the Wnt/β-catenin signaling pathway in colon cancer by targeting the NOD-like receptors</article-title>
        <source>Cell Signal</source>
        <year>2019</year>
        <volume>61</volume>
        <fpage>86</fpage>
        <lpage>92</lpage>
        <?supplied-pmid 31121307?>
        <pub-id pub-id-type="pmid">31121307</pub-id>
      </element-citation>
    </ref>
    <ref id="CR47">
      <label>47.</label>
      <element-citation publication-type="journal">
        <person-group person-group-type="author">
          <name>
            <surname>Li</surname>
            <given-names>C</given-names>
          </name>
          <name>
            <surname>Wang</surname>
            <given-names>C</given-names>
          </name>
        </person-group>
        <article-title>Current evidences on IL1B polymorphisms and lung cancer susceptibility: a meta-analysis</article-title>
        <source>Tumor Biol</source>
        <year>2013</year>
        <volume>34</volume>
        <issue>6</issue>
        <fpage>3477</fpage>
        <lpage>3482</lpage>
      </element-citation>
    </ref>
    <ref id="CR48">
      <label>48.</label>
      <element-citation publication-type="journal">
        <person-group person-group-type="author">
          <name>
            <surname>Ozawa</surname>
            <given-names>T</given-names>
          </name>
          <name>
            <surname>Hashiguchi</surname>
            <given-names>Y</given-names>
          </name>
          <name>
            <surname>Yagi</surname>
            <given-names>T</given-names>
          </name>
          <name>
            <surname>Fukushima</surname>
            <given-names>Y</given-names>
          </name>
          <name>
            <surname>Shimada</surname>
            <given-names>R</given-names>
          </name>
          <name>
            <surname>Hayama</surname>
            <given-names>T</given-names>
          </name>
          <name>
            <surname>Tsuchiya</surname>
            <given-names>T</given-names>
          </name>
          <name>
            <surname>Nozawa</surname>
            <given-names>K</given-names>
          </name>
          <name>
            <surname>Iinuma</surname>
            <given-names>H</given-names>
          </name>
          <name>
            <surname>Ishihara</surname>
            <given-names>S</given-names>
          </name>
        </person-group>
        <article-title>Angiotensin I-converting enzyme inhibitors/angiotensin II receptor blockers may reduce tumor recurrence in left-sided and early colorectal cancers</article-title>
        <source>Int J Colorectal Dis</source>
        <year>2019</year>
        <volume>34</volume>
        <issue>10</issue>
        <fpage>1731</fpage>
        <lpage>1739</lpage>
        <?supplied-pmid 31478086?>
        <pub-id pub-id-type="pmid">31478086</pub-id>
      </element-citation>
    </ref>
    <ref id="CR49">
      <label>49.</label>
      <mixed-citation publication-type="other">Makar GA, Holmes JH, Yang Y-X: Angiotensin-converting enzyme inhibitor therapy and colorectal cancer risk. JNCI  2014, 106(2).</mixed-citation>
    </ref>
    <ref id="CR50">
      <label>50.</label>
      <mixed-citation publication-type="other">Romero AM, Tafe L: CTNNB1 mutations and co-mutations in non-small cell lung cancer. In: Laboratory investigation: 2020. Nature publishing group 75 VARICK ST, 9TH FLR, NEW YORK, NY 10013–1917 USA: 1805–1806.</mixed-citation>
    </ref>
    <ref id="CR51">
      <label>51.</label>
      <element-citation publication-type="journal">
        <person-group person-group-type="author">
          <name>
            <surname>Zhou</surname>
            <given-names>C</given-names>
          </name>
          <name>
            <surname>Li</surname>
            <given-names>W</given-names>
          </name>
          <name>
            <surname>Shao</surname>
            <given-names>J</given-names>
          </name>
          <name>
            <surname>Zhao</surname>
            <given-names>J</given-names>
          </name>
          <name>
            <surname>Chen</surname>
            <given-names>C</given-names>
          </name>
        </person-group>
        <article-title>Analysis of the clinicopathologic characteristics of lung adenocarcinoma with CTNNB1 mutation</article-title>
        <source>Front Genet</source>
        <year>2020</year>
        <volume>10</volume>
        <fpage>1367</fpage>
        <?supplied-pmid 32117418?>
        <pub-id pub-id-type="pmid">32117418</pub-id>
      </element-citation>
    </ref>
    <ref id="CR52">
      <label>52.</label>
      <element-citation publication-type="journal">
        <person-group person-group-type="author">
          <name>
            <surname>Matsuda</surname>
            <given-names>Y</given-names>
          </name>
          <name>
            <surname>Saoo</surname>
            <given-names>K</given-names>
          </name>
          <name>
            <surname>Yamakawa</surname>
            <given-names>K</given-names>
          </name>
          <name>
            <surname>Yokohira</surname>
            <given-names>M</given-names>
          </name>
          <name>
            <surname>Suzuki</surname>
            <given-names>S</given-names>
          </name>
          <name>
            <surname>Kuno</surname>
            <given-names>T</given-names>
          </name>
          <name>
            <surname>Kamataki</surname>
            <given-names>T</given-names>
          </name>
          <name>
            <surname>Imaida</surname>
            <given-names>K</given-names>
          </name>
        </person-group>
        <article-title>Overexpression of CYP2A6 in human colorectal tumors</article-title>
        <source>Cancer Sci</source>
        <year>2007</year>
        <volume>98</volume>
        <issue>10</issue>
        <fpage>1582</fpage>
        <lpage>1585</lpage>
        <?supplied-pmid 17683511?>
        <pub-id pub-id-type="pmid">17683511</pub-id>
      </element-citation>
    </ref>
    <ref id="CR53">
      <label>53.</label>
      <mixed-citation publication-type="other">Li J, Ji Z, Luo X, Li Y, Yuan P, Long J, Shen N, Lu Q, Zeng Q, Zhong R: Urinary bisphenol A and its interaction with ESR1 genetic polymorphism associated with non-small cell lung cancer: findings from a case-control study in Chinese population. <italic>Chemosphere</italic> 2020, 254:126835.</mixed-citation>
    </ref>
    <ref id="CR54">
      <label>54.</label>
      <element-citation publication-type="journal">
        <person-group person-group-type="author">
          <name>
            <surname>Bekku</surname>
            <given-names>S</given-names>
          </name>
          <name>
            <surname>Mochizuki</surname>
            <given-names>H</given-names>
          </name>
          <name>
            <surname>Yamamoto</surname>
            <given-names>T</given-names>
          </name>
          <name>
            <surname>Ueno</surname>
            <given-names>H</given-names>
          </name>
          <name>
            <surname>Takayama</surname>
            <given-names>E</given-names>
          </name>
          <name>
            <surname>Tadakuma</surname>
            <given-names>T</given-names>
          </name>
        </person-group>
        <article-title>Expression of carbonic anhydrase I or II and correlation to clinical aspects of colorectal cancer</article-title>
        <source>Hepatogastroenterology</source>
        <year>2000</year>
        <volume>47</volume>
        <issue>34</issue>
        <fpage>998</fpage>
        <lpage>1001</lpage>
        <?supplied-pmid 11020863?>
        <pub-id pub-id-type="pmid">11020863</pub-id>
      </element-citation>
    </ref>
    <ref id="CR55">
      <label>55.</label>
      <element-citation publication-type="journal">
        <person-group person-group-type="author">
          <name>
            <surname>Cheng</surname>
            <given-names>X</given-names>
          </name>
          <name>
            <surname>Yang</surname>
            <given-names>Y</given-names>
          </name>
          <name>
            <surname>Fan</surname>
            <given-names>Z</given-names>
          </name>
          <name>
            <surname>Yu</surname>
            <given-names>L</given-names>
          </name>
          <name>
            <surname>Bai</surname>
            <given-names>H</given-names>
          </name>
          <name>
            <surname>Zhou</surname>
            <given-names>B</given-names>
          </name>
          <name>
            <surname>Wu</surname>
            <given-names>X</given-names>
          </name>
          <name>
            <surname>Xu</surname>
            <given-names>H</given-names>
          </name>
          <name>
            <surname>Fang</surname>
            <given-names>M</given-names>
          </name>
          <name>
            <surname>Shen</surname>
            <given-names>A</given-names>
          </name>
        </person-group>
        <article-title>MKL1 potentiates lung cancer cell migration and invasion by epigenetically activating MMP9 transcription</article-title>
        <source>Oncogene</source>
        <year>2015</year>
        <volume>34</volume>
        <issue>44</issue>
        <fpage>5570</fpage>
        <lpage>5581</lpage>
        <?supplied-pmid 25746000?>
        <pub-id pub-id-type="pmid">25746000</pub-id>
      </element-citation>
    </ref>
    <ref id="CR56">
      <label>56.</label>
      <mixed-citation publication-type="other">Voutsadakis IA: The Landscape of PIK3CA Mutations in Colorectal Cancer. Clinical Colorectal Cancer 2021.</mixed-citation>
    </ref>
    <ref id="CR57">
      <label>57.</label>
      <element-citation publication-type="journal">
        <person-group person-group-type="author">
          <name>
            <surname>Blackhall</surname>
            <given-names>FH</given-names>
          </name>
          <name>
            <surname>Pintilie</surname>
            <given-names>M</given-names>
          </name>
          <name>
            <surname>Michael</surname>
            <given-names>M</given-names>
          </name>
          <name>
            <surname>Leighl</surname>
            <given-names>N</given-names>
          </name>
          <name>
            <surname>Feld</surname>
            <given-names>R</given-names>
          </name>
          <name>
            <surname>Tsao</surname>
            <given-names>M-S</given-names>
          </name>
          <name>
            <surname>Shepherd</surname>
            <given-names>FA</given-names>
          </name>
        </person-group>
        <article-title>Expression and prognostic significance of kit, protein kinase B, and mitogen-activated protein kinase in patients with small cell lung cancer</article-title>
        <source>Clin Cancer Res</source>
        <year>2003</year>
        <volume>9</volume>
        <issue>6</issue>
        <fpage>2241</fpage>
        <lpage>2247</lpage>
        <?supplied-pmid 12796392?>
        <pub-id pub-id-type="pmid">12796392</pub-id>
      </element-citation>
    </ref>
    <ref id="CR58">
      <label>58.</label>
      <mixed-citation publication-type="other">Belaguli NS, Aftab M, Rigi M, Zhang M, Albo D, Berger DH: GATA6 promotes colon cancer cell invasion by regulating urokinase plasminogen activator gene expression. <italic>Neoplasia</italic> 2010, 12(11):856-IN851.</mixed-citation>
    </ref>
    <ref id="CR59">
      <label>59.</label>
      <element-citation publication-type="journal">
        <person-group person-group-type="author">
          <name>
            <surname>Somwar</surname>
            <given-names>R</given-names>
          </name>
          <name>
            <surname>Erdjument-Bromage</surname>
            <given-names>H</given-names>
          </name>
          <name>
            <surname>Larsson</surname>
            <given-names>E</given-names>
          </name>
          <name>
            <surname>Shum</surname>
            <given-names>D</given-names>
          </name>
          <name>
            <surname>Lockwood</surname>
            <given-names>WW</given-names>
          </name>
          <name>
            <surname>Yang</surname>
            <given-names>G</given-names>
          </name>
          <name>
            <surname>Sander</surname>
            <given-names>C</given-names>
          </name>
          <name>
            <surname>Ouerfelli</surname>
            <given-names>O</given-names>
          </name>
          <name>
            <surname>Tempst</surname>
            <given-names>PJ</given-names>
          </name>
          <name>
            <surname>Djaballah</surname>
            <given-names>H</given-names>
          </name>
        </person-group>
        <article-title>Superoxide dismutase 1 (SOD1) is a target for a small molecule identified in a screen for inhibitors of the growth of lung adenocarcinoma cell lines</article-title>
        <source>Proc Natl Acad Sci</source>
        <year>2011</year>
        <volume>108</volume>
        <issue>39</issue>
        <fpage>16375</fpage>
        <lpage>16380</lpage>
        <?supplied-pmid 21930909?>
        <pub-id pub-id-type="pmid">21930909</pub-id>
      </element-citation>
    </ref>
    <ref id="CR60">
      <label>60.</label>
      <element-citation publication-type="journal">
        <person-group person-group-type="author">
          <name>
            <surname>Morita</surname>
            <given-names>M</given-names>
          </name>
          <name>
            <surname>Le Marchand</surname>
            <given-names>L</given-names>
          </name>
          <name>
            <surname>Kono</surname>
            <given-names>S</given-names>
          </name>
          <name>
            <surname>Yin</surname>
            <given-names>G</given-names>
          </name>
          <name>
            <surname>Toyomura</surname>
            <given-names>K</given-names>
          </name>
          <name>
            <surname>Nagano</surname>
            <given-names>J</given-names>
          </name>
          <name>
            <surname>Mizoue</surname>
            <given-names>T</given-names>
          </name>
          <name>
            <surname>Mibu</surname>
            <given-names>R</given-names>
          </name>
          <name>
            <surname>Tanaka</surname>
            <given-names>M</given-names>
          </name>
          <name>
            <surname>Kakeji</surname>
            <given-names>Y</given-names>
          </name>
        </person-group>
        <article-title>Genetic polymorphisms of CYP2E1 and risk of colorectal cancer: the Fukuoka Colorectal Cancer Study</article-title>
        <source>Cancer Epidemiol Prevent Biomark</source>
        <year>2009</year>
        <volume>18</volume>
        <issue>1</issue>
        <fpage>235</fpage>
        <lpage>241</lpage>
      </element-citation>
    </ref>
    <ref id="CR61">
      <label>61.</label>
      <element-citation publication-type="journal">
        <person-group person-group-type="author">
          <name>
            <surname>Wu</surname>
            <given-names>H</given-names>
          </name>
          <name>
            <surname>Liu</surname>
            <given-names>HY</given-names>
          </name>
          <name>
            <surname>Liu</surname>
            <given-names>WJ</given-names>
          </name>
          <name>
            <surname>Shi</surname>
            <given-names>YL</given-names>
          </name>
          <name>
            <surname>Bao</surname>
            <given-names>D</given-names>
          </name>
        </person-group>
        <article-title>miR-377-5p inhibits lung cancer cell proliferation, invasion, and cell cycle progression by targeting AKT1 signaling</article-title>
        <source>J Cell Biochem</source>
        <year>2019</year>
        <volume>120</volume>
        <issue>5</issue>
        <fpage>8120</fpage>
        <lpage>8128</lpage>
      </element-citation>
    </ref>
    <ref id="CR62">
      <label>62.</label>
      <element-citation publication-type="journal">
        <person-group person-group-type="author">
          <name>
            <surname>Zhang</surname>
            <given-names>Z-y</given-names>
          </name>
          <name>
            <surname>Gao</surname>
            <given-names>X-h</given-names>
          </name>
          <name>
            <surname>Ma</surname>
            <given-names>M-y</given-names>
          </name>
          <name>
            <surname>Zhao</surname>
            <given-names>C-l</given-names>
          </name>
          <name>
            <surname>Zhang</surname>
            <given-names>Y-l</given-names>
          </name>
          <name>
            <surname>Guo</surname>
            <given-names>S-s</given-names>
          </name>
        </person-group>
        <article-title>CircRNA_101237 promotes NSCLC progression via the miRNA-490-3p/MAPK1 axis</article-title>
        <source>Sci Rep</source>
        <year>2020</year>
        <volume>10</volume>
        <issue>1</issue>
        <fpage>1</fpage>
        <lpage>10</lpage>
        <pub-id pub-id-type="pmid">31913322</pub-id>
      </element-citation>
    </ref>
    <ref id="CR63">
      <label>63.</label>
      <element-citation publication-type="journal">
        <person-group person-group-type="author">
          <name>
            <surname>Kontos</surname>
            <given-names>CK</given-names>
          </name>
          <name>
            <surname>Papageorgiou</surname>
            <given-names>SG</given-names>
          </name>
          <name>
            <surname>Diamantopoulos</surname>
            <given-names>MA</given-names>
          </name>
          <name>
            <surname>Scorilas</surname>
            <given-names>A</given-names>
          </name>
          <name>
            <surname>Bazani</surname>
            <given-names>E</given-names>
          </name>
          <name>
            <surname>Vasilatou</surname>
            <given-names>D</given-names>
          </name>
          <name>
            <surname>Gkontopoulos</surname>
            <given-names>K</given-names>
          </name>
          <name>
            <surname>Glezou</surname>
            <given-names>E</given-names>
          </name>
          <name>
            <surname>Stavroulaki</surname>
            <given-names>G</given-names>
          </name>
          <name>
            <surname>Dimitriadis</surname>
            <given-names>G</given-names>
          </name>
        </person-group>
        <article-title>mRNA overexpression of the hypoxia inducible factor 1 alpha subunit gene (HIF1A): An independent predictor of poor overall survival in chronic lymphocytic leukemia</article-title>
        <source>Leuk Res</source>
        <year>2017</year>
        <volume>53</volume>
        <fpage>65</fpage>
        <lpage>73</lpage>
        <?supplied-pmid 28038356?>
        <pub-id pub-id-type="pmid">28038356</pub-id>
      </element-citation>
    </ref>
    <ref id="CR64">
      <label>64.</label>
      <element-citation publication-type="journal">
        <person-group person-group-type="author">
          <name>
            <surname>Rausch</surname>
            <given-names>SM</given-names>
          </name>
          <name>
            <surname>Gonzalez</surname>
            <given-names>BD</given-names>
          </name>
          <name>
            <surname>Clark</surname>
            <given-names>MM</given-names>
          </name>
          <name>
            <surname>Patten</surname>
            <given-names>C</given-names>
          </name>
          <name>
            <surname>Felten</surname>
            <given-names>S</given-names>
          </name>
          <name>
            <surname>Liu</surname>
            <given-names>H</given-names>
          </name>
          <name>
            <surname>Li</surname>
            <given-names>Y</given-names>
          </name>
          <name>
            <surname>Sloan</surname>
            <given-names>J</given-names>
          </name>
          <name>
            <surname>Yang</surname>
            <given-names>P</given-names>
          </name>
        </person-group>
        <article-title>SNPs in PTGS2 and LTA predict pain and quality of life in long term lung cancer survivors</article-title>
        <source>Lung Cancer</source>
        <year>2012</year>
        <volume>77</volume>
        <issue>1</issue>
        <fpage>217</fpage>
        <lpage>223</lpage>
        <?supplied-pmid 22464751?>
        <pub-id pub-id-type="pmid">22464751</pub-id>
      </element-citation>
    </ref>
    <ref id="CR65">
      <label>65.</label>
      <element-citation publication-type="journal">
        <person-group person-group-type="author">
          <name>
            <surname>Mohammadzadeh</surname>
            <given-names>Z</given-names>
          </name>
          <name>
            <surname>Omidkhoda</surname>
            <given-names>A</given-names>
          </name>
          <name>
            <surname>Chahardouli</surname>
            <given-names>B</given-names>
          </name>
          <name>
            <surname>Hoseinzadeh</surname>
            <given-names>G</given-names>
          </name>
          <name>
            <surname>Moghaddam</surname>
            <given-names>KA</given-names>
          </name>
          <name>
            <surname>Mousavi</surname>
            <given-names>SA</given-names>
          </name>
          <name>
            <surname>Rostami</surname>
            <given-names>S</given-names>
          </name>
        </person-group>
        <article-title>The impact of ICAM-1, CCL2 and TGM2 gene polymorphisms on differentiation syndrome in acute promyelocytic leukemia</article-title>
        <source>BMC Cancer</source>
        <year>2021</year>
        <volume>21</volume>
        <issue>1</issue>
        <fpage>1</fpage>
        <lpage>7</lpage>
        <pub-id pub-id-type="pmid">33397301</pub-id>
      </element-citation>
    </ref>
    <ref id="CR66">
      <label>66.</label>
      <element-citation publication-type="journal">
        <person-group person-group-type="author">
          <name>
            <surname>Zhou</surname>
            <given-names>C</given-names>
          </name>
          <name>
            <surname>Martinez</surname>
            <given-names>E</given-names>
          </name>
          <name>
            <surname>Di Marcantonio</surname>
            <given-names>D</given-names>
          </name>
          <name>
            <surname>Solanki-Patel</surname>
            <given-names>N</given-names>
          </name>
          <name>
            <surname>Aghayev</surname>
            <given-names>T</given-names>
          </name>
          <name>
            <surname>Peri</surname>
            <given-names>S</given-names>
          </name>
          <name>
            <surname>Ferraro</surname>
            <given-names>F</given-names>
          </name>
          <name>
            <surname>Skorski</surname>
            <given-names>T</given-names>
          </name>
          <name>
            <surname>Scholl</surname>
            <given-names>C</given-names>
          </name>
          <name>
            <surname>Fröhling</surname>
            <given-names>S</given-names>
          </name>
        </person-group>
        <article-title>JUN is a key transcriptional regulator of the unfolded protein response in acute myeloid leukemia</article-title>
        <source>Leukemia</source>
        <year>2017</year>
        <volume>31</volume>
        <issue>5</issue>
        <fpage>1196</fpage>
        <lpage>1205</lpage>
        <?supplied-pmid 27840425?>
        <pub-id pub-id-type="pmid">27840425</pub-id>
      </element-citation>
    </ref>
    <ref id="CR67">
      <label>67.</label>
      <mixed-citation publication-type="other">Mamoor S: Differential expression of nuclear receptor subfamily 3 group C member 1 in cancers of the breast. 2021.</mixed-citation>
    </ref>
    <ref id="CR68">
      <label>68.</label>
      <element-citation publication-type="journal">
        <person-group person-group-type="author">
          <name>
            <surname>Prochazka</surname>
            <given-names>KT</given-names>
          </name>
          <name>
            <surname>Pregartner</surname>
            <given-names>G</given-names>
          </name>
          <name>
            <surname>Rücker</surname>
            <given-names>FG</given-names>
          </name>
          <name>
            <surname>Heitzer</surname>
            <given-names>E</given-names>
          </name>
          <name>
            <surname>Pabst</surname>
            <given-names>G</given-names>
          </name>
          <name>
            <surname>Wölfler</surname>
            <given-names>A</given-names>
          </name>
          <name>
            <surname>Zebisch</surname>
            <given-names>A</given-names>
          </name>
          <name>
            <surname>Berghold</surname>
            <given-names>A</given-names>
          </name>
          <name>
            <surname>Döhner</surname>
            <given-names>K</given-names>
          </name>
          <name>
            <surname>Sill</surname>
            <given-names>H</given-names>
          </name>
        </person-group>
        <article-title>Clinical implications of subclonal TP53 mutations in acute myeloid leukemia</article-title>
        <source>Haematologica</source>
        <year>2019</year>
        <volume>104</volume>
        <issue>3</issue>
        <fpage>516</fpage>
        <?supplied-pmid 30309854?>
        <pub-id pub-id-type="pmid">30309854</pub-id>
      </element-citation>
    </ref>
    <ref id="CR69">
      <label>69.</label>
      <element-citation publication-type="journal">
        <person-group person-group-type="author">
          <name>
            <surname>Wen</surname>
            <given-names>Y</given-names>
          </name>
          <name>
            <surname>Huang</surname>
            <given-names>Z</given-names>
          </name>
          <name>
            <surname>Zhang</surname>
            <given-names>X</given-names>
          </name>
          <name>
            <surname>Gao</surname>
            <given-names>B</given-names>
          </name>
          <name>
            <surname>He</surname>
            <given-names>Y</given-names>
          </name>
        </person-group>
        <article-title>Correlation between PON1 gene polymorphisms and breast cancer risk: a Meta-analysis</article-title>
        <source>Int J Clin Exp Med</source>
        <year>2015</year>
        <volume>8</volume>
        <issue>11</issue>
        <fpage>20343</fpage>
        <?supplied-pmid 26884950?>
        <pub-id pub-id-type="pmid">26884950</pub-id>
      </element-citation>
    </ref>
    <ref id="CR70">
      <label>70.</label>
      <element-citation publication-type="journal">
        <person-group person-group-type="author">
          <name>
            <surname>Bobin-Dubigeon</surname>
            <given-names>C</given-names>
          </name>
          <name>
            <surname>Jaffré</surname>
            <given-names>I</given-names>
          </name>
          <name>
            <surname>Joalland</surname>
            <given-names>M-P</given-names>
          </name>
          <name>
            <surname>Classe</surname>
            <given-names>J-M</given-names>
          </name>
          <name>
            <surname>Campone</surname>
            <given-names>M</given-names>
          </name>
          <name>
            <surname>Hervé</surname>
            <given-names>M</given-names>
          </name>
          <name>
            <surname>Bard</surname>
            <given-names>J-M</given-names>
          </name>
        </person-group>
        <article-title>Paraoxonase 1 (PON1) as a marker of short term death in breast cancer recurrence</article-title>
        <source>Clin Biochem</source>
        <year>2012</year>
        <volume>45</volume>
        <issue>16–17</issue>
        <fpage>1503</fpage>
        <lpage>1505</lpage>
        <?supplied-pmid 22659076?>
        <pub-id pub-id-type="pmid">22659076</pub-id>
      </element-citation>
    </ref>
    <ref id="CR71">
      <label>71.</label>
      <element-citation publication-type="journal">
        <person-group person-group-type="author">
          <name>
            <surname>Küçükcankurt</surname>
            <given-names>F</given-names>
          </name>
          <name>
            <surname>Erbilgin</surname>
            <given-names>Y</given-names>
          </name>
          <name>
            <surname>Fırtına</surname>
            <given-names>S</given-names>
          </name>
          <name>
            <surname>Ng</surname>
            <given-names>ÖH</given-names>
          </name>
          <name>
            <surname>Karakaş</surname>
            <given-names>Z</given-names>
          </name>
          <name>
            <surname>Celkan</surname>
            <given-names>T</given-names>
          </name>
          <name>
            <surname>Ünüvar</surname>
            <given-names>A</given-names>
          </name>
          <name>
            <surname>Özbek</surname>
            <given-names>U</given-names>
          </name>
          <name>
            <surname>Sayitoğlu</surname>
            <given-names>M</given-names>
          </name>
        </person-group>
        <article-title>PTEN and AKT1 variations in childhood T-Cell acute lymphoblastic leukemia</article-title>
        <source>Turkish J Hematol</source>
        <year>2020</year>
        <volume>37</volume>
        <issue>2</issue>
        <fpage>98</fpage>
      </element-citation>
    </ref>
    <ref id="CR72">
      <label>72.</label>
      <element-citation publication-type="journal">
        <person-group person-group-type="author">
          <name>
            <surname>Kim</surname>
            <given-names>JW</given-names>
          </name>
          <name>
            <surname>Gautam</surname>
            <given-names>J</given-names>
          </name>
          <name>
            <surname>Kim</surname>
            <given-names>JE</given-names>
          </name>
          <name>
            <surname>Kim</surname>
            <given-names>J</given-names>
          </name>
          <name>
            <surname>Kang</surname>
            <given-names>KW</given-names>
          </name>
        </person-group>
        <article-title>Inhibition of tumor growth and angiogenesis of tamoxifen-resistant breast cancer cells by ruxolitinib, a selective JAK2 inhibitor</article-title>
        <source>Oncol Lett</source>
        <year>2019</year>
        <volume>17</volume>
        <issue>4</issue>
        <fpage>3981</fpage>
        <lpage>3989</lpage>
        <?supplied-pmid 30930994?>
        <pub-id pub-id-type="pmid">30930994</pub-id>
      </element-citation>
    </ref>
    <ref id="CR73">
      <label>73.</label>
      <element-citation publication-type="journal">
        <person-group person-group-type="author">
          <name>
            <surname>Elhoseiny</surname>
            <given-names>S</given-names>
          </name>
          <name>
            <surname>El-Wakil</surname>
            <given-names>M</given-names>
          </name>
          <name>
            <surname>Fawzy</surname>
            <given-names>M</given-names>
          </name>
          <name>
            <surname>Rahman</surname>
            <given-names>AA</given-names>
          </name>
        </person-group>
        <article-title>GSTP1 (Ile105Val) gene polymorphism: risk and treatment response in chronic myeloid leukemia</article-title>
        <source>J Cancer Ther</source>
        <year>2013</year>
        <volume>5</volume>
        <issue>01</issue>
        <fpage>1</fpage>
      </element-citation>
    </ref>
    <ref id="CR74">
      <label>74.</label>
      <element-citation publication-type="journal">
        <person-group person-group-type="author">
          <name>
            <surname>Kagita Sailaja</surname>
            <given-names>D</given-names>
          </name>
          <name>
            <surname>Rao</surname>
            <given-names>DN</given-names>
          </name>
          <name>
            <surname>Rao</surname>
            <given-names>DR</given-names>
          </name>
          <name>
            <surname>Vishnupriya</surname>
            <given-names>S</given-names>
          </name>
        </person-group>
        <article-title>Association of the GSTP1 gene (Ile105Val) polymorphism with chronic myeloid leukemia</article-title>
        <source>Asian Pac J Cancer Prev</source>
        <year>2010</year>
        <volume>11</volume>
        <issue>2</issue>
        <fpage>461</fpage>
        <lpage>464</lpage>
        <?supplied-pmid 20843134?>
        <pub-id pub-id-type="pmid">20843134</pub-id>
      </element-citation>
    </ref>
    <ref id="CR75">
      <label>75.</label>
      <element-citation publication-type="journal">
        <person-group person-group-type="author">
          <name>
            <surname>Rosette</surname>
            <given-names>C</given-names>
          </name>
          <name>
            <surname>Roth</surname>
            <given-names>RB</given-names>
          </name>
          <name>
            <surname>Oeth</surname>
            <given-names>P</given-names>
          </name>
          <name>
            <surname>Braun</surname>
            <given-names>A</given-names>
          </name>
          <name>
            <surname>Kammerer</surname>
            <given-names>S</given-names>
          </name>
          <name>
            <surname>Ekblom</surname>
            <given-names>J</given-names>
          </name>
          <name>
            <surname>Denissenko</surname>
            <given-names>MF</given-names>
          </name>
        </person-group>
        <article-title>Role of ICAM1 in invasion of human breast cancer cells</article-title>
        <source>Carcinogenesis</source>
        <year>2005</year>
        <volume>26</volume>
        <issue>5</issue>
        <fpage>943</fpage>
        <lpage>950</lpage>
        <?supplied-pmid 15774488?>
        <pub-id pub-id-type="pmid">15774488</pub-id>
      </element-citation>
    </ref>
    <ref id="CR76">
      <label>76.</label>
      <element-citation publication-type="journal">
        <person-group person-group-type="author">
          <name>
            <surname>Sawai</surname>
            <given-names>CM</given-names>
          </name>
          <name>
            <surname>Freund</surname>
            <given-names>J</given-names>
          </name>
          <name>
            <surname>Oh</surname>
            <given-names>P</given-names>
          </name>
          <name>
            <surname>Ndiaye-Lobry</surname>
            <given-names>D</given-names>
          </name>
          <name>
            <surname>Bretz</surname>
            <given-names>JC</given-names>
          </name>
          <name>
            <surname>Strikoudis</surname>
            <given-names>A</given-names>
          </name>
          <name>
            <surname>Genesca</surname>
            <given-names>L</given-names>
          </name>
          <name>
            <surname>Trimarchi</surname>
            <given-names>T</given-names>
          </name>
          <name>
            <surname>Kelliher</surname>
            <given-names>MA</given-names>
          </name>
          <name>
            <surname>Clark</surname>
            <given-names>M</given-names>
          </name>
        </person-group>
        <article-title>Therapeutic targeting of the cyclin D3: CDK4/6 complex in T cell leukemia</article-title>
        <source>Cancer Cell</source>
        <year>2012</year>
        <volume>22</volume>
        <issue>4</issue>
        <fpage>452</fpage>
        <lpage>465</lpage>
        <?supplied-pmid 23079656?>
        <pub-id pub-id-type="pmid">23079656</pub-id>
      </element-citation>
    </ref>
    <ref id="CR77">
      <label>77.</label>
      <element-citation publication-type="journal">
        <person-group person-group-type="author">
          <name>
            <surname>Zou</surname>
            <given-names>G</given-names>
          </name>
          <name>
            <surname>Zhang</surname>
            <given-names>X</given-names>
          </name>
          <name>
            <surname>Wang</surname>
            <given-names>L</given-names>
          </name>
          <name>
            <surname>Li</surname>
            <given-names>X</given-names>
          </name>
          <name>
            <surname>Xie</surname>
            <given-names>T</given-names>
          </name>
          <name>
            <surname>Zhao</surname>
            <given-names>J</given-names>
          </name>
          <name>
            <surname>Yan</surname>
            <given-names>J</given-names>
          </name>
          <name>
            <surname>Wang</surname>
            <given-names>L</given-names>
          </name>
          <name>
            <surname>Ye</surname>
            <given-names>H</given-names>
          </name>
          <name>
            <surname>Jiao</surname>
            <given-names>S</given-names>
          </name>
        </person-group>
        <article-title>Herb-sourced emodin inhibits angiogenesis of breast cancer by targeting VEGFA transcription</article-title>
        <source>Theranostics</source>
        <year>2020</year>
        <volume>10</volume>
        <issue>15</issue>
        <fpage>6839</fpage>
        <?supplied-pmid 32550907?>
        <pub-id pub-id-type="pmid">32550907</pub-id>
      </element-citation>
    </ref>
    <ref id="CR78">
      <label>78.</label>
      <element-citation publication-type="book">
        <person-group person-group-type="author">
          <name>
            <surname>Shah</surname>
            <given-names>NP</given-names>
          </name>
          <name>
            <surname>Cortes</surname>
            <given-names>JE</given-names>
          </name>
          <name>
            <surname>Martinelli</surname>
            <given-names>G</given-names>
          </name>
          <name>
            <surname>Smith</surname>
            <given-names>BD</given-names>
          </name>
          <name>
            <surname>Clarke</surname>
            <given-names>E</given-names>
          </name>
          <name>
            <surname>Copland</surname>
            <given-names>M</given-names>
          </name>
          <name>
            <surname>Strauss</surname>
            <given-names>L</given-names>
          </name>
          <name>
            <surname>Talpaz</surname>
            <given-names>M</given-names>
          </name>
        </person-group>
        <source>Dasatinib plus smoothened (SMO) inhibitor BMS-833923 in chronic myeloid leukemia (CML) with resistance or suboptimal response to a prior tyrosine kinase inhibitor (TKI): phase I study CA180323</source>
        <year>2014</year>
        <publisher-loc>In.</publisher-loc>
        <publisher-name>American Society of Hematology Washington, DC</publisher-name>
      </element-citation>
    </ref>
    <ref id="CR79">
      <label>79.</label>
      <element-citation publication-type="journal">
        <person-group person-group-type="author">
          <name>
            <surname>Bonapace</surname>
            <given-names>L</given-names>
          </name>
          <name>
            <surname>Coissieux</surname>
            <given-names>M-M</given-names>
          </name>
          <name>
            <surname>Wyckoff</surname>
            <given-names>J</given-names>
          </name>
          <name>
            <surname>Mertz</surname>
            <given-names>KD</given-names>
          </name>
          <name>
            <surname>Varga</surname>
            <given-names>Z</given-names>
          </name>
          <name>
            <surname>Junt</surname>
            <given-names>T</given-names>
          </name>
          <name>
            <surname>Bentires-Alj</surname>
            <given-names>M</given-names>
          </name>
        </person-group>
        <article-title>Cessation of CCL2 inhibition accelerates breast cancer metastasis by promoting angiogenesis</article-title>
        <source>Nature</source>
        <year>2014</year>
        <volume>515</volume>
        <issue>7525</issue>
        <fpage>130</fpage>
        <lpage>133</lpage>
        <?supplied-pmid 25337873?>
        <pub-id pub-id-type="pmid">25337873</pub-id>
      </element-citation>
    </ref>
    <ref id="CR80">
      <label>80.</label>
      <element-citation publication-type="journal">
        <person-group person-group-type="author">
          <name>
            <surname>Feigelson</surname>
            <given-names>HS</given-names>
          </name>
          <name>
            <surname>Teras</surname>
            <given-names>LR</given-names>
          </name>
          <name>
            <surname>Diver</surname>
            <given-names>WR</given-names>
          </name>
          <name>
            <surname>Tang</surname>
            <given-names>W</given-names>
          </name>
          <name>
            <surname>Patel</surname>
            <given-names>AV</given-names>
          </name>
          <name>
            <surname>Stevens</surname>
            <given-names>VL</given-names>
          </name>
          <name>
            <surname>Calle</surname>
            <given-names>EE</given-names>
          </name>
          <name>
            <surname>Thun</surname>
            <given-names>MJ</given-names>
          </name>
          <name>
            <surname>Bouzyk</surname>
            <given-names>M</given-names>
          </name>
        </person-group>
        <article-title>Genetic variation in candidate obesity genes ADRB2, ADRB3, GHRL, HSD11B1, IRS1, IRS2, and SHC1 and risk for breast cancer in the Cancer Prevention Study II</article-title>
        <source>Breast Cancer Res</source>
        <year>2008</year>
        <volume>10</volume>
        <issue>4</issue>
        <fpage>1</fpage>
        <lpage>11</lpage>
      </element-citation>
    </ref>
    <ref id="CR81">
      <label>81.</label>
      <element-citation publication-type="journal">
        <person-group person-group-type="author">
          <name>
            <surname>Correia</surname>
            <given-names>C</given-names>
          </name>
          <name>
            <surname>Schneider</surname>
            <given-names>PA</given-names>
          </name>
          <name>
            <surname>Dai</surname>
            <given-names>H</given-names>
          </name>
          <name>
            <surname>Dogan</surname>
            <given-names>A</given-names>
          </name>
          <name>
            <surname>Maurer</surname>
            <given-names>MJ</given-names>
          </name>
          <name>
            <surname>Church</surname>
            <given-names>AK</given-names>
          </name>
          <name>
            <surname>Novak</surname>
            <given-names>AJ</given-names>
          </name>
          <name>
            <surname>Feldman</surname>
            <given-names>AL</given-names>
          </name>
          <name>
            <surname>Wu</surname>
            <given-names>X</given-names>
          </name>
          <name>
            <surname>Ding</surname>
            <given-names>H</given-names>
          </name>
        </person-group>
        <article-title>BCL2 mutations are associated with increased risk of transformation and shortened survival in follicular lymphoma</article-title>
        <source>Blood J Am Soc Hematol</source>
        <year>2015</year>
        <volume>125</volume>
        <issue>4</issue>
        <fpage>658</fpage>
        <lpage>667</lpage>
      </element-citation>
    </ref>
    <ref id="CR82">
      <label>82.</label>
      <element-citation publication-type="journal">
        <person-group person-group-type="author">
          <name>
            <surname>Jin</surname>
            <given-names>H</given-names>
          </name>
          <name>
            <surname>Choi</surname>
            <given-names>H</given-names>
          </name>
          <name>
            <surname>Kim</surname>
            <given-names>ES</given-names>
          </name>
          <name>
            <surname>Lee</surname>
            <given-names>HH</given-names>
          </name>
          <name>
            <surname>Cho</surname>
            <given-names>H</given-names>
          </name>
          <name>
            <surname>Moon</surname>
            <given-names>A</given-names>
          </name>
        </person-group>
        <article-title>Natural killer cells inhibit breast cancer cell invasion through downregulation of urokinase-type plasminogen activator</article-title>
        <source>Oncol Rep</source>
        <year>2021</year>
        <volume>45</volume>
        <issue>1</issue>
        <fpage>299</fpage>
        <lpage>308</lpage>
        <?supplied-pmid 33155661?>
        <pub-id pub-id-type="pmid">33155661</pub-id>
      </element-citation>
    </ref>
    <ref id="CR83">
      <label>83.</label>
      <element-citation publication-type="journal">
        <person-group person-group-type="author">
          <name>
            <surname>Belfiore</surname>
            <given-names>L</given-names>
          </name>
          <name>
            <surname>Saunders</surname>
            <given-names>DN</given-names>
          </name>
          <name>
            <surname>Ranson</surname>
            <given-names>M</given-names>
          </name>
          <name>
            <surname>Vine</surname>
            <given-names>KL</given-names>
          </name>
        </person-group>
        <article-title>N-alkylisatin-loaded liposomes target the urokinase plasminogen activator system in breast cancer</article-title>
        <source>Pharmaceutics</source>
        <year>2020</year>
        <volume>12</volume>
        <issue>7</issue>
        <fpage>641</fpage>
      </element-citation>
    </ref>
    <ref id="CR84">
      <label>84.</label>
      <element-citation publication-type="journal">
        <person-group person-group-type="author">
          <name>
            <surname>Ibrahim</surname>
            <given-names>NY</given-names>
          </name>
          <name>
            <surname>Sami</surname>
            <given-names>RM</given-names>
          </name>
          <name>
            <surname>Nasr</surname>
            <given-names>AS</given-names>
          </name>
        </person-group>
        <article-title>GSTP1 and CYP1A1 gene polymorphisms and non-hodgkin lymphoma</article-title>
        <source>Lab Med</source>
        <year>2012</year>
        <volume>43</volume>
        <issue>4</issue>
        <fpage>22</fpage>
        <lpage>26</lpage>
      </element-citation>
    </ref>
    <ref id="CR85">
      <label>85.</label>
      <element-citation publication-type="journal">
        <person-group person-group-type="author">
          <name>
            <surname>Nakamichi</surname>
            <given-names>I</given-names>
          </name>
          <name>
            <surname>Tomita</surname>
            <given-names>Y</given-names>
          </name>
          <name>
            <surname>Zhang</surname>
            <given-names>B</given-names>
          </name>
          <name>
            <surname>Sugiyama</surname>
            <given-names>H</given-names>
          </name>
          <name>
            <surname>Kanakura</surname>
            <given-names>Y</given-names>
          </name>
          <name>
            <surname>Fukuhara</surname>
            <given-names>S</given-names>
          </name>
          <name>
            <surname>Hino</surname>
            <given-names>M</given-names>
          </name>
          <name>
            <surname>Kanamaru</surname>
            <given-names>A</given-names>
          </name>
          <name>
            <surname>Ogawa</surname>
            <given-names>H</given-names>
          </name>
          <name>
            <surname>Aozasa</surname>
            <given-names>K</given-names>
          </name>
        </person-group>
        <article-title>Correlation between promoter hypermethylation of GSTP1 and response to chemotherapy in diffuse large B cell lymphoma</article-title>
        <source>Ann Hematol</source>
        <year>2007</year>
        <volume>86</volume>
        <issue>8</issue>
        <fpage>557</fpage>
        <lpage>564</lpage>
        <?supplied-pmid 17508213?>
        <pub-id pub-id-type="pmid">17508213</pub-id>
      </element-citation>
    </ref>
    <ref id="CR86">
      <label>86.</label>
      <element-citation publication-type="journal">
        <person-group person-group-type="author">
          <name>
            <surname>Weiss</surname>
            <given-names>M</given-names>
          </name>
          <name>
            <surname>Michael</surname>
            <given-names>J</given-names>
          </name>
          <name>
            <surname>Pesce</surname>
            <given-names>A</given-names>
          </name>
          <name>
            <surname>DiPersio</surname>
            <given-names>L</given-names>
          </name>
        </person-group>
        <article-title>Heterogeneity of beta 2-microglobulin in human breast carcinoma</article-title>
        <source>Lab Invest J Tech Methods Pathol</source>
        <year>1981</year>
        <volume>45</volume>
        <issue>1</issue>
        <fpage>46</fpage>
        <lpage>57</lpage>
      </element-citation>
    </ref>
    <ref id="CR87">
      <label>87.</label>
      <mixed-citation publication-type="other">Nakashima M, Watanabe M, Nakano K, Uchimaru K, Horie R: Differentiation of Hodgkin lymphoma cells by reactive oxygen species and regulation by heme oxygenase‐1 through HIF‐1α. Cancer Science 2021.</mixed-citation>
    </ref>
    <ref id="CR88">
      <label>88.</label>
      <element-citation publication-type="journal">
        <person-group person-group-type="author">
          <name>
            <surname>Wang</surname>
            <given-names>F</given-names>
          </name>
          <name>
            <surname>Gatica</surname>
            <given-names>D</given-names>
          </name>
          <name>
            <surname>Ying</surname>
            <given-names>ZX</given-names>
          </name>
          <name>
            <surname>Peterson</surname>
            <given-names>LF</given-names>
          </name>
          <name>
            <surname>Kim</surname>
            <given-names>P</given-names>
          </name>
          <name>
            <surname>Bernard</surname>
            <given-names>D</given-names>
          </name>
          <name>
            <surname>Saiya-Cork</surname>
            <given-names>K</given-names>
          </name>
          <name>
            <surname>Wang</surname>
            <given-names>S</given-names>
          </name>
          <name>
            <surname>Kaminski</surname>
            <given-names>MS</given-names>
          </name>
          <name>
            <surname>Chang</surname>
            <given-names>AE</given-names>
          </name>
        </person-group>
        <article-title>Follicular lymphoma–associated mutations in vacuolar ATPase ATP6V1B2 activate autophagic flux and mTOR</article-title>
        <source>J Clin Investig</source>
        <year>2019</year>
        <volume>129</volume>
        <issue>4</issue>
        <fpage>1626</fpage>
        <lpage>1640</lpage>
        <?supplied-pmid 30720463?>
        <pub-id pub-id-type="pmid">30720463</pub-id>
      </element-citation>
    </ref>
    <ref id="CR89">
      <label>89.</label>
      <element-citation publication-type="journal">
        <person-group person-group-type="author">
          <name>
            <surname>Jeong</surname>
            <given-names>S</given-names>
          </name>
          <name>
            <surname>Kim</surname>
            <given-names>BG</given-names>
          </name>
          <name>
            <surname>Kim</surname>
            <given-names>DY</given-names>
          </name>
          <name>
            <surname>Kim</surname>
            <given-names>BR</given-names>
          </name>
          <name>
            <surname>Kim</surname>
            <given-names>JL</given-names>
          </name>
          <name>
            <surname>Park</surname>
            <given-names>SH</given-names>
          </name>
          <name>
            <surname>Na</surname>
            <given-names>YJ</given-names>
          </name>
          <name>
            <surname>Jo</surname>
            <given-names>MJ</given-names>
          </name>
          <name>
            <surname>Yun</surname>
            <given-names>HK</given-names>
          </name>
          <name>
            <surname>Jeong</surname>
            <given-names>YA</given-names>
          </name>
        </person-group>
        <article-title>Cannabidiol overcomes oxaliplatin resistance by enhancing NOS3-and SOD2-induced autophagy in human colorectal cancer cells</article-title>
        <source>Cancers</source>
        <year>2019</year>
        <volume>11</volume>
        <issue>6</issue>
        <fpage>781</fpage>
      </element-citation>
    </ref>
    <ref id="CR90">
      <label>90.</label>
      <element-citation publication-type="journal">
        <person-group person-group-type="author">
          <name>
            <surname>Eskelund</surname>
            <given-names>CW</given-names>
          </name>
          <name>
            <surname>Dahl</surname>
            <given-names>C</given-names>
          </name>
          <name>
            <surname>Hansen</surname>
            <given-names>JW</given-names>
          </name>
          <name>
            <surname>Westman</surname>
            <given-names>M</given-names>
          </name>
          <name>
            <surname>Kolstad</surname>
            <given-names>A</given-names>
          </name>
          <name>
            <surname>Pedersen</surname>
            <given-names>LB</given-names>
          </name>
          <name>
            <surname>Montano-Almendras</surname>
            <given-names>CP</given-names>
          </name>
          <name>
            <surname>Husby</surname>
            <given-names>S</given-names>
          </name>
          <name>
            <surname>Freiburghaus</surname>
            <given-names>C</given-names>
          </name>
          <name>
            <surname>Ek</surname>
            <given-names>S</given-names>
          </name>
        </person-group>
        <article-title>TP53 mutations identify younger mantle cell lymphoma patients who do not benefit from intensive chemoimmunotherapy</article-title>
        <source>Blood J Am Soc Hematol</source>
        <year>2017</year>
        <volume>130</volume>
        <issue>17</issue>
        <fpage>1903</fpage>
        <lpage>1910</lpage>
      </element-citation>
    </ref>
    <ref id="CR91">
      <label>91.</label>
      <element-citation publication-type="journal">
        <person-group person-group-type="author">
          <name>
            <surname>Zenz</surname>
            <given-names>T</given-names>
          </name>
          <name>
            <surname>Kreuz</surname>
            <given-names>M</given-names>
          </name>
          <name>
            <surname>Fuge</surname>
            <given-names>M</given-names>
          </name>
          <name>
            <surname>Klapper</surname>
            <given-names>W</given-names>
          </name>
          <name>
            <surname>Horn</surname>
            <given-names>H</given-names>
          </name>
          <name>
            <surname>Staiger</surname>
            <given-names>AM</given-names>
          </name>
          <name>
            <surname>Winter</surname>
            <given-names>D</given-names>
          </name>
          <name>
            <surname>Helfrich</surname>
            <given-names>H</given-names>
          </name>
          <name>
            <surname>Huellein</surname>
            <given-names>J</given-names>
          </name>
          <name>
            <surname>Hansmann</surname>
            <given-names>ML</given-names>
          </name>
        </person-group>
        <article-title>TP53 mutation and survival in aggressive B cell lymphoma</article-title>
        <source>Int J Cancer</source>
        <year>2017</year>
        <volume>141</volume>
        <issue>7</issue>
        <fpage>1381</fpage>
        <lpage>1388</lpage>
        <?supplied-pmid 28614910?>
        <pub-id pub-id-type="pmid">28614910</pub-id>
      </element-citation>
    </ref>
    <ref id="CR92">
      <label>92.</label>
      <element-citation publication-type="journal">
        <person-group person-group-type="author">
          <name>
            <surname>Sainz</surname>
            <given-names>J</given-names>
          </name>
          <name>
            <surname>Rudolph</surname>
            <given-names>A</given-names>
          </name>
          <name>
            <surname>Hein</surname>
            <given-names>R</given-names>
          </name>
          <name>
            <surname>Hoffmeister</surname>
            <given-names>M</given-names>
          </name>
          <name>
            <surname>Buch</surname>
            <given-names>S</given-names>
          </name>
          <name>
            <surname>Von Schönfels</surname>
            <given-names>W</given-names>
          </name>
          <name>
            <surname>Hampe</surname>
            <given-names>J</given-names>
          </name>
          <name>
            <surname>Schafmayer</surname>
            <given-names>C</given-names>
          </name>
          <name>
            <surname>Völzke</surname>
            <given-names>H</given-names>
          </name>
          <name>
            <surname>Frank</surname>
            <given-names>B</given-names>
          </name>
        </person-group>
        <article-title>Association of genetic polymorphisms in ESR2, HSD17B1, ABCB1, and SHBG genes with colorectal cancer risk</article-title>
        <source>Endocrine Related Cancer</source>
        <year>2011</year>
        <volume>18</volume>
        <issue>2</issue>
        <fpage>265</fpage>
        <?supplied-pmid 21317201?>
        <pub-id pub-id-type="pmid">21317201</pub-id>
      </element-citation>
    </ref>
    <ref id="CR93">
      <label>93.</label>
      <mixed-citation publication-type="other">Mashhadi MA, Arbabi N, Sargazi S, Kazemi-Lomedasht F, Jahantigh D, Miri-Moghaddam E: Association of VEGFA gene polymorphisms with susceptibility to non-Hodgkin's lymphoma: Evidences from population-based and in silico studies. Gene Rep 2020, 20:100696.</mixed-citation>
    </ref>
    <ref id="CR94">
      <label>94.</label>
      <element-citation publication-type="journal">
        <person-group person-group-type="author">
          <name>
            <surname>Kiyohara</surname>
            <given-names>C</given-names>
          </name>
          <name>
            <surname>Yoshimasu</surname>
            <given-names>K</given-names>
          </name>
          <name>
            <surname>Takayama</surname>
            <given-names>K</given-names>
          </name>
          <name>
            <surname>Nakanishi</surname>
            <given-names>Y</given-names>
          </name>
        </person-group>
        <article-title>NQO1, MPO, and the risk of lung cancer: a HuGE review</article-title>
        <source>Genet Med</source>
        <year>2005</year>
        <volume>7</volume>
        <issue>7</issue>
        <fpage>463</fpage>
        <lpage>478</lpage>
        <?supplied-pmid 16170238?>
        <pub-id pub-id-type="pmid">16170238</pub-id>
      </element-citation>
    </ref>
    <ref id="CR95">
      <label>95.</label>
      <element-citation publication-type="journal">
        <person-group person-group-type="author">
          <name>
            <surname>Wang</surname>
            <given-names>Y-Z</given-names>
          </name>
          <name>
            <surname>Wu</surname>
            <given-names>K-P</given-names>
          </name>
          <name>
            <surname>Wu</surname>
            <given-names>A-B</given-names>
          </name>
          <name>
            <surname>Yang</surname>
            <given-names>Z-C</given-names>
          </name>
          <name>
            <surname>Li</surname>
            <given-names>J-M</given-names>
          </name>
        </person-group>
        <article-title>Mo Y-l, Xu M, Wu B, Yang Z-x: MMP-14 overexpression correlates with poor prognosis in non-small cell lung cancer</article-title>
        <source>Tumor Biol</source>
        <year>2014</year>
        <volume>35</volume>
        <issue>10</issue>
        <fpage>9815</fpage>
        <lpage>9821</lpage>
      </element-citation>
    </ref>
    <ref id="CR96">
      <label>96.</label>
      <element-citation publication-type="journal">
        <person-group person-group-type="author">
          <name>
            <surname>Zhou</surname>
            <given-names>H</given-names>
          </name>
          <name>
            <surname>Wu</surname>
            <given-names>A</given-names>
          </name>
          <name>
            <surname>Fu</surname>
            <given-names>W</given-names>
          </name>
          <name>
            <surname>Lv</surname>
            <given-names>Z</given-names>
          </name>
          <name>
            <surname>Zhang</surname>
            <given-names>Z</given-names>
          </name>
        </person-group>
        <article-title>Significance of semaphorin-3A and MMP-14 protein expression in non-small cell lung cancer</article-title>
        <source>Oncol Lett</source>
        <year>2014</year>
        <volume>7</volume>
        <issue>5</issue>
        <fpage>1395</fpage>
        <lpage>1400</lpage>
        <?supplied-pmid 24765144?>
        <pub-id pub-id-type="pmid">24765144</pub-id>
      </element-citation>
    </ref>
    <ref id="CR97">
      <label>97.</label>
      <mixed-citation publication-type="other">Jung YY, Jung WH, Koo JS: BRAF mutation in breast cancer by BRAF V600E mutation-specific antibody. 2016.</mixed-citation>
    </ref>
    <ref id="CR98">
      <label>98.</label>
      <element-citation publication-type="journal">
        <person-group person-group-type="author">
          <name>
            <surname>Kloth</surname>
            <given-names>M</given-names>
          </name>
          <name>
            <surname>Ruesseler</surname>
            <given-names>V</given-names>
          </name>
          <name>
            <surname>Engel</surname>
            <given-names>C</given-names>
          </name>
          <name>
            <surname>Koenig</surname>
            <given-names>K</given-names>
          </name>
          <name>
            <surname>Peifer</surname>
            <given-names>M</given-names>
          </name>
          <name>
            <surname>Mariotti</surname>
            <given-names>E</given-names>
          </name>
          <name>
            <surname>Kuenstlinger</surname>
            <given-names>H</given-names>
          </name>
          <name>
            <surname>Florin</surname>
            <given-names>A</given-names>
          </name>
          <name>
            <surname>Rommerscheidt-Fuss</surname>
            <given-names>U</given-names>
          </name>
          <name>
            <surname>Koitzsch</surname>
            <given-names>U</given-names>
          </name>
        </person-group>
        <article-title>Activating ERBB2/HER2 mutations indicate susceptibility to pan-HER inhibitors in Lynch and Lynch-like colorectal cancer</article-title>
        <source>Gut</source>
        <year>2016</year>
        <volume>65</volume>
        <issue>8</issue>
        <fpage>1296</fpage>
        <lpage>1305</lpage>
        <?supplied-pmid 26001389?>
        <pub-id pub-id-type="pmid">26001389</pub-id>
      </element-citation>
    </ref>
    <ref id="CR99">
      <label>99.</label>
      <element-citation publication-type="journal">
        <person-group person-group-type="author">
          <name>
            <surname>Maurer</surname>
            <given-names>CA</given-names>
          </name>
          <name>
            <surname>Friess</surname>
            <given-names>H</given-names>
          </name>
          <name>
            <surname>Kretschmann</surname>
            <given-names>B</given-names>
          </name>
          <name>
            <surname>Zimmermann</surname>
            <given-names>A</given-names>
          </name>
          <name>
            <surname>Stauffer</surname>
            <given-names>A</given-names>
          </name>
          <name>
            <surname>Baer</surname>
            <given-names>HU</given-names>
          </name>
          <name>
            <surname>Korc</surname>
            <given-names>M</given-names>
          </name>
          <name>
            <surname>Buchler</surname>
            <given-names>MW</given-names>
          </name>
        </person-group>
        <article-title>Increased expression of erbB3 in colorectal cancer is associated with concomitant increase in the level of erbB2</article-title>
        <source>Hum Pathol</source>
        <year>1998</year>
        <volume>29</volume>
        <issue>8</issue>
        <fpage>771</fpage>
        <lpage>777</lpage>
        <?supplied-pmid 9712416?>
        <pub-id pub-id-type="pmid">9712416</pub-id>
      </element-citation>
    </ref>
    <ref id="CR100">
      <label>100.</label>
      <element-citation publication-type="journal">
        <person-group person-group-type="author">
          <name>
            <surname>Zhuoyu</surname>
            <given-names>G</given-names>
          </name>
          <name>
            <surname>Siyuan</surname>
            <given-names>L</given-names>
          </name>
          <name>
            <surname>Xiao</surname>
            <given-names>Z</given-names>
          </name>
          <name>
            <surname>Zhou</surname>
            <given-names>T</given-names>
          </name>
          <name>
            <surname>Jun</surname>
            <given-names>L</given-names>
          </name>
        </person-group>
        <article-title>Expression and role of MMP-14 protein in invasion and metastasis of stomach carcinoma</article-title>
        <source>Chongqing Med</source>
        <year>2015</year>
        <volume>10</volume>
        <fpage>1364</fpage>
        <lpage>1366</lpage>
      </element-citation>
    </ref>
    <ref id="CR101">
      <label>101.</label>
      <element-citation publication-type="journal">
        <person-group person-group-type="author">
          <name>
            <surname>Wong</surname>
            <given-names>CI</given-names>
          </name>
          <name>
            <surname>Yap</surname>
            <given-names>HL</given-names>
          </name>
          <name>
            <surname>Lim</surname>
            <given-names>SG</given-names>
          </name>
          <name>
            <surname>Guo</surname>
            <given-names>JY</given-names>
          </name>
          <name>
            <surname>Goh</surname>
            <given-names>BC</given-names>
          </name>
          <name>
            <surname>Lee</surname>
            <given-names>SC</given-names>
          </name>
        </person-group>
        <article-title>Lack of somatic ErbB2 tyrosine kinase domain mutations in hepatocellular carcinoma</article-title>
        <source>Hepatol Res</source>
        <year>2008</year>
        <volume>38</volume>
        <issue>8</issue>
        <fpage>838</fpage>
        <lpage>841</lpage>
        <?supplied-pmid 18462377?>
        <pub-id pub-id-type="pmid">18462377</pub-id>
      </element-citation>
    </ref>
    <ref id="CR102">
      <label>102.</label>
      <element-citation publication-type="journal">
        <person-group person-group-type="author">
          <name>
            <surname>Bekaii-Saab</surname>
            <given-names>T</given-names>
          </name>
          <name>
            <surname>Williams</surname>
            <given-names>N</given-names>
          </name>
          <name>
            <surname>Plass</surname>
            <given-names>C</given-names>
          </name>
          <name>
            <surname>Calero</surname>
            <given-names>MV</given-names>
          </name>
          <name>
            <surname>Eng</surname>
            <given-names>C</given-names>
          </name>
        </person-group>
        <article-title>A novel mutation in the tyrosine kinase domain of ERBB2 in hepatocellular carcinoma</article-title>
        <source>BMC Cancer</source>
        <year>2006</year>
        <volume>6</volume>
        <issue>1</issue>
        <fpage>1</fpage>
        <lpage>5</lpage>
        <pub-id pub-id-type="pmid">16390557</pub-id>
      </element-citation>
    </ref>
  </ref-list>
</back>
